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ABSTRACT OF THE DISSERTATION 
GLYCEMIC CONTROL: RISK FACTORS, QUALITY OF LIFE, WORKFORCE 
PARTICIPATION, AND MORTALITY AMONG US ADULTS WITH TYPE 2 
DIABETES 
by 
Evelyn Patricia Davila 
Florida International University, 2010 
Miami, Florida 
Professor Theophile Niyonsenga, Major Professor 
Despite research showing the benefits of glycemic control, it remains suboptimal 
among adults with diabetes in the United States. Possible reasons include unaddressed 
risk factors as well as lack of awareness of its immediate and long term consequences.  
The objectives of this study were to, using cross-sectional data, 1) ascertain the 
association between suboptimal (Hemoglobin A1c (HbA1c) ≥7%), borderline (HbA1c 7-
8.9%), and poor (HbA1c ≥9%) glycemic control and potentially new risk factors (e.g. 
work characteristics), and 2) assess whether aspects of poor health and well-being such as 
poor health related quality of life (HRQOL), unemployment, and missed-work are 
associated with glycemic control; and 3) using prospective data, assess the relationship 
between mortality risk and glycemic control in US adults with type 2 diabetes. Data from 
the 1988-1994 and 1999-2004 National Health and Nutrition Examination Surveys were 
used. HbA1c values were used to create dichotomous glycemic control indicators. Binary 
logistic regression models were used to assess relationships between risk factors, 
employment status and glycemic control. Multinomial logistic regression analyses were 
 vi
conducted to assess relationships between glycemic control and HRQOL variables. Zero-
inflated Poisson regression models were used to assess relationships between missed 
work days and glycemic control. Cox-proportional hazard models were used to assess 
effects of glycemic control on mortality risk. Using STATA software, analyses were 
weighted to account for complex survey design and non-response. Multivariable models 
adjusted for socio-demographics, body mass index, among other variables.  Results 
revealed that being a farm worker and working over 40 hours/week were risk factors for 
suboptimal glycemic control. Having greater days of poor mental was associated with 
suboptimal, borderline, and poor glycemic control. Having greater days of inactivity was 
associated with poor glycemic control while having greater days of poor physical health 
was associated with borderline glycemic control. There were no statistically significant 
relationships between glycemic control, self-reported general health, employment, and 
missed work. Finally, having an HbA1c value less than 6.5% was protective against 
mortality. The findings suggest that work-related factors are important in a person’s 
ability to reach optimal diabetes management levels. Poor glycemic control appears to 
have significant detrimental effects on HRQOL.  
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CHAPTER I. 
INTRODUCTION 
Overview 
Diabetes mellitus is one of the most serious chronic diseases in the United States 
(US) and in the world. In the US alone, diabetes affects an estimated 7.0% (20.8 million) 
of the total population, and another 54 million are at risk.1 The prevalence of diabetes in 
the US is expected to rise in the future given the continued increase in the prevalence of 
associated risk factors such as older age, obesity, and minority race and ethnicity (e.g. 
Blacks and Hispanics).2  Projections have indicated that the prevalence of diabetes will 
increase to 366 million worldwide by the year 2030,3 with 39 million in the US by the 
year 2050.4 In the US, the death rate for diabetes increased by 45% from 1970 to 2002,5 
and in 2006, diabetes was the sixth leading cause of death in the US.6  In addition to the 
high risk of mortality associated with diabetes, diabetes is also associated with great 
morbidity and disability. For example, among adults over 20 years of age, diabetes is the 
leading cause of blindness, leg amputations, and kidney disease.1, 7 Consequently, both 
indirect (e.g. due to disability, unemployment, premature death) and direct (e.g. medical 
costs including hospitalizations and treatment) costs associated with diabetes are high, 
with the total costs estimated at about $174 billion, of which $116 billion are medical.7 In 
fact, the medical expenditures among those individuals with diabetes are estimated to be 
more than twice of those without.7 Therefore, the public health and economic burden 
associated with diabetes is large and is likely to increase.  
Diabetes is generally diagnosed using a fasting plasma glucose test with a glucose 
result of 126 mg/dl after an eight-hour fast or by a two hour oral glucose tolerance test 
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with a glucose result of 200 mg/dl or more.8 Diabetes is primarily categorized as type 1 
or type 2. Type 1 diabetes is the least common, accounting for less than 10% of all cases; 
it is caused by almost complete lack of insulin secretion, usually due to the autoimmune 
destruction of pancreatic beta cells.9 Type 2 diabetes is much more common accounting 
for 90-95% of cases. Type 2 diabetes is characterized by impaired insulin secretion that 
could arise due to insulin resistance and it is highly associated with obesity.9 Although 
diabetes can be diagnosed at any age, individuals diagnosed at an older age are usually 
diagnosed with type 2 diabetes.  Regardless of the classification of diabetes, the outcome 
is the same, namely high levels of blood glucose or hyperglycemia due to a combination 
of an increase in insulin resistance, a decrease in beta cell function, and a decrease in 
insulin secretion by the pancreas.1 
People can live with diabetes without major complications as long as it is well 
controlled and managed. The aim of diabetes management is to adequately maintain 
normal blood glucose levels (i.e. 70-130 mg/dl) in order to prevent microvascular (e.g., 
retinopathy, neuropathy, nephropathy) and macrovascular (e.g., peripheral vascular or 
cardiovascular disease [CVD]) complications.10  A key element in diabetes management 
is glycemic control, which may be indicated by a person’s HbA1c. The hemoglobin A1C 
test measures the percent of glucose in the bloodstream attached to hemoglobin 
molecules in the previous two to three months, which is the lifespan of red blood cells. 
Thus, the more excess glucose in the bloodstream, the higher the percentage of 
hemoglobin molecules attached, the higher the HbA1c level. This test has been 
considered the gold standard for assessing glycemic control in diabetes care for the last 
25 years.10, 11 Although there are other methods of assessing glycemic control, the HbA1c 
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test has been shown to be better than serum fructosamine tests because the latter only 
measures glycemic control in the last 2 weeks.12 Although continuous (daily) blood 
glucose monitoring would provide the most accurate evaluation of a person’s average 
blood glucose levels, the HbA1c test is more practical, less costly, and more convenient 
than continuous blood glucose monitoring.  
Several guidelines for glycemic control currently exist. The American Diabetes 
Association (ADA) treatment goals for glycemic control recommend HbA1c values of < 
7.0%.9  The International Diabetes Federation and the American Association of Clinical 
Endocrinologists (AACE) recommend an HbA1c value of <6.5 %.13 However, an HbA1c 
value of <7.0% is not always realistic for individuals who are older and with several co-
existing conditions and/or those facing terminal illness.14 Thus, two commonly used 
thresholds for glycemic control are a HbA1c value of > 7%, which is generally 
considered suboptimal glycemic control, and a HbA1c value of > 9%, which is an 
indicator of poor glycemic control and more often used as a target value for patients in 
worse health (e.g., greater comorbidity and/or terminally ill).15-18   
 Research has shown clear evidence of the benefits of good glycemic control in 
terms of diabetes-related complications. For example, it has been noted that a 1% 
decrease in the HbA1c value can lead to a 10% reduction in risk of coronary artery 
disease.19, 20 Moreover, good glycemic control has been associated with fewer diabetic 
complications and better metabolic control.11  Studies have also shown that 
macrovascular and microvascular complications are related to poor glycemic control. For 
example, poor glycemic control has been associated with severe periodontitis,21 incidence 
of proteinuria and symptoms consistent with diabetic neuropathy,22 and elevated C-
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reactive protein, a marker of systemic inflammation and risk factor for cardiovascular 
disease.23  
Given the medical benefits of good glycemic control, strong efforts by public 
health advocates and the medical community have been made to improve glycemic 
control among adults with diabetes. For example, national diabetes programs, targeted at 
the general public, such as the National Diabetes Education Program have launched 
campaigns like the “Control the ABC’s” campaign, which stresses the importance of the 
HbA1c test, in addition to frequent blood pressure and cholesterol check-ups.24 The 
Diabetes Quality Improvement Project is another diabetes program that has been 
developed in order to improve diabetes management.25  This program’s mission is to 
develop a set of standardized performance and outcome measures in order to make equal 
comparisons of diabetes management health care plans across the US.25  
Despite research showing the importance of lower HbA1c levels for preventing 
diabetic complications and despite public health efforts towards diabetes management, 
glycemic control remains a serious public health problem in the US. For example, in the 
1980s and 1990s, only about 37% of US adults diagnosed with diabetes had HbA1c 
levels < 7% (i.e. optimal glycemic control).25 Others have noted that 18% of the US 
population with diabetes in the 1980s and 1990s had HbA1c values of >9.5%.26 More 
recent data have shown slight improvements, yet still about 44% of the population with 
diabetes has an HbA1c value of suboptimal glycemic control.27  
There are several possible reasons why adults with diabetes are not reaching 
optimal (i.e. HbA1c of <7%) or good (HbA1c of < 9%) glycemic control. One of the 
reasons could be the presence of unknown risk factors for suboptimal or poor glycemic 
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control that may be acting as barriers to proper diabetes management. Another reason 
could be the fact that information about the known morbidity outcomes does not promote 
a sense of urgency to the individuals with diabetes that would otherwise motivate them to 
adhere to their diabetes treatment regimen. Thus, it is important to assess potentially new 
risk factors for suboptimal, borderline, and poor glycemic control, as well as to learn 
about the consequences of suboptimal, borderline, and poor glycemic control other than 
those that are traditionally studied and reported (e.g., macrovascular and microvascuar 
complications).  
The objectives of this study were to: 1) ascertain whether suboptimal, borderline, 
or poor glycemic control are associated with factors such as numbers of hours worked, 
type of occupation, secondhand smoke (SHS) exposure, and desire to lose weight in US 
adults with type 2 diabetes; 2) assess whether aspects of poor health and well-being such 
as poor quality of life, unemployment and missed work days are associated with 
suboptimal, borderline, and poor glycemic control in US adults with type 2 diabetes; and 
3) assess the relationship between the risk of mortality and suboptimal, borderline, and 
poor glycemic control in US adults with type 2 diabetes.  
 
Research questions and hypotheses 
This research used secondary, cross-sectional data from a nationally 
representative sample survey (1999-2004 NHANES) and a prospective study design 
(1988-1994 NHANES and its linked mortality file) to assess the relationship between 
suboptimal, borderline, and poor glycemic control and potentially four new risk factors i) 
number of hours worked per week, (ii) type of occupation, (iii) SHS exposure, and (iv) 
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desire to lose weight. In addition, this study assessed the relationship between 
suboptimal, borderline, and poor glycemic control and employment status, absenteeism 
and mortality. NHANES is a series of population based surveys conducted by the Centers 
for Disease Control and Prevention (CDC) and designed to monitor several aspects of 
health, thereby providing a nationally representative picture of the health and nutritional 
status of the US population.28 A summary of the research questions and hypotheses for 
this study is shown in figure 1.  
 
Figure 1. A diagrammatic view of study hypotheses   
 Research Question 1:                                                   Research Questions 2 and 3: 
 
 
Research Question 1: Are suboptimal (HbA1c > 7%), borderline (HbA1c 7-
8.9%),  and poor (HbA1c > 9%) glycemic control associated with potentially new risk 
factors such as i) number of hours worked per week, (ii) type of occupation, (iii) SHS 
Suboptimal/ 
borderline/poor 
glycemic control 
Employed in 
service or blue- 
collar industry 
Greater hours 
worked 
Secondhand smoke 
exposure 
Desire to lose 
weight 
Greater days of 
inactivity, poor 
mental, and 
physical health    
Greater missed 
work days  
Unemployment  
All-cause and 
CVD mortality   
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exposure, and (iv) desire to lose weight among US adults with type 2 diabetes? This 
question leads to the following hypotheses. 
Hypothesis 1a: Suboptimal, borderline, and poor glycemic control are associated 
with greater number of hours worked per week after controlling for potential confounders 
such as (i) duration of diagnosis, (ii) body mass index (BMI), (iii) alcohol use, (iv) 
greater number of non-CVD chronic conditions, (v) family history of diabetes, (vi) 
insurance status, (vii) sex, (viii) physical activity, (ix) diabetes treatment, and (x) 
race/ethnicity.  
Hypothesis 1b: Suboptimal, borderline, and poor glycemic control are associated 
with occupational groups with greater time constraints or demands such as blue collar 
and service workers versus white collar workers after controlling for potential 
confounders such as (i) duration of diagnosis, (ii) BMI, (iii) alcohol use, (iv) greater 
number of non-CVD chronic conditions, (v) family history of diabetes, (vi) insurance 
status, (vii) sex, (viii) physical activity, (ix) diabetes treatment, and (x) race/ethnicity.  
Hypothesis 1c: Among self-reported non-smokers, suboptimal, borderline, and 
poor glycemic control are associated with being exposed to secondhand smoke after 
controlling for potential confounders such as (i) duration of diagnosis, (ii) BMI, (iii) 
alcohol use, (iv) greater number of non-CVD chronic conditions, (v) family history of 
diabetes, (vi) insurance status, (vii) sex, (viii) physical activity, (ix) diabetes treatment, 
and (x) race/ethnicity.  
Hypothesis 1d: Suboptimal, borderline, and poor glycemic control are associated 
with desire to lose weight after controlling for potential confounders such as (i) duration 
of diagnosis, (ii) BMI, (iii) alcohol use, (iv) greater number of non-CVD chronic 
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conditions, (v) family history of diabetes, (vi) insurance status, (vii) sex, (viii) physical 
activity, (ix) diabetes treatment, and (x) race/ethnicity.  
 Research Question 2: Are a) health-related quality of life (HRQOL) measures 
indicative of poor health [i.e. (i) poor self-reported general health and greater number of 
days (ii) poor physical health, (iii) poor mental health and (iv) limited activity in the past 
30 days]; b) greater days of missed work in the past 12 months (i.e. absenteeism), and c) 
unemployment, associated with suboptimal (HbA1c > 7%), borderline (HbA1c 7-8.9%), 
and poor (HbA1c > 9%) glycemic control among US adults with type 2 diabetes, after 
controlling for potential confounders (mentioned in hypothesis 1)? This research question 
leads to the following hypotheses: 
 Hypothesis 2a: All four HRQOL measures are associated with suboptimal, 
borderline, and poor glycemic control, after controlling for potential confounders.  
 Hypothesis 2b: Greater number of missed work days in the past 12 months is 
associated with suboptimal, borderline, and poor glycemic control, after controlling for 
potential confounders.  
 Hypothesis 2c: Unemployment is associated with suboptimal, borderline, and 
poor glycemic controls, after controlling for potential confounders.  
Research Question 3: Greater mortality risk among are associated with suboptimal 
(HbA1c > 7%), borderline (HbA1c 7-8.9%), and poor (HbA1c > 9%) glycemic control 
among US adults with type 2 diabetes after controlling for potential confounders as noted 
in hypothesis 1? Two hypotheses are derived from this research question. 
 Hypothesis 3a: All-cause mortality risk is associated with suboptimal, borderline, 
and poor glycemic control, after controlling for potential confounders.  
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 Hypothesis 3b: CVD mortality risk is associated with suboptimal, borderline, and 
poor glycemic control, after controlling for potential confounders. 
 
Significance of the present study 
Results from this study will provide information of public health significance for 
several reasons. First, by using a nationally representative sample of adults, this proposed 
study will allow generalization of the findings related to glycemic control among US 
adults with a self-reported diagnosis of diabetes. Second, by using a large nationally 
representative database, a comprehensive and thorough statistical assessment of the 
relationship between potentially new risk factors (e. g. type of occupation, hours worked, 
secondhand smoke exposure, and desire to lose weight) with suboptimal, borderline, and 
poor glycemic control, while adjusting for potential confounders, will be possible. Third, 
by studying the relationship between glycemic control and HRQOL, as well as 
employment and absenteeism, a better understanding of the overall well-being and the 
disability/dysfunction associated with poorly managed diabetes will be gained; thus, 
providing an estimate of the impact of disease that is not obtained in traditional morbidity 
and mortality outcome measures.29 Fourth, by studying the association between glycemic 
control and mortality risk using prospective data, the long-term benefits due to good 
diabetes management will be elucidated. 
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CHAPTER II. 
LITERATURE REVIEW 
Overview 
The literature search for this study included a comprehensive review of scientific articles 
in English available in databases such as MEDLINE using MeSH and keywords such as 
glycemic control, A1C, diabetes management, diabetes control, hemoglobin, diabetes 
treatment, among others from all years, as early as from 1950. In addition, articles that 
were found to be relevant from these searchers were used to capture additional articles by 
examining their reference lists as well as by looking at others who cited them. The 
literature review is presented separately for each research question and hypothesis.   
 
Risk factors of suboptimal and poor glycemic control  
There have been several national and international studies assessing factors 
associated with poor glycemic control such as (i) minority race-ethnicity (e.g. Blacks and 
Hispanics), (ii) older age, (iii) male sex, (iv) drinking alcohol, (v) longer duration of 
diabetes, (vi) diabetes treatment (e.g., insulin or oral antidiabetic drugs), (vii) lack of 
insurance, (viii) having a CVD-related comorbidity (e.g. hypercholesterolemia, 
hypertension, microalbuminuria, kidney disease), (ix) positive family history of diabetes, 
BMI, smoking, (x) greater physical activity, (xi) lack of adherence to diabetes 
management, and (xii) certain non-CVD chronic conditions (such as depression).30-39  
Though these traditionally studied factors are important in glycemic control, research has 
suggested that other factors such as work characteristics (e.g. an individual’s occupation40 
and the number of hours worked per week),41, 42 secondhand smoke exposure,43 and the 
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desire to lose weight may also influence glycemic control; yet the nature of the 
relationship between these factors and glycemic control has not been well studied.  
 
Potentially new risk factors for suboptimal and poor glycemic control 
Work constitutes an important part of most adult lives, and under several 
conditions can be the cause of the ill health. Thus, it is possible that glycemic control is 
also affected by work factors. However, few studies exist relating work characteristics 
with glycemic control among adults with diabetes.  
The number of hours a person works is one factor that may be associated with 
poor glycemic control. Indeed, it is plausible that individuals working long hours are less 
likely to be able to properly manage their diabetes due to the lack of time to check their 
blood glucose levels, inject insulin, take oral agents when necessary, or eat well-balanced 
meals at regular time intervals, all factors that may affect glucose levels. Furthermore, 
research has shown that individuals with diabetes do consider their disease as an issue of 
concern affecting the type of jobs they seek, as well as the breaks and the work schedule 
they need.44, 45 Although work-hours alone have not been linked to glycemic control, a 
related variable, job stress, has been associated with greater HbA1c levels even among 
employed individuals without diabetes in non-US studies.42, 46, 47  Job stress, a term used 
to describe the psychological and physiological effects resulting from being employed in 
a high pressure and pace job coupled with lack of workplace decision or control, has even 
been associated with other cardiovascular risk factors.48-51   
Work characteristics including the length of and control over work schedules may 
also affect glycemic control. In fact, commercial truck drivers reported problems 
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regulating their glucose levels and have blamed their unhealthy dietary patterns due to 
being on the road.52  In relation to diabetes, certain occupations that are characterized as 
having high work demands (e.g. long work hours with limited breaks) have been shown 
to have a higher prevalence of diabetes.53  For example, in a study of industrial factory 
workers in Japan, Japanese transport workers (e.g. those picking up and delivering 
factory materials) were shown to have greater risk of developing type 2 diabetes, 
compared to Japanese managers, clerical workers, and technical workers, even after 
adjusting for obesity and other potential confounders.54 Industrial male workers and 
female nurses have also been shown to have greater risk of type 2 diabetes.41, 55 
Nonetheless, office workers have also been shown to be at lower risk for incidence of 
diabetes.56 In the only known study relating occupation to glycemic control, which was 
based on data of adults with diabetes in New Zealand, the authors showed that glycemic 
control, as measured by fructosamine levels, did not vary by type of occupation (i.e. no 
difference found among administrative, clerical/sales/service, skilled trades, and 
unskilled manual workers).57 Given the few studies relating occupation to glycemic 
control diabetes,41, 54-57 more research is needed to determine the association between 
glycemic control and occupational factors.  
Another factor that has not been fully investigated but is gaining recognition as a 
major determinant of several chronic conditions is passive smoking, also known as SHS 
exposure or environmental tobacco smoke. Aside from its effects on lung and respiratory 
functions, SHS exposure has been associated with greater acute coronary syndromes and 
an increase in inflammatory markers.58 Research has shown that there is an association 
between diabetes and smoking.59 Specifically, studies have shown that smoking 
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contributes to worse metabolic control among individuals with diabetes,60 greater 
likelihood of both microvascular61 and macrovascular complications,62 and worse 
glycemic control.63, 64 There have been fewer studies on the relationship between SHS 
and diabetes.43, 65 Nevertheless, these studies have shown a relationship between SHS and 
glucose intolerance among young adults43 as well as incidence of diabetes.65 To date, 
there are very few if any studies, to the author’s knowledge based on a robust MEDLINE 
search of published articles since 1950, investigating the effects of SHS and glycemic 
control.   
 Another potential risk factor for suboptimal and poor glycemic control is an 
individual’s desire to lose weight or control their weight. For example, it is possible that 
some adults with diabetes who want to lose or control their weight avoid taking insulin as 
recommended by their physician knowing that weight gain is one of the potential side 
effects of insulin use.66-69 Thus, not taking insulin when needed may result in poor 
glycemic control, particularly if the individual has other unhealthy dietary  and eating 
behaviors. In fact, poor glycemic control has been found among adolescents and young 
adult females with eating disorders70-72 and among adolescents that perceived themselves 
as being overweight.73 Furthermore, not taking insulin in order to avoid weight gain is 
actually considered one of the DSM-IV diagnostic criteria for bulimia.72 However, there 
are very few if any studies specifically assessing the relationship between the desire to 
lose weight and glycemic control among US adults with diabetes.  
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Consequences of suboptimal and poor glycemic control  
Increasing the years of healthy life and improving the quality of life (QOL) are 
some of the overarching goals of Healthy People 2010.74 Although the term QOL is 
mostly used by the social sciences, in public health and the medical professions, the focus 
has been placed on the concept of Health Related Quality of life (HRQOL). The CDC 
defines HRQOL as an individual’s “perceived physical and mental health over time”, a 
measure which provides a better insight into how an illness or condition can affect 
everyday life.75 In general, HRQOL indicators can be thought of as a way to assess 
overall disability and poor function resulting from a disease or condition, aspects that 
may not be determined when looking at traditional measures of morbidity and 
mortality.76 In addition, HRQOL measures can be especially useful when assessing the 
long term consequences of chronic conditions since poor disease management can take 
years to develop as a clinical or medical outcome,77 impairing a person’s overall health 
status and well-being, particularly one’s mental health.  
Since the 1990s, there has been growing interest in HRQOL, partly due to the 
growth of the US aging and chronically-ill population.76 Consequently, the CDC 
developed four “core” HRQOL questions, also referred to as “Core Healthy Day” 
measures, which were first included in the Behavioral Risk Factor Surveillance System 
(BRFSS) in 1993, and were then included in the National Health and Nutrition 
Examination Surveys (NHANES) beginning with the 2001-2002 cycle. These four 
questions measure: 1) overall self-rated general health [fair/poor versus excellent/very 
good/good]; 2) physical health based on the number of days with poor physical health in 
the past 30 days; 3) mental health based on the number of days with poor mental and 
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emotional health in the past 30 days; and 4) disability and loss in productivity based on 
the number of days with activity limitation in the past 30 days. These core HRQOL 
questions have been found to have an acceptable validity and reliability when compared 
to the Medical Outcomes Short-Form 36 (SF-36).78  The SF-36 is a validated instrument 
with 36 questions about perceived health status and number of disability days, and is 
considered the gold standard for evaluating overall health including physical and mental 
health.78 
 
Diabetes, glycemic control and health related quality of life 
 Individuals with diabetes have been shown to have poor quality of life.79 One of 
the reasons for such poor quality of life could be the increased number of daily medical 
(or health) responsibilities adults diagnosed with diabetes have. The constant reminder of 
the importance and necessity of responsibilities and activities such as taking insulin or 
oral diabetic medication at regular time intervals (e.g. after consuming certain meals or 
performing various physical activities) can take its toll in a person’s life.79  In fact, 
because of the potential effects on HRQOL, it is believed that some physicians delay the 
initiation of insulin treatment, although a study showed that initiation of insulin treatment 
does not necessarily alter quality of life in a negative way.80 Nevertheless, it is possible 
that adults with diabetes have poor quality of life because of the health complications 
related to poorly managed diabetes, such as retinopathy, neuropathy, and cardiovascular 
conditions.77, 81, 82 Furthermore, given that fewer diabetic complications are found among 
those with better glycemic control, HRQOL is likely to be associated with glycemic 
control. However, the effect of glycemic control on HRQOL among diabetics is not clear. 
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Indeed, while some studies have found poor glycemic control to be associated with poor 
quality of life,83-85 other studies have not found any association.86-89  For example, 
functional disability, which is a component of HRQOL, has shown an inconsistent 
relationship with glycemic control among adults with diabetes.90, 91 
 None of the studies relating QOL and glycemic control were based on a nationally 
representative data of adults with diabetes. In addition, the discrepancies in the results of 
these studies could be a function of the different QOL measurement instruments 
employed. For example, while some studies have used what are known as “generic” QOL 
measures such as those developed and used by the CDC, others have used more “illness 
oriented” measures that are developed specifically for health conditions such as  diabetes 
and include the Diabetes Qualify of Life Measure, the Diabetes Treatment Satisfaction 
Questionnaire, and the Problem Areas in Diabetes.77, 79 Thus, there is a need of nationally 
representative studies aimed at understanding the association between poor glycemic 
control and HRQOL among US adults with diabetes using validated measures.  
 
Workforce participation: unemployment and absenteeism 
As the US population continues to change, so does the US workforce. 
Specifically, the workforce is expected to become increasingly diverse with growing 
number of elderly and minority workers. In fact, Hispanics are projected to represent 
17% of the workforce by 2020, an increase of 11% from the1980s.40 Moreover, by the 
year 2012, there will be over 40 million American workers aged 65 and older.92 Since the 
elderly, racial and ethnic subgroups such as Hispanics and Blacks are known to have a 
higher prevalence of many chronic health conditions such as diabetes,93 the number of 
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workers with these chronic conditions is expected to steadily increase. The consequences 
of these increases are likely to adversely impact workplace productivity, resulting in 
economic losses not only to the individual or the employer, but also to the nation as a 
whole.94  Furthermore, a person’s employment status, and consequently economic status, 
may directly influence their access to health care and their ability to pay for medications 
or treatment requirements, which in turn affect proper management of the disease, and 
therefore may worsen patient prognosis.  In addition to employment status, the number of 
missed work days is another individual-level measure for monitoring the impact of 
chronic disease on worker productivity. Missed work or “absenteeism” may provide a 
reflection of the disability that is experienced by diabetics with poor health and well-
being that may perhaps not be obtainable by employment statistics.95, 96 The disability 
and consequently diminished productivity at work may be of particular concern for 
employers given the financial implications such as decreased productivity.  
 
Workforce participation and glycemic control 
There are various studies assessing the relationship between diabetes status and 
workforce participation.  For example, studies have shown that diabetics are both less 
likely to be represented in the workforce and more likely to miss work,57, 97-99 particularly 
among those individuals with more severe diabetic complications.94, 100, 101 
What makes some adults with diabetes more likely to miss work or be unemployed 
versus other adults with diabetes is not entirely clear. However, one of the reasons could 
be a person’s level of glycemic control.  
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There are few studies assessing the relationship between glycemic control and 
workforce participation.  In a double-blind randomized controlled trial of adults with type 
2 diabetes, the treatment group with more strict diabetes treatment regimens (e.g. lower 
HbA1c target) had a more favorable outcome in terms of retained employment and less 
absenteeism.102 In a cross-sectional study of diabetic patients from Michigan, having 
more hours of missed work in the past month was associated with poor glycemic 
control.103 However, in a study of adults with diabetes referred to a multi-center diabetes 
program in the US, there appeared to be no significant relationship between glycemic 
control and the risk of days lost from school or work even after controlling for 
confounders.104 Thus, the association between glycemic control and missed work days 
requires further study.  
 
Glycemic control and mortality risk   
Along with improved quality of life and reduction in health disparity, increased 
life expectancy is a major goal of Healthy People 2010. Most studies that have assessed 
the relationship between glycemic control and mortality have been based on international 
studies, adults without diabetes, and/or chronically-ill populations. These studies have 
found that greater mortality risk is associated with poor glycemic control. For example, 
greater mortality risk among advanced chronic kidney disease and dialysis patients with 
poor glycemic control has been observed.105-107  In a prospective study of individuals in 
the United Kingdom to assess the relationship between HbA1c levels and all-cause and 
CVD mortality (after a 6 year follow-up), it was shown that the all-cause and CVD 
mortality risk increased with greater HbA1c levels.108   
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Furthermore, most of the studies investigating the relationship between diabetes 
management measures (e.g., fasting blood glucose, HbA1c) and CVD events, including 
mortality risk, have been primarily of men.108 The few studies that do exist among 
women have suggested differences in risk for CVD events and/or mortality, with most of 
them noting a lower mortality risk among women.108-110  Some studies have even found a 
counterintuitive relationship between HbA1c and mortality, suggesting that strict diabetic 
treatment regimes may eventually be more harmful than beneficial in certain populations 
such as those with greater comorbidity.111, 112 Thus, more research is needed to determine 
the association between glycemic control and mortality risk among US adults with 
diabetes. 
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CHAPTER III. 
METHODOLOGY 
Overview 
 This study used cross-sectional secondary data from a nationally representative 
survey sample (1988-1994 NHANES [also known as NHANES III] and 1999-2004 
NHANES) to assess the relationship between four potentially new risk factors (type of 
occupation, number of hours worked per week, SHS exposure, and desire to lose weight) 
and suboptimal, borderline, and poor glycemic control. In addition, this study estimated 
the association between suboptimal, borderline, and poor glycemic control and 
employment status, missed work, and mortality.  
 
Sample and description of data sets 
The National Health and Nutrition Examination Survey (NHANES) is a health 
survey developed by the National Center for Health Statistics (NCHS) to gather 
information about the health status of the US population. NHANES uses a stratified, 
multi-stage complex probability design that allows for a nationally representative 
estimation of the non-institutionalized US population.28  
Briefly, the sampling scheme in NHANES consists of four stages. The first stage 
involves selecting primary sampling units (PSU) from the entire nation. These are 
approximately the size of a large county or several small ones. The second stage involves 
the PSU units being divided in to small sections, usually about the size of city blocks. 
The third stage consists of selecting households at random within each of the sectors. 
Finally, stage four is where individuals are chosen from selected households, and 
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selection is based on age-sex-race screening strata. Weights are based on the probability 
of a person being selected at each of these stages. Sampling weights are created to 
provide unbiased national estimates, and are adjusted for non-response and then post-
stratified to match with the US population census counts of subpopulations.28  
NHANES data are collected by a trained team of professionals through a series of 
in-person interviews and medical examinations conducted at mobile examination clinics 
or at home. All NHANES data are de-identified, with only sequential numbers 
identifying each participant in order to protect participant confidentiality. Most NHANES 
data files are public-use files and the NHANES files used in this study were all public-
use files that were downloaded from the NCHS website. The NHANES III linked 
Mortality File used in this study was the public-use file that contains data of the major 
causes of death (i.e. not specific cause of death) from the National Death Index, with 
follow-up through December 31, 2000.113 Depending on the hypotheses being tested in 
this study, different NHANES survey years were used. The reason for this is because not 
all variables were available in all survey years. In addition, depending on the sampling 
methodology, NCHS does not recommend merging of the older NHANES (i.e. 1988-
1994) with the more recent NHANES survey years.  NHANES 1999-2004 was used for 
hypotheses 1, 2b, and 2c for utilized.  NHANES 2001-2004 was used for hypothesis 2a, 
while NHANES 1988-1994 and its Mortality file for hypothesis 3a and 3b was used.  
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Inclusion and exclusion criteria 
Individuals with a self-report of diabetes, aged 20 years or older, and not pregnant 
were included in the study.  Individuals defined as having type 1 diabetes were excluded; 
the remaining sample was considered to have type 2 diabetes, as defined in previous 
studies.31, 36, 40  
 
Variables used for inclusion/exclusion criteria: 
Self-report of diabetes: This was a categorical variable defined as: 1) yes and 2) 
no, based to the question “Other than during pregnancy, have you been ever been told by 
a physician that you have diabetes or sugar diabetes?”  Participants who were diagnosed 
with diabetes before the age of 30 (see variable question below), and were treated with 
insulin only were further classified as having type 1 diabetes. This definition is consistent 
with that used in previous studies utilizing NHANES data and is due to the agreement 
within clinicians that an individual diagnosed with diabetes before the age of 30 is more 
likely to have type 1 diabetes, but since type 2 diabetes is becoming more prevalent 
among youth, taking insulin only is likely a result of having type 1 diabetes.31, 36, 40 Those 
individuals considered not to have type 1 diabetes, were classified as having type 2 
diabetes, a definition consistent with previous NHANES analyses.31, 36, 40  
Age at diabetes diagnosis: This was a continuous variable expressed in years 
based on the question “How old were you when a doctor or health care professional told 
you that you had diabetes or sugar diabetes?” and asked among all individuals that self-
reported being diagnosed with diabetes.  
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Outcome and predictor variables:  
Glycemic control: the HbA1c value was a continuous variable expressed as a 
percentage of glucose in the bloodstream that is attached to hemoglobin molecules.  
Suboptimal and poor glycemic control: An individual with a HbA1c value equal 
to or greater than 7% was said to have suboptimal glycemic control. On the other hand, 
an individual with a HbA1c value equal to or greater than 9% was said to have poor 
glycemic control. To be consistent with many of the studies using glycemic control 
variables, suboptimal glycemic control was defined as: 1) yes, if HbA1c > 7%, and 2) no, 
if HbA1c < 7% (reference group); while poor glycemic control was defined as:  1) yes, if 
HbA1c > 9%, and 2) no, if HbA1c < 9% (reference group).  
Since a response of “yes” to the suboptimal glycemic control variable actually 
includes individuals with poor glycemic control and there are clinical differences or 
manifestations between suboptimal and poor glycemic control, a third glycemic control 
variable was also created, labeled “borderline” glycemic control, for the purposes of this 
study. This variable was defined as: 1) yes if HbA1c >7% but HbA1c <9%, and 2) no, if 
HbA1c < 7% (reference group); thus, for this variable all individuals with HbA1c >9% 
were excluded from the analyses.  All analyses were repeated for this new glycemic 
control variable.  
In the 1999-2004 NHANES, glycosylated hemoglobin in whole blood was 
measured by the Diabetes Diagnostic Laboratory at the University of Missouri-Columbia 
using Primus CLC330 and Primus CLC 385 (Primus Corporation, Kansas City, MO) 
with a high performance liquid chromatography system among all participants age 12 
years of age or older.114 Several quality control procedures were taken to ensure accuracy 
 24 
  
of measures. These measures included verifying and repeating plasma (or blood) 
specimens of HbA1c that were above 14% or below 4% (the accepted range for HbA1c 
measures were from 2% to 20%).114 From the measurements that were repeated, a few 
were selected at random and the coefficient of variation (CV) calculated. The CV 
provides an estimate of the amount of dispersion in the measure, in other words, how 
much one measure differs from the second measure taken, with a lower CV indicating 
lower dispersion and less measurement error. The CV for these specimens ranged from 
1.53 to 1.29, which indicates adequate similarity in the specimens when repeated.114 
Health related quality of life: HRQOL was based on four different variables: self-
rated general health, number of days of poor mental health, days of poor physical health, 
and days of activity limitation. Each HRQOL measure, except for the general health 
variable, was categorized into three levels in order to be consistent with previous studies 
while the general health variable was dichotomized.115, 116  
 General health: General health was a categorical variable based on the question 
“Would you say your health in general is fair, poor, good, very good, and excellent?” It 
was recoded to include only two categories: 1) fair/poor and 2) good/very good/excellent 
(reference group).  
 Days with poor mental health: This was a discrete variable expressed in days and 
based on the question “Now thinking about your mental health, which includes stress, 
depression, and problems with emotions, for how many days during the past 30 days was 
your mental health not good?.” This variable was recoded into a categorical variable as 
follows: 1) > 14 days, 2) 1-13 days, and 3) none (reference group).  
 Days with poor physical health: This was a discrete variable expressed as days, 
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and based on the question “Now thinking about your physical health, which includes 
physical illness and injury, for how many days during the past 30 days was your physical 
health not good?.” For purpose of the analyses, this variable was redefined into a 
categorical variable as follows: 1) ≥ 14 days, 2) 1-13 days, 3) none (reference group). 
 Days with limited activity: This was a discrete variable expressed as days, and 
based on the question “During the past 30 days, for about how many days did poor 
physical or mental health keep you from doing your usual activities, such as self-care, 
work, school or recreation?.” For the analyses, this variable was redefined into a 
categorical variable as follows: 1) ≥14 days, 2) 1-13 days, and 3) none (reference group). 
All-causes and CVD mortality:  The all-cause mortality variable was defined 
consistent with NCHS standards. Among participants in the NHANES III file, those that 
were found in the NHANES III Linked Mortality public-use file were considered dead, 
but if the person was not found in the file than the person was assumed alive.113, 117 
Briefly, this linkage was conducted by the NCHS and was done by a probabilistic match 
of information from participants aged 17 years or older in NHANES III with information 
from the National Death Index through December 31, 2000 to determine mortality status. 
More detail about the matching on mortality conducted by NCHS can be found 
elsewhere.113, 117 Verification of correct matches was also conducted by NCHS staff. The 
underlying causes of death were based on the International Classification of Diseases 
(ICD), 9th and 10th Revision Clinical Modification and were grouped by the NCHS staff 
into a standard list of 113 death categories. The CVD mortality variable was defined 
based on the ICD-10 variable for CVD mortality, and coded as: 1) yes, and 2) no. The yes 
category corresponds to ICD-10 deaths codes: I10-I13, I20-I25, I44-I49, I50, I60-I69, and 
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I70-I78.113, 117  The no category corresponds to anyone who died from another cause. 
Person-years of follow-up is included as a variable in the NHANES III linked mortality 
data file and were calculated by NCHS staff by subtracting the NHANES III examination 
date (as listed in the NHANES III data file) from the date of follow-up (when the death 
status was ascertained).  
 Desire to lose weight: This was a categorical variable based on the question 
“Would you like to weigh less, about the same, or more.” For the purposes of the present 
analyses, this variable was defined as: 1) less, and 2) about the same or more (reference 
group). 
Employment status: This was a categorical variable based on the question “Did 
you work last week (at a job or business)?” This variable was defined as: 1) yes, and 2) 
no (reference group).  
 Numbers of hours worked: This was a numeric variable expressed in hours, based 
on the question “How many hours did you work last week at all jobs or businesses?” 
Along with using this variable as a numeric variable, it was also categorized into three 
categories: 1) 1-20 hours (to include those with part-time or less), 2) 21-40 (to include 
those with more than a part-time and inclusive of full-time, and 3) 41+ (to include those 
considered generally to be working overtime). These categories were partially based on 
the definitions of part-time, full-time, and over-time employment based on federal labor 
laws, particularly over-time work which is defined as more than 40 hours by the Bureau 
of Labor Statistics.118, 119  
 Number of missed work days (absenteeism): This was a variable expressed in days 
based on the question “During the past 12 months, about how many days did you miss 
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work at a job or business because of an illness or injury (do not include maternity leave)?  
Type of occupation: This was a categorical variable based on the NCHS industry 
codes.120 This variable was collapsed into four NCHS occupational groups: 1) white 
collar, 2) blue collar, 3) service, and 4) farm worker, as done in previous studies.121 
 Smoking status: This was a categorical variable created from several variables to 
have the following categories: 1) non-smoker with undetectable cotinine (reference 
group), 2) non-smoker with detectable cotinine, and 3) smoker. For this study, smoking 
status was defined as a combination of self-report and serum cotinine levels. Current 
smokers were participants who answered yes to the question “Do you smoke cigarettes 
now?”, and/or with serum cotinine levels >15 ng/mL.122 Participants who answered yes 
to the question “Does anyone who lives [with you] smoke cigarettes, cigars, or pipes 
anywhere inside this home?” and/or had had a serum cotinine level at or above the level 
of detection but below < 15 ng/ml, and reported not being current smokers were 
categorized as being exposed to secondhand smoke. Non-exposed non-smokers were 
participants who reported being former smokers or never smoking, no reported home 
secondhand smoke, and had cotinine levels below the detection limit. The detection limit 
for NHANES III and NHANES 1999-2000 surveys was 0.035 ng/ml, while for NHANES 
2001-2004 it was 0.015 ng/ml.123, 124 
 
Potential confounding variables 
Confounding variables that were tested included the following:  
Sex was a categorical variable defined as: 1) female (reference group), 2) male. 
Age group in years was a continuous variable that was also categorized as 
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follows: 1) 20-44 (reference group), 2) 45-64, and 3) 65 or more. Most analyses used the 
categorized variable in order to be consistent with the other continuous variables that 
were categorized, such as body mass index.  
 Race/ethnicity was a categorical variable defined as: 1) non-Hispanic White 
(reference group), 2) non-Hispanic Black, 3) Hispanic, and 4) other.  
 Educational level was a categorical variable defined as: 1) less than high school 
(reference group), 2) high school graduate or equivalent, and 3) > high school.  
 Marital status was a categorical variable defined as: 1) not married (reference 
group), and 2) married/with partner. The not married category included responses of 
single, divorced, and widowed, while the married category included living with partner.  
 Alcohol consumer was a categorical variable created based on the question “In 
your entire life did you drink at least 12 drinks of any type of alcoholic beverage?”.  It 
was defined as: 1) no, and 2) yes. This question was the only question related to alcohol 
that was used because of the large number of missing data for the other alcohol-related 
questions that exist in the NHANES data files. 
 Insurance status was a categorical variable defined as: 1) uninsured (reference 
group), and 2) insured.  
 Physical activity (PA) level was a categorical variable defined as 1) vigorous, 2) 
moderate, and 3) none (reference group). “Vigorous” was a response of yes to the 
question: “Over the past 30 days did you do any vigorous PA for at least 10 minutes that 
caused heavy sweating, or large increases in breathing or heart rate?. “Moderate” was a 
response of yes to the question “Over the past 30 days did you do any moderate PA for at 
least 10 minutes that caused heavy sweating, or large increases in breathing or heart 
 29 
  
rate?” but no to the question of vigorous physical activity. A response of “no” to both the 
vigorous or moderate physical activity questions was defined as none. [Note: Although 
NHANES has other questions related to PA, these were the ones that where consistently 
asked from 1999-2004 and contained the least missing data. 
 Measured BMI group (kg/m2) was continuous variable that was redefined into a 
categorical variable as: 1) BMI < 25 (reference group), 2) BMI 25-29.9, and 3) BMI >30.  
 Take insulin was a dichotomous variable based on the self report of currently 
taking insulin defined as: 1) yes take insulin, and 2) do not take insulin (reference group). 
 Take anti-diabetic pills was a dichotomous variable based on self-report of taking 
diabetic pills defined as: 1) yes take diabetic pills, and 2) do not take diabetic pills 
(reference group). 
Duration of diabetes was a numeric variable expressed in number of years based 
on the variable for age of diabetes diagnosis and the variable for age.  
 Hypertension diagnosis was a categorical variable defined as: 1) no (reference), 
and 2) yes.  
 Total cholesterol (milligrams (mg)/deciliter(dl) was a continuous variable 
expressed in mg/dl. 
 Albumin/creatinine ratio was a continuous variable based on a formula using two 
other variables: urinary albumin divided by urinary creatinine.   
 Percent (%) carbs in diet was a continuous variable representing the percent of 
calories in the diet that came from carbohydrates and was based on a formula using two 
separate questions in the nutrition file of NHANES: the number of total calories in the 
diet and the number of calories from carbohydrates consumed (derived based on grams of 
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carbohydrates consumed in the previous day; a 24 hour diet recall).  
 Cancer history was a created as a dichotomous variable based on the following 
two questions: “Has a doctor ever told you had skin cancer?” and “Has a doctor ever told 
you had other cancer?”  A response of yes to either of the questions was defined as: 1) 
yes, while a response of no to both question was defined as 2) no (reference group).  
 History of stroke or heart failure was a dichotomous variable based on the 
following two questions: “Has a doctor ever told you had a stroke” and “Has a doctor 
ever told you had  congestive heart failure.” A response of yes to either question was 
defined as 1) yes, while a response of no to both questions was defined as 2) no 
(reference group).   
 Presence of asthma was a dichotomous variable based on the questions: “has a 
doctor ever told you had asthma” and “do you still have asthma?”  A response of yes to 
both was defined as 1) yes, while a response of no to these two questions was defined as 
2) no (reference group).  
 
Sample weight variables  
Each sampled person has a sampling weight providing unbiased national 
estimates.  NHANES surveys use an unequal selection probability design.  It is 
particularly important to know the weights when analyzing NHANES data because the 
NHANES oversamples some subgroups that may be of greater public health interest (e.g. 
African Americans). Weights are created by calculating a base weight (the reciprocal of 
the final probability of selection at each stage), then adjusting for non-response, and 
finally adjusting for post-stratification.28   
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Sample weight variables are calculated by the NCHS in two-year increments. For 
the continuous NHANES 1999-2002, a sample weight variable was created by NCHS 
(based on population estimates by the Bureau of the Census before the 2000 Decennial 
Census counts prior to public release), and can be obtained from the demographic data 
files for both cycles.28 The variable name for the weight variable depends on the type of 
data that are being investigated in the analysis and what data exists for the individuals in 
the study. Only one weight variable is typed in the command line in the STATA software 
for the analyses, and this weight variable is the one for the data file with a smaller sample 
size. For example, the questionnaire data files are those that have data on questions asked 
to participants while the laboratory files are those files that have data on blood or urine 
samples drawn from participants. Since it is more feasible and inexpensive to ask only 
questions in person rather than collect urine and blood samples, not all individuals have 
laboratory data. If one is interested in data from the laboratory file and an individual exist 
in both the questionnaire and laboratory files, then the weight variable for the laboratory 
file would be used.  
As detailed in the NCHS documentation,28 each survey participant has several 
weights given differences in overall response rates to different survey components (e.g. 
home interview versus physical examination or laboratory specimen collection) as well as 
differences in population estimates provided from the Bureau of the Census for each 
given year. When using the NHANES III data file, we used the NCHS weight variable 
labeled wtpfhx6, which is the weight variable to be used for survey participants who had 
not only in-person interview data but also examination and laboratory data.125  
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Because we analyzed pooled NHANES data across years 1999 to 2004, we 
created a 6-year sample weight variable for these analyses. In addition, we also created a 
4-year sample weight for analyses involving data from survey years 2001-2004.  These 
variables had to be created since NHANES data files only contain 2-year sample weights 
and a 4 year sample weight for NHANES 1999-2004. The 6-year (1999-2004) sample 
weight variable was created as follows: 1) the 4-year sample weight variable created by 
NCHS staff for participants sampled from 1999-2002 (labeled by NCHS as MEC4YR) 
was downloaded, 2) the 2-year sample weight created by NCHS staff for participants 
sampled from 2003-2004 (labeled by NCHS as MEC2YR) was downloaded,  3) a new 
variable was created based on the multiplication of the MEC4YR variable by 2/3 if the 
participant was sampled from the 1999-2000 or the 2001-2002 survey years data file and 
multiplication by 1/3 if the participant was sampled from the 2003-2004 survey years 
data file. The multiplication by 2/3 was done for participants sampled from 1999-2002 
because they are contributing 2/3 of the total 6 years of weights while the multiplication 
by 1/3 was done for participants sampled from 2003-2004 because they are contributing 
only 1/3 of the total 6 years of weights.  The 2001-2004 weight variable was created by 
dividing the weight from the 2001-2002 or the 2003-2004 by half, depending on which of 
the two 2-year survey cycles the person was sampled in.  
 
Primary sampling units (PSU) and strata variables: 
 The NHANES uses various methods and survey software to calculate sampling 
errors, which is used to determine the reliability of the statistics performed. These 
variables, however, are not disclosed to the public. Variances thus need to be calculated 
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based on masked variance units (MVUs). Variance units are based on strata and PSU 
variables. The NCHS created these PSU and strata variables and has them available in all 
NHANES data files. These variables are labeled sdmvpsu and sdmvstra for the NHANES 
1999 to 2004 cycles, and sdppsu6 and sdpstra6 for NHANES III. Both PSU and strata 
variables are used to provide appropriate adjustment in all statistical models for the 
complex sample design of the NHANES.  
 
Data management and preparation   
 The public-use NHANES data files were downloaded from the NCHS website 
(http://www.cdc.gov/nchs/nhanes.htm). The consistency of variable labels across all 
cycle years was checked; variable labels were changed if needed. Data files were then 
appended. Certain variables were redefined in order to allow for appendage. In order to 
determine the extent of missing data, the presence of outliers (by looking at extreme 
values outside the upper or lower quartiles in boxplots) , and any non-normality issues, 
frequency distributions were performed for discrete variables, and mean, standard 
deviation, and range for continuous variables were checked. Normality plots were also 
done. Transformations were not performed. Extreme outliers were not found.  
 
Missing data 
 In addition to variables that are naturally defined as missing because they were 
left blank, values that were defined as “don’t know” were redefined as missing and 
excluded from the analyses. Following the NCHS rule for missing data, if a variable had 
less than <10% missing data, that variable was used. However, if there was more missing 
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data for a variable, sample characteristics were compared in terms of demographic 
variables (e.g. age, sex, race/ethnicity) to determine if there were any nonrandom missing 
data pattern that may indicate selection bias. If there were no differences in demographic 
characteristics, then an imputation method was proposed to be used to replace missing 
values. In the present analyses however, none of the variables used had more than 10% 
missing data (responses of “don’t know” or left blank) and therefore imputation method 
not used. Variables that were omitted in the analyses were those that were asked of only a 
small portion of survey participants. The variables omitted from the analyses included 
variables related to the frequency and duration of physical activity and variables related 
to the frequency and the number of alcohol beverages consumed.    
 
Model criteria and strategy  
The purpose or goal of the present study was to test the proposed hypotheses 
derived from the research questions. Because for the first research question there was a 
relatively small sample and in order to avoid an over-parameterized model,126, 127  
parsimonious models (i.e. models with less variables) that would best explain the 
relationship between the main independent (predictor) variables and the outcome variable 
while controlling for potential confounders were sought. In general, the more variables 
added to a model, the more significant the model is or the better fit of the model; at the 
same time, this may lead to confusion in the interpretation of the findings and to complex 
interactions.126, 127 128 In this study, model evaluation was not based on the overall fit or 
model significance, but rather the inclusion of the most important variables that if were 
otherwise omitted could lead to a type I error (false positive).126, 127 128  
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This method of model evaluation allowed for a parsimonious model with mainly 
important and clinically relevant variables and ease of interpretation of findings.  
Variables were added in a step-wise fashion (i.e. one at a time) with the main 
independent variable added first. At each time a variable was added, any changes in the 
coefficients and the p-value of the main independent variables as well as other covariates 
of interest in the model were noted; changes of 20-25% of the coefficients were 
considered meaningful.126 Thus, the assessment of the interactions and/or confounding 
was possible using this approach. The approach used in the present analyses is not the 
same as stepwise modeling. This stepwise modeling approach is mainly concerned with 
the inclusion of variables that are statistically significant.126, 127  
Variables that were candidates for inclusion in the models were those that were 
pre-determined based on the literature to have clinical significance and/or that were 
significant at the 0.20 alpha level in univariable analyses.  The 0.20 alpha level was 
chosen in order to allow for inclusion of variables that were perhaps clinically significant 
but not statistically significant at a stricter 0.05 alpha level; the age group, race/ethnicity, 
and sex variables were automatically included in all models regardless of statistical 
significance.126, 127   
However, since a parsimonious model was sought and because by definition a 
confounder has to be associated with both the main predictor variable and the outcome 
variable, only variables associated with both were used in the multivariable regression 
analyses (either logistic, multinomial, or Poisson models). For example, since 
occupational group was one of the potentially new factors of interest which was 
associated with glycemic control at the univariable level, variables associated with both 
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occupational group and with glycemic control at the univariable level were included in 
the multivariable logistic regression model as well as were age group, sex, and 
race/ethnicity.   
 
Interaction terms 
Several potential interactions were tested based on other studies that found them 
to be important.36, 41, 55, 129, 130 The following interactions were tested for each hypothesis:  
Hypotheses 1a-1d:  
o ‘age group’*sex 
o ‘age group’*race/ethnicity 
o race/ethnicity*education 
o race/ethnicity*sex 
o physical activity*sex 
o  occupation*marital status 
o desire to lose weight*sex. 
Hypotheses 2a-2c:  
o ‘age group’*sex 
o ‘age group’*race/ethnicity 
o race/ethnicity*education 
o race/ethnicity*sex,  
o ‘suboptimal glycemic control’*sex‘ 
o ‘borderline glycemic control’*sex 
o  ‘poor glycemic control’*sex. 
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Hypotheses 3a-3b:  
o ‘age group’*sex 
o age group*race/ethnicity 
o race/ethnicity*sex 
o sex*education,  
o ‘suboptimal glycemic control’*sex‘ 
o ‘borderline glycemic control’*sex 
o  ‘poor glycemic control’*sex, and sex*’BMI category’ 
 
Only statistically significant interactions at the 0.05 alpha level were included in 
the adjusted models or discussed in the results sections for each hypothesis. 
 
Statistical analyses 
 All analyses were conducted using STATA 10.0 statistical software (College 
Station, TX, USA) because of its ability to adjust for the complex sample survey design 
of the NHANES. The type I error was set at 0.05, and an observed statistic was deemed 
statistically significant if the association was at or below the alpha 0.05 level. Several 
statistical analyses were performed after the preliminary analyses. Preliminary analyses 
included assessing if the assumptions to perform the regression analyses were met. For 
example, before performing multivariable logistic regression analyses, the linearity in the 
residuals was assessed using residual versus predicted plots and scatter plots, for each 
predictor variable. The assumption of independence and randomness was checked by 
looking at any patterns in the residuals. Nevertheless, independence and randomness are 
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more likely because this was a cross-sectional study (except for the mortality analyses) 
with a multi-stage complex sampling frame that includes a random selection of 
participants at the first stage of sampling. The proportionality assumption for Cox 
proportional hazard analyses was also assessed. The SVYSET and SVY commands in 
STATA, for indicating survey analyses, take into account the complex survey sample, 
and were used for all univariable and multivariable regression analyses.  
 In general, first descriptive statistics and other preliminary analyses such as chi-
square tests were performed.131 Chi-square tests were done in order to evaluate if there 
were statistically significant differences in the percentage of the outcome variables based 
on the independent variable. In addition, cross-tabulations allowed for the assessment of 
any cell sizes of less than 5 that could possibly lead to unstable regression estimates or 
prevent regression models to run properly. Second, univariable regression analyses were 
performed in order to evaluate the un-adjusted relationship (e.g. odds ratio or hazards 
rate) between the outcome variable and each independent variable. Third, multivariable 
regression analyses were performed with only clinically and/or statistically significant 
covariates included in the final models while controlling for potential confounders.127 
Dummy variables were automatically created by STATA for categorical variables when 
performing regression analyses. However, when testing interactions, dummy variables 
were created manually (e.g. a variable with 4 categories would have 3 dummy variables, 
each dummy variable as 0 vs. 1).  
 Where the literature suggested the need for stratified analyses (e.g. sex-specific 
analyses) or the use of variables in a different fashion (e.g. numerical versus categorical) 
or using different categorization, analyses in addition to the ones proposed were also 
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conducted. Moreover, mediation tests, such as the Sobel test,132 were also performed to 
help explain the association (or indirect effect) between the main independent variable 
being tested and the outcome variable. The indirect effect of the mediator is the product 
of path “a” (the estimate of the independent variable predicting the mediator) and “b” (the 
estimate of the mediator predicting the dependent variable). This test is conducted by first 
determining the standard error of the indirect effect, dividing the estimate of the path 
“ab” with the standard error of the indirect effect; a Z test is then used comparing this 
ratio with a critical value for a given alpha level.132 Statistical analyses for each 
hypothesis derived from the different research questions are described below.  
 
Hypothesis 1a  
It was hypothesized that individuals with type 2 diabetes who worked more hours 
were more likely to have suboptimal, borderline, and/or poor glycemic control, after 
controlling for potential confounders.  
Hypothesis 1b  
It was hypothesized that individuals with type 2 diabetes who had occupations 
which are known for having stricter or demanding time schedules (i.e. service workers 
and blue collar workers relative to white collar workers) were more likely to have 
suboptimal, borderline, and/or poor glycemic control, after controlling for potential 
confounders.  
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Hypothesis 1c:  
It was hypothesized that individuals with type 2 diabetes who were exposed to 
secondhand smoke that were self-reported non-smokers were more likely to have 
suboptimal, borderline, and/or poor glycemic control compared to non-smokers not 
exposed to secondhand smoke, after controlling for potential confounders.  
Hypothesis 1d:  
It was hypothesized that individuals with type 2 diabetes who desired to lose 
weight were more likely to have suboptimal, borderline, and/or poor glycemic control, 
after controlling for potential confounders.  
The NHANES 1999-2004 merged data file was used to test hypotheses 1a-1d 
using the sample of adults classified with type 2 diabetes. Only the employed sample, 
based on self-report of being employed, was used when testing the association between 
glycemic control and occupation and work hours. However, when using the desire to lose 
weight and the secondhand smoke exposure as independent variables, the full sample (i.e. 
regardless of employment) was used. 
Chi-square tests were first conducted cross-tabulating the independent variables 
separately with each of the three measures of glycemic control status (i.e. suboptimal, 
borderline, and poor glycemic control). For the independent variables that were 
continuous, t tests were conducted instead of chi-square tests; these variables had normal 
distributions. After these preliminary analyses, univariable and multivariable logistic 
regression analyses were performed since the dependent variables were each 
dichotomous variables. The LOGISTIC command in STATA was used. The dependent 
variables were suboptimal, borderline, and poor glycemic control (0 if no, 1 if yes).  
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Hypothesis 2a 
It was hypothesized that individuals with type 2 diabetes who had suboptimal, 
borderline, and poor glycemic control would be more likely to have poor health-related 
quality of life (HRQOL) (i.e. poor self reported general health, more days with poor 
mental and physical health, and more days of inactivity in the past 30 days), after 
controlling for potential confounders.  
 The NHANES 2001-2004 data were used to test hypothesis 2a, using the sample 
of adults classified with type 2 diabetes. Chi-square tests were first conducted cross-
tabulating separately the four HRQOL measures with the three variables for glycemic 
control status. Univariable analyses for the general health variable were performed since 
it was a dichotomous variable. Univariable and multivariable multinomial 
(polychotomous) logistic regressions were then performed for dependent variables for 
number of days of poor mental health, poor physical health, and limited activity since 
these dependent variables are each categorical with three levels. The MLOGIT command 
in STATA was used, which does not assume ordering of the dependent variable 
categories. The dependent variables are the four HRQOL measures [1) general health, 2) 
days of poor mental health, 3) days of poor physical health, and 4) days of limited 
activity due to poor health in the past 30 days]). For the general health variable, 
‘excellent health, very good, and good’ was the reference group, and it was compared to a 
response of ‘fair or poor health’. For the ‘days or poor mental health’ and ‘days of poor 
physical health’ variables, ‘0 days with poor health’ was the reference group, and it was 
compared to ‘1-13 days of poor health’ and ‘>14 days of poor health’. Similarly, for the 
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‘days with limited activity’ variable, ‘0 days with inactivity’ was the reference group, and 
it was compared to ‘1-13 days of inactivity’ and ‘>14 days of inactivity’. 
 
Hypothesis 2b 
 It was hypothesized that individuals with type 2 diabetes who had suboptimal, 
borderline, and poor glycemic control would have a greater number of missed work days 
in the past 12 months, after controlling for potential confounders. 
 The NHANES 1999-2004 data were analyzed using the sample of adults 
classified with type 2 diabetes. Univariable and multivariable Zero Inflated Poisson (ZIP) 
regression analyses were performed since the dependent variable, missed work days, was 
a count variable associated with rare events. The variable missed work days also showed 
over-dispersion (i.e., the mean was larger than the variance, with dispersion index or 
variance-to-mean ratio [VMR]) of 126) and excess zeros (over 50% were zero). Zero-
inflated Poisson (ZIP) regression models were used because, unlike traditional Poisson 
regression, this analytic approach is robust even in the presence excess zeros and over-
dispersions.133, 134  The ZIP regression protocol was used for these analyses because 
STATA is capable of incorporating adjustments for the NHANES complex sample 
survey design.133, 134 
 
Hypothesis 2c  
 It was hypothesized that individuals with type 2 diabetes who had suboptimal, 
borderline, and poor glycemic control would be less likely to be employed, after 
controlling for confounders. 
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The NHANES 1999-2004 merged data file was used to test hypothesis 2c, using 
all adults classified with type 2 diabetes. Chi-square tests were first conducted, cross-
tabulating employment status and the three glycemic control variables separately. 
Univariable and multivariable logistic regression analyses were then performed since the 
dependent variable was a dichotomous variable, employed [1) yes, 2) no (reference 
group)]. The LOGISTIC command in STATA was used.  
 
Hypotheses 3a  
It was hypothesized that individuals with type 2 diabetes who had suboptimal, 
borderline, and poor glycemic control would have a greater risk of all-cause mortality, 
after controlling for potential confounders. 
The NHANES III (1988-1994) data file was used to test hypothesis 3a, using all 
adults classified with type 2 diabetes. Cox proportional hazards regression analyses were 
performed since the dependent variable was time to death (the event of interest) and the 
death indicator was defined as 1 if the person died, and 0 if otherwise (event-free or 
censored). The STCOX command in STATA was used.  
 
Hypotheses 3b 
It was hypothesized that individuals with type 2 diabetes who had suboptimal, 
borderline, and poor glycemic control would have a greater CVD mortality risk, after 
controlling for potential confounders.  
The NHANES III (1988-1994) data file was used to test hypothesis 3a, using all 
adults classified with type 2 diabetes. Cox proportional hazards regression analyses were 
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performed since the dependent variable was time to death (the event of interest) and the 
death indicator was defined as 1 if the person died, and 0 if otherwise (event-free or 
censored). The STCOX command in STATA was used.  
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CHAPTER IV. 
 
RESULTS 
 
Overview 
 
 All statistical analyses for the present study are described for adults with type 2 
diabetes and were conducted using weighted statistics and using STATA software 10.0.  
Table 1 provides a summary of the STATA commands used in this study.  Descriptive 
statistics for all NHANES datasets used are shown first.  For ease of presentation (e.g. to 
avoid very long tables) descriptive tables and tables of preliminary analyses (e.g. cross-
tabulations) are generally divided into the following sections: 1) demographics, 2) 
potentially new risk factors, and 3) health indicators and behaviors. Following these 
tables, the main results (i.e., multivariable regression models) are presented based on the 
research question and hypothesis tested. Results are divided into sections based on the 
outcome variable. For example, for hypotheses 1a-1d, 2a, and 3a-3b, the results are 
shown based on the glycemic control variable used (i.e. suboptimal, borderline, or poor 
glycemic control). For research question 2a, the results are shown based on the variable 
for HRQOL used (i.e. self-reported general health, poor mental or physical health, and 
days of inactivity). The results for each hypothesis are embedded in the section for that 
hypothesis. A summary of results for each research question is also included at the end of 
the results for that research question.  
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Table 1. List of key STATA commands used in the present study 
STATA Command Purpose 
svy Indicates analyses of surveys, weighted analyses 
svyset Sets all future STATA commands to be using weighted 
analyses of survey data 
svy: tab For cross-tabulations of weighted analyses of survey data 
stset  Sets all future STATA commands to be using weighted 
mortality analyses of survey data. For example the following 
commands were written in STATA: 
 
svyset sdmvpsu [pweight=mec6yr], strata (sdmvstra) 
svy: mean  For means of weighted analyses of survey data 
svy: reg For univariable and multivariable regression analyses of 
weighted analyses of survey data 
svy: logistic  For univariable and multivariable logistic regression analyses 
of weighted analyses of survey data 
st cox For Cox-proportional analyses of weighted analyses of 
survey data 
svy: mlogit For multinomial logistic regression analyses of weighted 
analyses of survey data 
svy: zip For Zero Inflated Poisson (ZIP) regression analyses of 
weighted analyses of survey data 
pweight Indicates that a weight will be used in the analyses, precedes 
the weight variable used 
sdmvpsu Indicates that a psu variable is being used in the analyses 
strata Indicates that a strata variable will be used in the analyses, 
precedes the strata variable used 
xi: Indicates that categorical variables will be used in the 
analyses and tells STATA to automatically create dummy 
variables for the categorical variables. For example the 
following commands were written in STATA:  
 
xi: svy, subpop (if adultdiabetic): logistic suboptimala1c 
i.workhours 
i. Must precede the categorical independent variable being 
used and indicates that the variable should be made into 
dummy variables automatically (i.e. not manually) by 
STATA software 
subpop Indicates that the analyses will only be using a subsample of 
the entire date set file and usually follows the “svy” 
command 
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General characteristics of study sample 
 
 The general characteristics of the study sample for all NHANES data files are 
described in Tables 2a-2d.  A total of 1273 individuals classified as type 2 diabetics aged 
20 years or older who participated in the NHANES surveys anytime from 1999-2004 
were included in the study. Of these, 384 (28.5%) were employed (at a job or business in 
the prior week). In the 2001-2004 NHANES survey period, there were a total of 827 
individuals classified as type 2 diabetes, aged 20 years or older, while there were a total 
of 1381 individuals with type 2 diabetes, aged 20 years and older, who participated in 
NHANES III (1988-1994) and who had mortality data available. There was a fairly equal 
representation of males and females across all NHANES.  
The mean age across all NHANES data files ranged from 53 (in the employed 
NHANES 1999-2004 sample) to 65 (in the NHANES III sample). The mean duration of 
diabetes ranged from 8.7 years (employed NHANES 1999-2004 sample) to 13.2 years 
(NHANES 2001-2004 sample). Furthermore, over half of the study sample had at least a 
high school education irrespective of survey period. The sample had a slightly greater 
percentage of individuals who were married or living with a partner versus single, 
divorced or widowed across all survey periods. The majority of the sample across all 
NHANES survey periods was overweight or obese (79.3 to 85.2%). In the NHANES 
1999-2004, among all adults with type 2 diabetes, there were 671 (52.7%) with 
suboptimal glycemic control (HbA1c ≥7), 449 (42.7%) with borderline glycemic control 
(i.e. 7≥ HbA1c < 9), and 222 (17.4%) with poor glycemic control (HbA1c ≥9). In the 
employed NHANES 1999-2004 sample, there were 216 (58.5%) adults with suboptimal 
glycemic control, 134 (46.7%) with borderline glycemic control, and 82 (22.2%) with 
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poor glycemic control. In the NHANES 2001-2004, there were 423 (48.0%) adults with 
suboptimal glycemic control, 289 (38.7%) with borderline glycemic control, and 134 
(15.2%) had poor glycemic control. In the NHANES III data file, there were 507 (43.2%) 
adults with suboptimal glycemic control, 204 (23.4%) with borderline glycemic control, 
and 303 (25.8%) with poor glycemic control. There were a total of 600 (43.5%) deaths 
from 1986 to 2000 among adults with type 2 diabetes sampled in NHANES from 1986-
2000. Of these deaths, 315 (52.5%) were due to cardiovascular disease.    
 
Table 2a. Demographic characteristics among individuals classified with type 2 diabetes, 20+ years 
of age,  NHANES III (1988-1994) and NHANES 1999-2004 
 NHANESa 
 All Adults Employed 
Adults 
 1988-1994 
(n=1381) 
2001-2004 
(n=921) 
1999-2004 
(n=1348) 
1999-2004 
(n=384) 
Characteristic Frequency 
(Percent) 
Frequency 
(Percent) 
Frequency 
(Percent) 
Frequency 
(Percent) 
Sex     
   Female 755 (54.7) 459 (49.8) 678 (50.3) 157 (40.9) 
   Male 626 (45.3) 462 (50.2) 670 (49.7) 227 (59.1) 
Age group     
   20-44 124 (9.0) 91 (9.9) 128 (9.5) 86 (22.4) 
   45-64 483 (35.0) 356 (38.7) 522 (38.7)  241 (62.8) 
   65+ 774 (56.1) 474 (51.5) 698 (51.8) 57 (14.8) 
Race/ethnicity     
   Non-Hispanic White 563 (40.8) 387 (42.0) 513 (38.1) 132 (34.4) 
   Non-Hispanic Black 365 (26.4) 208 (22.6) 326 (24.2) 101 (26.3) 
   Hispanic  402 (29.1) 287 (31.2) 454 (33.7) 134 (34.9) 
   Other 51 (3.7) 39 (4.2) 55 (4.1) 17 (4.4) 
Education^     
   < HS 861 (63.1) 397 (43.2) 657 (48.8) 128 (33.3) 
      HS 287 (21.0) 201 (21.9) 277 (20.6) 85 (22.1) 
   > HS 216 (15.8) 322 (35.0) 412 (30.6) 171 (44.5) 
Marital status     
   Not married/divorced/widowed  547 (39.8) 335 (36.4) 477 (36.6) 99 (26.9) 
   Married/living with partner  829 (60.3) 586 (63.6) 826 (63.4) 269 (73.1) 
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Table 2a (continue) 
 All Adults Employed 
Adults 
 1988-1994 
(n=1381) 
2001-2004 
(n=921) 
1999-2004 
(n=1348) 
1999-2004 
(n=384) 
 Frequency 
(Percent) 
Frequency 
(Percent) 
Frequency 
(Percent) 
Frequency 
(Percent) 
Employment status     
   Unemployed -- 656 (71.3) 963 (71.5) --- 
   Employed -- 264 (28.7) 384 (28.5) --- 
Insurance status     
   Uninsured  -- 91 (10.0) 150 ( 11.3) 73 (19.3) 
   Insured -- 823 (90.0) 1,182 (88.7) 306 (80.7) 
aSample sizes do not always equal column totals due to missing data. 
^ HS=High School 
 
 
 
 
 
Table 2b. Presence of potentially new risk factors among individuals classified with type 2 
diabetes, 20+ years of age,  NHANES III (1988-1994) and NHANES 1999-2004 
 NHANESa 
 All Adults Employed 
Adults 
 1988-1994 
(n=1381) 
2001-2004 
(n=921) 
1999-2004 
(n=1348) 
1999-2004 
(n=384) 
Characteristic Frequency 
(Percent) 
Frequency 
(Percent) 
Frequency 
(Percent) 
Frequency 
(Percent) 
Smoking and secondhand smoke 
(SHS) exposure 
    
    Non-Smoker & no SHS exposure 185 (15.8) 187 (21.4) 357 (28.5) 77 (21.0) 
    Non-Smoker with SHS exposure 685 (58.3) 485 (55.5) 629 (50.2) 195 (53.3) 
    Smoker  306 (26.0) 202 (23.1) 267 (21.3) 94 (25.7) 
Weight desirability     
   Stay the same or gain weight  --- 326 (35.4) 498 (37.0) 113 (29.4) 
   Lose weight --- 595 (64.6) 849 (63.0) 271 (70.6) 
Hours worked      
   0-20 hours --- --- --- 54 (14.8) 
   21-40 hours --- --- --- 188 (51.5) 
   41+ hours --- --- --- 123 (33.7) 
Occupational group     
   White collar worker --- --- --- 177 (46.2) 
   Service worker --- --- --- 78 (20.3) 
   Farm worker --- --- --- 10 (2.6) 
   Blue collar worker --- --- --- 118 (30.8) 
aSample sizes do not always equal column totals due to missing data. 
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Table 2c. Presence of glycemic control group characteristics among individuals classified with 
type 2 diabetes, 20+ years of age,  NHANES III (1988-1994) and NHANES 1999-2004 
 NHANESa 
 All Adults Employed 
Adults 
 1988-1994 
(n=1381) 
2001-2004 
(n=921) 
1999-2004 
(n=1348) 
1999-2004 
(n=384) 
Characteristic Frequency 
(Percent) 
Frequency 
(Percent) 
Frequency 
(Percent) 
Frequency 
(Percent) 
Suboptimal glycemic 
controlb  
    
    No   666 (56.8) 458 (52.0) 602 (47.3) 153 (41.5) 
    Yes  507 (43.2) 423 (48.0) 671 (52.7) 216 (58.5) 
Borderline glycemic controlc     
    No 666 (76.6) 458 (61.3) 602 (57.3) 153 (53.3) 
    Yes  204 (23.4) 289 (38.7) 449 (42.7) 134 (46.7) 
Poor glycemic controld     
    No 870 (74.2) 747 (84.8) 1051 (82.6) 287 (77.8) 
    Yes  303 (25.8) 134 (15.2) 222 (17.4) 82 (22.2) 
aSample sizes do not always equal column totals due to missing data. 
bAn individual is said to have suboptimal glycemic control if she or he has an HbA1c of  > 7.0%.  
cAn individual is said to have suboptimal glycemic control if she or he has an HbA1c 7-8.9%. In these 
analyses, individuals with an HbA1c >9.0% are excluded from the analyses.  
dAn individual is said to have suboptimal glycemic control if she or he has an HbA1c >9.0%. 
 
 
 
Table 2d. Categorical health indicators and behavioral characteristics among individuals 
classified with type 2 diabetes, 20+ years of age,  NHANES III (1988-1994) and NHANES 1999-
2004 
 NHANESa 
 All Adults Employed 
Adults 
 1988-1994 
(n=1381) 
2001-2004 
(n=921) 
1999-2004 
(n=1348) 
1999-2004 
(n=384) 
Characteristic Frequency 
(Percent) 
Frequency 
(Percent) 
Frequency 
(Percent) 
Frequency 
(Percent) 
History of cardiovascular 
disease  
    
   No --- 662 (71.9) 937 (69.5) 338 (88.0) 
  Yes --- 259 (28.1) 411 (30.5) 46 (12.0) 
Cancer diagnosis       
   No 1225 (88.7) --- --- --- 
   Yes 156 (11.3) --- --- - 
Alcohol Use     
   No -- 370 (42.8) 136 (36.7) 555 (44.0) 
   Yes -- 494 (57.2) 235 (63.3) 707 (56.0) 
Physical activity      
  None --- 418 (51.8) 634 (54.3) 170 (45.2) 
  Moderate --- 270 (33.5) 355 (30.4) 115 (30.6) 
  Vigorous  --- 119 (14.8) 178 (15.3) 91 (24.2) 
Take anti-diabetic Pills     
   No 690 (50.2) 254 (27.7) 375 (27.9) 114 (29.7) 
   Yes 685 (49.8) 664 (72.3) 969 (72.1) 270 (70.3) 
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Table 2d (continue)     
 All Adults Employed 
Adults 
 1988-1994 
(n=1381) 
2001-2004 
(n=921) 
1999-2004 
(n=1348) 
1999-2004 
(n=384) 
 Frequency 
(Percent) 
Frequency 
(Percent) 
Frequency 
(Percent) 
Frequency 
(Percent) 
Take insulin      
   No 972 (70.4) 727 (78.9) 1052 (78.1) 323 (84.1) 
   Yes 408 (29.6) 194 (21.1) 295 (21.9) 61 (15.9) 
Table 2d (continue)     
Family history of diabetes     
   No  --- 218 (24.5) 331 (25.3) 60 (15.9) 
   Yes --- 672 (75.5) 976 (74.7) 316 (84.0) 
Hypertension diagnosis      
   No  596 (43.3) 297 (32.3) 419 (31.2) 169 (44.0) 
   Yes 782 (56.8) 624 (67.8) 929 (68.9) 215 (55.0) 
BMI category     
   Normal/under weight 253 (20.7) 143 (16.5) 210 (16.6) 55 (14.8) 
   Overweight 475 (38.9) 299 (34.6) 442 (34.9) 128 (34.3) 
   Obese 494 (40.4) 423 (48.9) 616 (48.6)  190 (50.9) 
aSample sizes do not always equal column totals due to missing data. 
 
 
Table 2e. Numerical health indicators and behavioral characteristics among individuals 
classified with type 2 diabetes, 20+ years of age,  NHANES III (1988-1994) and NHANES 1999-
2004 
 NHANESa 
 All Adults Employed 
Adults 
 1988-1994 
(n=1381) 
2001-2004 
(n=921) 
1999-2004 
(n=1348) 
1999-2004 
(n=384) 
Characteristic Mean (SE) Mean (SE) Mean (SE) Mean (SE) 
Diabetes duration (years) 10.61 (9.6) 13.19 (15.0) 12.79 (14.3) 8.57 (10.4) 
Total cholesterol (mg/dl) --- 199.77 
(47.8) 
200.27 
(47.1) 
201.64 (44.6) 
Albumin/Creatinine Ratio --- 20.34 (95.9) 25.17 
(110.2) 
21.23 (136.9) 
Percent calories from 
carbohydrates 
--- 49.44 (12.1) 49.51  
(12. 2) 
47.73 (12.2) 
aSample sizes do not always equal column totals due to missing data.  
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Potentially new risk factors and glycemic control  
The first research question was whether the work hours, the type of occupation, 
secondhand smoke exposure, and the desire to lose weight were associated with 
suboptimal, borderline, and poor glycemic control among individuals with type 2 
diabetes who were 20 years of age or older. It was hypothesized that individuals who 
worked greater number of hours (i.e. 20-40 hours or more than 40 hours relative to less 
than 20 hours), had occupations which are known for having stringent or demanding time 
schedules (i.e. service worker and blue collar workers relative to white collar workers), 
were exposed to secondhand smoke, and desired to lose weight were more likely to have 
suboptimal and/or poor glycemic control, after for potential confounders. 
 The associations between categorical independent variables involved in 
hypothesis 1a-1d and suboptimal, borderline poor, and poor glycemic control among the 
employed sample of adults with type 2 diabetes are tabulated and the significance of the 
chi-square statistics are presented in Tables 3a-3c. In addition, the means of numerical 
independent variables involved in hypothesis 1a-1d and significance of the t-test statistics 
are presented in Table 3d. Furthermore, univariable logistic regression analyses for 
suboptimal, borderline, and poor glycemic control among the employed sample of adults 
with type 2 diabetes are presented in Table 4a-4c. Odds ratios are presented along with 
95% confidence intervals and the corresponding p values. P values are shown only for 
tables 4a-4d since p values at the 0.20 alpha level in the univariable analyses were used to 
determine which variables were to be included in subsequent multivariable analyses. 
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Table 3a.  Cross-tabulations† of demographic variables with suboptimal (HbA1c > 7.0%), 
borderline (HbA1c > 7.0-8.9%), and poor (HbA1c > 9.0%) glycemic control, employed adults 
classified with type 2 diabetes, NHANES 1999-2004 
 Glycemic Control* 
 Suboptimal** Borderline** Poor** 
 N (%) N (%) N (%) 
 No Yes No Yes No Yes 
Sex       
   Male 93 (46.2) 131(53.8) 93(58.1) 77 (41.9) 170(77.0) 54 (23.0) 
   Female 60 (49.5) 85 (50.5) 60 (60.0) 57 (40.0) 117(85.3) 28 (14.7) 
Age group       
   20-44 29 (42.6) 51 (57.4) 29 (58.8) 27 (41.2) 56 (72.4) 24 (27.6) 
   45-64 93 (47.7) 140(52.3) 93 (59.0) 85 (41.0) 178(80.7) 55 (19.3) 
   65+ 31 (58.5) 25 (41.5) 31 (60.7) 22 (39.3) 53 (96.4) 3 (3.6) 
Race/ethnicity       
   Non-Hispanic 
White 
72 (55.7) 56 (44.3) 72 (65.3) 39 (34.7) 111(85.3) 17 (14.7) 
   Non-Hispanic 
Black 
29 (30.7) 63 ( 69.3) 29 (44.2) 36 (55.9) 65 (69.5) 27 (30.5) 
   Hispanic  46 (40.1) 87 (59.9) 46 (57.6) 52 (42.4) 98 (69.6) 35 (30.4) 
   Other 6 (30.0) 10  (70.0) 6 (36.6)  7 (63.6) 13 (82.2) 3 (17.8) 
Education^       
   < HS  39 (33.5) 86 (66.5) 39 (46.6) 49 (53.4) 88 (72.0) 37 (28.0) 
      HS 40 (51.5) 40 (48.5) 40 (65.0) 26 (35.0 ) 66 (79.3) 14 (20.7) 
   > HS 74 (50.9) 90 (49.1) 74 (60.8) 59 (39.2) 133(83.7) 31 (16.3) 
Marital status       
   Not married 109(47.7) 152(52.3) 109(57.8) 94 (42.2) 203(82.5) 58 (17.5) 
   Married/living 
with partner  
38 (45.8) 54 (54.2) 38 (61.7) 34 (38.3)  72 (74.3) 20 (25.7) 
Insurance Status       
   Uninsured  32 (46.1) 40 (53.9) 32 (76.6) 120(57.8) 48 (60.1) 24 (39.9) 
   Insured 120(48.2) 172(51.8) 16 (23.4) 115(42.2) 235(83.3) 57 (16.7) 
*row percentages=100, percentages do not reflect sample size in each cell due to weighted analyses. 
** Statistically significant differences at the 0.05 level appear in bold.  
†Designed based Pearson statistics performed to account for complex survey design.  
^ HS=High School 
 
Table 3b.  Cross-tabulations† of potentially new risk factors variables with suboptimal (HbA1c > 
7.0%), borderline (HbA1c > 7.0-8.9%), and poor (HbA1c > 9.0%) glycemic control, Employed 
adults classified with type 2 diabetes, NHANES 1999-2004 
 Glycemic Control* 
  Suboptimal** Borderline** Poor** 
 N (%) N (%) N (%) 
 No Yes No Yes No Yes 
Smoking and 
Secondhand 
smoke (SHS) 
exposure 
      
    None smoker/& 
no SHS  
30 (48.4) 47 (51.6) 30 (57.0) 31 (43.0) 61 (88.0) 16 (15.0) 
    Non-smoker 
with SHS  
81 (47.3) 111(52.7) 81 (60.0) 67 (40.0) 148 (78.9) 44 (21.1) 
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Table 3b (continue) 
 Glycemic Control* 
  Suboptimal**  Suboptimal**  Suboptimal**  
 N (%) N (%) N (%) 
 No Yes No Yes No Yes 
    Smoker  38 (45.1) 53 (54.9) 38 (57.1) 34 (43.0) 72 (79.0) 19 (21.0) 
Weight 
Desirability 
      
   Stay the same or 
gain   weight  
48 (57.6) 36 (42.4) 48 (57.6) 36 (42.4) 84 (76.3) 27 (23.7) 
   Lose weight 105 (59.8) 98 (40.2) 105(59.8) 98 (40.3) 203 (81.5) 55 (18.5) 
Hours of worked 
group 
      
   0-20 hours 26 (61.50 26 (38.5) 26 (68.3) 19 (31.7) 45 (90.0) 7 (10.0) 
   21-40 hours 74 (49.8) 106(50.2) 74 (62.4) 62 (37.6) 136 (79.7) 44 (20.3) 
   41+ hours 44 (38.6) 75 (61.4) 44 (50.8) 47 (49.2) 91 (76.0) 28 (24.0) 
Occupational 
group 
      
   White collar 
worker 
75 (53.1) 91 (46.9) 75 (62.2) 61 (37.8) 136 (85.5) 30 (14.6) 
   Service worker 28 (42.5) 46 (57.5) 28 (52.1) 31 (47.9) 59 (81.7) 15 (18.3) 
   Farm worker 1 (4.9) 9 (95.1) 1 (12.5) 6 (87.5) 7 (38.9) 3 (61.1) 
   Blue collar 
worker 
48 (41.5) 70 (58.6) 48 (58.0) 36 (42.0) 84 (71.5) 34 (28.5) 
*row percentages=100, percentages do not reflect sample size in each cell due to weighted analyses. 
** Statistically significant differences at the 0.05 level appear in bold.  
†Designed based Pearson statistics performed to account for complex survey design.  
 
 
Table 3c.  Cross-tabulations† of health indicators and behaviors variables with suboptimal 
(HbA1c > 7.0%), borderline (HbA1c > 7.0-8.9%), and poor (HbA1c > 9.0%) glycemic control, 
employed adults classified with type 2 diabetes, NHANES 1999-2004 
 Glycemic Control* 
 Suboptimal** Borderline** Poor** 
 N (%) N (%) N (%) 
 No Yes No Yes No Yes 
History of CVD       
   No 132(47.2) 192(52.8) 132(60.1) 117(39.9) 249(78.5) 75 (21.5) 
   Yes 21 (49.0) 24 (51.0) 21 (53.9) 17 (46.1) 38 (91.0) 7 (9.0) 
Alcohol Use       
   No 49 (42.8) 78 (57.3) 49 (50.7) 51 (49.3) 100(84.4) 27 (15.6) 
   Yes 101(49.7) 131(50.3) 101(63.3) 81 (36.7) 182(78.5) 50 (21.5) 
Physical activity       
   None 63 (44.8) 101(55.2) 63  (59.6) 61 (40.4) 124(75.2) 40 (24.8) 
   Moderate 46 (47.4) 64 (52.6) 46 (54.6) 44 (45.4) 90 (86.8) 20 (13.2) 
   Vigorous  39 (48.9) 48 (51.1) 39 (60.7) 29 (39.3) 68 (80.6) 19 (19.4) 
Take anti-
diabetic pills 
      
   No 62 (57.9) 50 (42.1) 62 (74) 91 (52.6) 90 (78.3) 22 (21.7) 
   Yes 91 (42.6) 166(57.4) 28 (26) 106(47.4) 197(81.0) 60 (19.0) 
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Table 3c (continue) 
 Glycemic Control* 
 Suboptimal** Suboptimal** Suboptimal** 
 N (%) N (%) N (%) 
 No Yes No Yes No Yes 
Take insulin        
   No 140(50.8) 171(49.2) 140(62.2) 107(37.8) 247(81.7) 64 (18.3) 
   Yes 13 (27.5) 45 (72.5) 13 (39.0) 27 (61.0) 40 (70.7) 18 (29.3) 
Family history 
of diabetes 
      
   No  33 (59.4) 26 (40.6) 33 (70.1) 19 (29.9) 52 (84.7) 7 (15.4) 
   Yes 116(45.4) 186(54.6) 116(56.4) 114(43.6) 230(80.4) 72 (19.6) 
Hypertension 
diagnosis  
      
   No  62 (45.0) 101(55.0) 62 (55.6) 62 (44.4) 124(80.9) 39 (19.1) 
   Yes 91 (49.6) 115(50.4) 91 (62.5) 72 (37.5) 163(79.4) 43 (20.6) 
BMI category       
   Normal/under 
weight 
22 (34.7) 33 (65.3) 22 (49.9) 17 (50.1) 39 (69.5) 16 (30.5) 
   Overweight 53 (54.1) 71 (45.9) 53 (71.8) 42 (28.2) 95 (75.4) 29 (24.6) 
   Obese 75 (46.3) 108(53.7) 75 (54.7) 72 (45.3) 147(84.7) 36 (15.3) 
*row percentages=100, percentages do not reflect sample size in each cell due to weighted analyses. 
** Statistically significant differences at the 0.05 level appear in bold.  
†Designed based Pearson statistics performed to account for complex survey design.  
 
 
 
 
Table 3d.  Mean comparisons for numerical variables with suboptimal (HbA1c > 7.0%), 
borderline (HbA1c > 7.0-8.9%), and poor (HbA1c > 9.0%) glycemic control, employed adults 
classified with type 2 diabetes, NHANES 1999-2004 
 Glycemic Control* 
 Suboptimal Borderline Poor 
Characteristic Mean  
(SE) 
Mean 
 (SE) 
Mean  
(SE) 
 No Yes No Yes No Yes 
Diabetes duration 
(years) 
7.07 
(1.07) 
8.13  
(0.78) 
7.07  
(1.07) 
8.22  
(1.14) 
7.55  
(0.90) 
8.0  
(0.86) 
Total cholesterol (mg/dl) 197.0  
(6.29) 
211.0  
(5.02) 
197.2  
(3.01) 
198.4  
(5.15) 
197.69 
(2.79) 
232.01  
(8.76) 
Albumin/Creatinine 
Ratio 
2.98 
(0.67) 
15.60  
(4.87) 
2.98  
(0.67) 
13.98  
(7.14) 
7.42  
(2.91) 
18.21  
(5.45) 
Percent calories from 
carbohydrates 
0.47 
(0.01) 
0.45  
(0.01) 
0.47  
(0.01) 
0.46  
(0.012) 
0.47  
(0.01) 
0.44  
(0.02) 
* Statistically significant differences at the 0.05 level appear in bold. 
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Table 4a.  Univariable logistic regression. Relationships between demographic characteristics 
with suboptimal (HbA1c > 7.0%), borderline (HbA1c > 7.0-8.9%), and poor (HbA1c > 9.0%) 
glycemic control, employed adults classified with type 2 diabetes, NHANES 1999-2004 
 Glycemic Control 
 Suboptimal  Borderline  Poor  
Characteristic Odds Ratio (95% 
Confidence Interval), 
p value 
Odds Ratio (95% 
Confidence Interval), 
p value 
Odds Ratio (95% 
Confidence Interval), 
p value 
Sex    
   Female 1.00 1.00 1.00 
   Male 1.14 (0.60-2.17), 0.68 0.92 (0.49-1.74), 0.80 1.73 (0.87-3.44), 0.12 
Age group    
   20-44 1.00 1.00 1.00 
   45-64 0.81 (0.38-1.76),0.60 0.99 (0.41-2.37), 0.98 0.63 (0.26-1.50), 0.29 
   65+ 0.530 (0.21-1.30), 0.16 0.93 (0.37-2.33), 0.87 0.10 (0.02-0.66), 0.02 
Race/ethnicity    
   Non-Hispanic 
White 
1.00 1.00 1.00 
   Non-Hispanic 
Black 
2.84 (1.56-5.17), 0.00 2.37 (1.26-4.49), 0.01 2.55 (1.13-5.7), 0.03 
   Hispanic  1.88 (1.11-3.12) 0.02 1.38 (0.87-2.20), 0.17 2.54 (1.08-5.97), 0.03 
   Other 2.94 (0.74-11.64) 0.12 3.28 (0.73-14.72), 0.12 1.26 (0.39-4.06), 0.69 
Education^    
   < HS 1.00 1.00 1.00 
      HS 0.47 (0.22-1.04),0 .06 0.47 (0.20-1.11), 0.08 1.67 (0.30-1.52), 0.33 
   > HS 0.49 (0.28-0.84), 0.01 0.56 (0.30-1.01), 0.08 0.50 (0.28-0.89), 0.02 
Marital status    
   Not married 1.00 1.00 1.00 
   Married/living with 
partner  
1.08 (0.60-1.93), 0.79 0.85 (0.44-1.65), 0.62 1.64 (0.88-3.04), 0.12 
Insurance status    
   Uninsured  1.00 1.00 1.00 
   Insured 0.28 (0.15-0.53), 0.00 2.40 (1.19-4.79), 0.02 0.30 (0.14-0.64), 0.00 
^ HS=high school  
 
Table 4b.  Univariable logistic regression.  Relationship between potentially new risk factors 
with suboptimal (HbA1c > 7.0%), borderline (HbA1c > 7.0-8.9%), and poor (HbA1c > 9.0%) 
glycemic control, employed adults classified with type 2 diabetes, NHANES 1999-2004 
 Glycemic Control 
 Suboptimal  Borderline  Poor  
Characteristic Odds Ratio (95% 
Confidence Interval), 
p value 
Odds Ratio (95% 
Confidence Interval), 
p value 
Odds Ratio (95% 
Confidence Interval), 
p value 
Smoking and 
secondhand smoke 
(SHS) exposure 
   
    None smoker/& no 
SHS  
 
 
1.00 1.00 1.00 
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Table 4b (continue) 
 Glycemic Control 
 Suboptimal  Borderline  Poor  
 Odds Ratio (95% 
Confidence Interval), 
p value 
Odds Ratio (95% 
Confidence Interval), 
p value 
Odds Ratio (95% 
Confidence Interval), 
p value 
    Non-smoker with 
SHS exposure 
1.05 (0.45-2.38), 
0.92 
1.72 (0.27-11.01), 0.56 1.51 (0.58-3.92),  
0.39 
    Smoker  1.14 (0.45-2.93), 
 0.77 
0.70 (0.288-1.68), 0.41 1.50 (0.52-4.37), 
 0.45 
Weight desirability    
   Stay the same or 
gain weight  
1.00 1.00 1.00 
   Lose weight 0.83 (0.44-1.56), 
0.55 
0.91 (0.46-1.83),  
0.80 
0.73 (0.33-1.62), 
 0.43 
Hours of worked 
group 
   
   0-20 hours 1.00 1.00 1.00 
   21-40 hours 1.61 (0.77-3.38),  
0.20 
1.30 (0.52-3.26),  
0.57 
2.28 (0.59-8.78), 
 0.22 
   41+ hours 2.54 (1.24-5.22),  
0.01 
2.10 (0.93-4.68),  
0.07 
2.84 (0.72-11.18), 0.13 
Occupational group    
   White collar worker 1.00 1.00 1.00 
   Service worker 1.52 (0.77-3.04),  
0.89 
1.51 (0.67-3.38),  
3.57 
1.31 (0.49-3.51), 
0.58 
   Farm worker 22.07(2.47-
202.11),0.01 
11.45 (1.17-112.09), 
0.03 
9.21 (1.66-51.09), 0.01 
   Blue collar worker 1.60 (0.85-3.01),  
0.14 
1.19 (0.57-2.47),  
0.64 
2.34 (1.05-5.21),  
0.04 
 
 
Table 4c.  Univariable logistic regression. Health indicators and behaviors factors associated 
suboptimal (HbA1c > 7.0%), borderline (HbA1c > 7.0-8.9%), and poor (HbA1c > 9.0%) 
glycemic control employed adults classified with type 2 diabetes, NHANES 1999-2004 
 Glycemic Control 
 Suboptimal  Borderline  Poor  
Characteristic Odds Ratio (95% 
Confidence Interval), 
p value 
Odds Ratio (95% 
Confidence Interval), 
p value 
Odds Ratio (95% 
Confidence Interval), 
p value 
CVD history     
  No 1.00 1.00 1.00 
  Yes 0.93 (0.40-2.16), 0.86 1.29 (0.52-3.23), 0.58 0.36 (0.12-1.08), 0.07 
Alcohol use    
   No 1.00 1.00 1.00 
   Yes 1.35 (0.96-1.90), 0.08 0.60 (0.32-1.17), 0.10 1.48 (0.82-2.66), 0.19 
Physical activity     
  None 1.00 1.00 1.00 
  Moderate 0.90 (0.46-1.77),0.76 1.23(0.59-2.55), 0.58 0.46 (0.22-0.99), 0.05 
  Vigorous  0.85 (0.45-1.62), 0.61 0.96 (0.47-1.94), 0.90 0.73 (0.32-1.64), 0.44 
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Table 4c (continue) 
 Glycemic Control 
 Suboptimal  Borderline  Poor  
 Odds Ratio (95% 
Confidence Interval), 
p value 
Odds Ratio (95% 
Confidence Interval), 
p value 
Odds Ratio (95% 
Confidence Interval), 
p value 
Take anti-diabetic 
pills 
   
  No 1.00 1.00 1.00 
  Yes 1.17 (0.69-1.97), 0.55 2.57 (1.39-4.72), 0.00 0.85 (0.39-1.81), 0.66 
Take insulin     
   No 1.00 1.00 1.00 
   Yes 2.07 (1.34-3.21), 0.00 2.57 (1.12-5.88), 0.03 1.85 (0.85-4.05), 0.12 
Family history of 
diabetes 
   
   Yes 1.30 (0.78-2.14),0.31 1.61 (1.13-2.27), 0.01 1.34 (0.47-3.83), 0.66 
Hypertension 
diagnosis  
   
   No  1.00 1.00 1.00 
   Yes 0.85 (0.55-1.30), 0.44 0.75 (0.41-1.38), 0.35 1.10 (0.54-2.23), 0.78 
BMI category    
   Normal/under 
weight 
1.00 1.00 1.00 
   Overweight 0.45 (0.17-1.22), 0.11 0.39 (0.15-1.01), 0.05 0.74 (0.26-2.11), 0.57 
   Obese 0.62 (0.27-1.40), 0.24 0.82 (0.34-1.98), 0.66 0.42 (0.16-1.04), 0.06 
Diabetes duration 
(years) 
0.99 (0.98-1.00), 0.25 1.01 (0.98-1.04), 0.41 1.01 (0.98-1.03), 0.72 
Total cholesterol 
(mg/dl) 
1.02 (1.00-1.02), 0.00 1.00 (0.99-1.00),0.83 1.02 (1.01-1.03), 0.00 
Albumin/Creatinine 
Ratio 
1.00 (1.00-1.00), 0.05 1.00 (1.00-1.02), 0.11 1.00( 0.98-1.01), 0.35 
% calories from 
carbohydrates 
0.36 (0.03-3.96), 0.40 0.64 (0.05-8.08), 0.73 0.15 (0.01-2.53), 0.18 
 
Suboptimal glycemic control 
Among the employed sample, individuals with type 2 diabetes who worked 
greater than 40 hours relative to those who worked 20 hours or less had greater odds for 
suboptimal (HbA1c >7) glycemic control (Odds Ratio, OR,= 2.54 [95% confidence 
interval, CI, = 1.24-5.22]) (Tables 4a-c). In addition, farm workers were more likely than 
white collar workers to have suboptimal glycemic control (OR=22.07 [CI=2.40-202.11]). 
Other factors associated with suboptimal glycemic control at the 0.20 alpha level ( the 
level for determining potential confounders) included: taking insulin (OR=2.70 [p 
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<0.001]), being 65 years of age or older relative to 20-44 years of age (OR=0.53 
[p=0.016), being insured (0.28 [p<0.001]), being non-Hispanic Black (OR=2.37 
[p=0.01]), Hispanic (OR 1.38 [p=0.17]), being of ‘other’ race (OR=2.94 [p=0.12]), and 
being overweight (OR=0.39 [p=0.05]). The other independent variables of interest for 
research question 1 (i.e. secondhand smoke exposure and desire to lose weight) were not 
statistically associated with suboptimal glycemic control at the 0.20 alpha level among all 
adults of the sample (i.e., regardless of employment status).  
Multivariable model development: For the model to assess the relationship 
between work hours and suboptimal glycemic control, variables were entered in this 
logistic regression model in the following order: 1) work hours, 2) sex, 3) age group, 4) 
race/ethnicity, 5) occupation, 6) education, 7) insurance status, 8) taking insulin, and 9) 
BMI category.  
These variables were added because they have shown clinical significance in the 
literature30-39 and were statistically associated with work characteristics and glycemic 
control in the present study (see for example tables 4a-4d). 
The order for the model was based on adding variables that had the greatest magnitude in 
the association with glycemic control in the univariable model. Only the variables 
statistically associated with both work hours and glycemic control and that had clinical 
significance were entered in the model. There were no notable difference (i.e. change of 
20% or greater in coefficients or p values) in the direction of the estimates (odds ratios) 
and the p values for each category of the work hours variable and the other covariates in 
the models at each step in the mode building procedure.  
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 The final multivariable logistic regression model assessing the relationship 
between suboptimal glycemic control, work hours, and occupation among employed 
adults with type 2 diabetes using NHANES 1999-2004 data are presented in Table 5. 
Individuals aged 20 years or older with type 2 diabetes working greater than 40 hours 
were more likely to have suboptimal glycemic control compared to those working 1-20 
hours (OR= 5.03 [CI=1.37-18.42]), after controlling for sex, age group, race/ethnicity, 
occupation, education, insurance, taking insulin, and BMI category. Although not 
statistically significant at the 0.05 alpha level, individuals working 21-40 hours also had 
greater odds for suboptimal glycemic control compared to those working 20 hours or less 
(OR=1.91 [CI= 0.72-5.07]). In addition, farm workers were more likely to have 
suboptimal glycemic control relative to white collar workers (OR=28.2 [CI=1.96-403.3]).  
 
Table 5. Multivariable logistic regression. Relationship between suboptimal glycemic 
control and work characteristics among employed adults with type 2 diabetes, 
NHANES 1999-2004 
Characteristic Odds Ratio 95% Confidence Interval 
Work hours   
  1-20 hours 1.00  
  21-40 hours 1.91 0.72- 5.07 
  41+ hours 5.03 1.37-18.42 
Sex   
  Male 1.00  
  Female 0.92 0.35-2.44 
Age group (yrs)   
  20-44 1.00  
  45-64 0.89 0.39- 2.02 
  65+ 0.94 0.36-2.45 
Race/Ethnicity   
  Non-Hispanic White  1.00  
  Non-Hispanic Black         3.36 1.49-7.58 
  Hispanic         2.10 0.91-4.81 
  Other 4.24 0.91-19.79 
Occupation    
  White collar worker 1.00  
  Service worker 1.18 0.51- 2.72 
  Farm worker     
 
28.2 1.96- 403.3 
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Table 5 (continue)     
Characteristic Odds Ratio 95% Confidence Interval 
  Blue Collar worker  0.77 0.37-1.62 
Education^   
 <HS 1.00  
  HS 0.53 0.20-1.40 
 >HS 0.61 0.29-1.29 
Have insurance   
  No 1.00  
  Yes 0.87 0.35- 2.12 
Taking insulin   
  No 1.00  
  Yes 3.97 1.45-10.89 
BMI category   
  Under/normal weight 1.00  
  Overweight      0.48 0.16-1.48 
  Obese 0.79 0.34-1.82 
^ HS=High School 
 
 
Borderline glycemic control 
Among the employed sample, univariable analyses indicated that individuals with 
type 2 diabetes who worked greater than 40 hours relative to those who worked 20 hours 
or less had greater odds for borderline glycemic control (OR=2.09 [CI=0.93-4.68]) 
(Table 4a-c). Although not statistically significant at the 0.20 alpha level (the level for 
determining potential confounders), employed individuals with type 2 diabetes who 
worked 21-40 hours were more likely than those who worked less than 20 hours 
(OR=1.30 [CI=0.52-3.26]) to have borderline glycemic control. In addition, the type of 
occupation was marginally associated with borderline glycemic control at the 0.20 alpha 
level (the level for determining potential confounders). Specifically, farm workers were 
also more likely than white collar workers to have borderline glycemic control 
(OR=11.25 [p=0.03]). Other factors associated with greater odds of borderline glycemic 
control at the 0.20 alpha level included: being a non-Hispanic Black (OR=2.37 [p=0.01]), 
Hispanic (OR=1.38 [p=0.17]), or of other race/ethnic background (3.28 [p=0.12]) relative 
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to non-Hispanic whites, taking diabetic pills (OR=2.57 [p=<0.001]), taking insulin 
(OR=2.57 [p=0.03]), and having family history of diabetes (OR=1.61 [p=0.01]).  
The other 2 main independent variables of interest for research question 1 (i.e., 
secondhand smoke exposure and desire to lose weight) were not statistically associated 
with borderline glycemic control at the 0.20 alpha level among all adults or the employed 
sample.  
Multivariable model development: For the model to assess the relationship 
between work hours, occupation, and borderline glycemic control, the order of how the 
variables were entered in this logistic regression model was as follows: 1) work hours 
category, 2) sex, 3) age group, 4), race/ethnicity, 5) occupation, 6) education, 7) 
insurance status, 8) taking insulin, and 9) BMI category. These variables were added 
because they have shown clinical significance in the literature30-39 and were statistically 
associated with work characteristics and glycemic control in the present study (see for 
example tables 4a-4d). The order for the model was based on adding variables that had 
the greatest magnitude in the association with glycemic control in the univariable model. 
Only the variables statistically associated with both work hours and glycemic control and 
that had clinical significance were entered in the model.  
When sex, age group, race/ethnicity, occupation, education, and insurance status 
were added in the model, the direction of the estimates (odds ratios) for each category of 
the work hours variable and the corresponding p values remained relatively unchanged 
except that the work hours variable category of 41+ hours became statistically significant 
when sex was added. When the variable ‘taking insulin’ was added, the odds ratio for the 
category for ‘21-40 work hours’ and ‘41+ work hours’ doubled. When the BMI category 
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and hypertension diagnosis were added, the direction of the estimates and the p values for 
the work hours and the covariates (i.e., sex, age group, race/ethnicity, occupation, 
education, and insurance status) remained relatively unchanged.  
  The final multivariable logistic regression model assessing the relationship 
between borderline glycemic control, work hours, and occupation among employed 
adults with type 2 diabetes using adjusting for confounders is presented in Table 6. 
Individuals aged 20 years or older with type 2 diabetes working over 40 hours were more 
likely to have borderline glycemic control compared to those working 1-20 hours 
(OR=7.19 [CI= 1.88-27.45]), after controlling for sex, age group, race/ethnicity, 
occupation, education, insurance, taking insulin, and BMI category.  
 
Table 6. Multivariable logistic regression. Relationship between borderline (HbA1c 
7-8.9%) glycemic control and work characteristics among employed adults with type 
2 diabetes, NHANES 1999-2004 
Characteristic Odds Ratio 95% Confidence Interval 
Work hours   
  1-20 hours 1.00  
  21-40 hours 2.39 0.82-6.90 
  41+ hours 7.19 1.88-27.45 
Sex   
  Male 1.00  
  Female 1.03 0.37-2.83 
Age group (yrs)   
 20-44 1.00  
 45-64 1.04 0.43-2.57 
 65+ 1.90 0.59-6.12 
Race/Ethnicity   
  Non-Hispanic White  1.00  
  Non-Hispanic Black         2.93 1.16-7.38 
  Hispanic         1.95 0.90-4.24 
  Other 4.99 0.83- 29.90 
Occupation    
  White collar worker 1.00  
  Service worker 1.47 0.56-3.83 
  Farm worker     13.30 0.51-347.65 
  Blue Collar worker 0.71 0.28-1.83 
Education   
  <HS 1.00 
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Table 6 (continue)   
Characteristic Odds Ratio 95% Confidence Interval 
  HS 0.36 0.10-1.29 
 >HS 0.56 0.22-1.43 
Have insurance   
  No   
  Yes 2.67 0.98-7.27 
Taking insulin   
  No 1.00  
  Yes 3.35 1.13-9.88 
BMI category   
  Under/normal weight 1.00  
  Overweight      0.35 0.12-1.07 
  Obese 1.04  0.38- 2.81 
^ HS=High School 
 
 Of the interactions that were tested for the borderline glycemic control variable, 
only ‘desire to lose weight’*race/ethnicity and ‘desire to lose weight’*sex were 
significant.  Individuals who wanted to lose weight and were of other race were 
significantly less likely to have borderline glycemic control compared to individuals who 
did not want to lose weight and were white (OR=0.23 [CI=0.06-0.95]). Females who 
wanted to lose weight were more likely to have borderline glycemic control compared to 
males who did not want to lose weight (OR=2.17 [CI=1.18-4.02]). The addition of these 
interactions in the model did not appreciably alter the OR estimates for the ‘desire to lose 
weight’ variable or the work hours or occupation variables in the logistic regression 
model. Therefore the interaction variable was not included in the final model shown in 
Table 6.   
 
Poor glycemic control  
At the 0.20 alpha level, among the employed sample, individuals with type 2 
diabetes who were farm workers or blue collar workers were more likely to have poor 
glycemic control relative to white collar workers (OR=9.21 [CI=1.66-51.09]) and 
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(OR=2.35 [CI=1.06-5.21]), respectively (Table 2). Other factors associated with greater 
odds of poor glycemic control included at the 0.20 alpha level included: being a non-
Hispanic Black (OR=2.55 [p=0.03]), and Hispanic (OR=2.54 [p=0.03]) relative to non-
Hispanic whites. Factors that were inversely related to poor glycemic control included 
having more than a high school education compared to having less than a high school 
education (OR=0.50 [p=0.03]), being 65 years of age or older relative to those aged 20-
44 years (OR=0.10 [p=0.02]), and having insurance (0.30 [p<0.01). The other 3 main 
independent variables of interest for research question (i.e. work hours category, 
secondhand smoke exposure and desire to lose weight) were not statistically associated 
with poor glycemic control at the 0.20 alpha level among all adults or the employed 
sample.   
Multivariable model development: For the model to assess the relationship 
between occupation and poor glycemic control, the order of how the variables were 
entered in this logistic regression model was as follows: 1) occupation, 2) sex, 3) age 
group, 4) race/ethnicity, 5) work hours category, 6) education, 7) insurance status, 8) 
taking insulin, and 9) BMI category.  
These variables were added because they have shown clinical significance in the 
literature30-39 and because they were statistically associated with work characteristics and 
glycemic control in the present study (see for example tables 4a-4d). 
The order for the model was based on adding variables that had the greatest magnitude in 
the association with glycemic control in the univariable model. Only the variables 
statistically associated with both work hours and glycemic control and that had clinical 
significance were entered in the model. When age group, race/ethnicity, and work hours, 
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education, insurance, taking insulin, and BMI category were added, the direction of the 
estimates and the p values for the occupation and the other covariates remained relatively 
unchanged.  
The final multivariable logistic regression model assessing the relationship 
between poor glycemic control, occupation, and work hours among employed adults with 
type 2 diabetes using NHANES 1999-2004 data are presented in Table 7. Among 
individuals aged 20 years or older with type 2 diabetes and after adjusting for potential 
confounders such as sex, age group, race/ethnicity, work hours category, education, 
insurance, taking insulin, and BMI category, there was no statistically significant 
relationship between poor glycemic control and being a farm worker (OR=9.93 [CI=0.94-
105.21]).  
 
Table 7. Multivariable logistic regression. Relationship between poor glycemic 
control (HbA1c > 9.0%) and work characteristics among employed adults with type 
2 diabetes, NHANES 1999-2004 
Characteristic Odds Ratio 95% Confidence Interval 
Work hours   
  1-20 hours 1.00  
  21-40 hours 1.32 0.30- 5.93 
  41+ hours 1.88 0.37-9.44 
Sex   
  Male 1.00  
  Female 0.68 0.32-1.46 
Age group (yrs)   
 20-44 1.00  
 45-64 0.58 0.24-1.38 
 65+ 0.10 0.02- 0.73 
Race/Ethnicity   
  NH White  1.00  
  NH Black         3.18 1.24-8.15 
  Hispanic         2.02 0.70-5.86 
  Other 1.51 0.42-5.35 
Occupation    
  White collar 1.00  
  Service 0.89 0.29-2.72 
  Farm worker     9.93 0.94-105.21 
  Blue Collar     1.20 0.43-3.34 
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Table 7 (continue)   
Characteristic Odds Ratio 95% Confidence Interval 
Education^   
 <HS 1.00  
  HS 1.21 0.41-3.63 
 >HS 0.78 0.34 -1.82 
Have insurance   
  No   
  Yes 0.37 0.15-0.91 
Taking insulin   
  No   
  Yes 2.21 1.10-4.84 
BMI category   
  Under/normal weight 1.00  
  Overweight      0.77 0.27-2.24 
  Obese 0.42 0.16-1.10 
^ HS=High School 
 
 
The Sobel test for mediation was used to test for the indirect effect of work hours 
on suboptimal and borderline glycemic control through the number of visits to a 
healthcare provider. This test was not statistically significant for suboptimal or borderline 
glycemic control (test statistic 1.294, [p=0.195] and 0.744 [p=0.456]) or for the indirect 
effect of farm worker occupation on suboptimal glycemic control (test statistic 1.817, 
[p=0.069]).  
 
Summary of results of research question 1 
 In summary, it was found that diabetics working greater than 40 hours per week, 
relative to those working 1-20 hours per week, had greater odds of having suboptimal and 
borderline glycemic control, after adjusting for potential confounders.  Farm workers, 
relative to white collar workers, were also at greater odds for suboptimal glycemic 
control, after adjusting for potential confounders. In addition, being a non-Hispanic 
Black, compared to non-Hispanic white, and taking insulin as opposed to not taking 
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insulin, were risk factors for suboptimal, borderline, and poor glycemic control. 
However, secondhand smoke exposure among non-smokers and desire to lose weight 
were not found to be statistically significant with glycemic control.  
 
The association between glycemic control and HRQOL 
 Part of the second research question in this study was whether suboptimal, 
borderline, and poor glycemic control were associated with HRQOL measures indicative 
of poor health (i.e., greater days of poor physical and mental health and inactivity and 
poor self-reported general health). It was hypothesized that suboptimal, borderline, and 
poor glycemic control would be inversely associated with all four HRQOL measures, 
after controlling for potential confounders.  
 Cross-tabulations for each of the four HRQOL measures and each of the three 
glycemic control variables and the corresponding chi-square test statistics are shown in 
Table 8.  The univariable multinomial regression analyses for number days of poor 
mental health, physical health and activity limitation are presented in Table 9.  The 
univariable analyses for the self-reported general health variable are reported separately 
(i.e., not in Table 9) because it is a dichotomous variable requiring logistic regression as 
opposed to the other HRQOL variables that require multinomial logistic regression due to 
the three categories for each variable.   
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Table 8.  Cross-tabulations† of health related quality of life variables and suboptimal (HbA1c > 
7.0%), borderline (HbA1c > 7.0-8.9%), and poor (HbA1c > 9.0%) glycemic control, adults classified 
with type 2 diabetes, NHANES 1999-2004 
 Glycemic Control* 
 Suboptimal** Borderline** Poor** 
 N (%) N (%) N (%) 
 No Yes No Yes No Yes 
Self-rated health        
   Fair/poor 227(56.3) 200(43.7) 227(65.2) 139(34.8) 366 (84.3) 75 (15.7) 
   Good/very 
good/excellent 
213 (57.1 198(42.9) 213(65.4) 133(34.6) 346 (84.0) 77 (16.0) 
Days of poor 
mental health 
      
   0 287(54.5) 273(45.5) 287(58.9) 188 63.1) 475 (84.4) 98 (15.6) 
   1-13 102(67.0) 63 (33.0) 102(74.3) 44 (25.7) 146 (86.5) 24 (13.6) 
   14-30 69 (49.0) 87 (51.0) 69 (59.5) 57(40.5)) 126 (72.6) 52 (27.4) 
Days of poor 
physical health 
      
   0 244(58.5) 213(41.9) 244(54.5) 137(45.8) 381 (82.5) 88 (17.5) 
   1-13 100(52.8) 104(47.2) 100(58.9) 77 (28.8) 177 (86.8) 34 (13.2) 
   14-30 114(62.5) 106(46.0) 114(23.1) 75 (37.5) 189 (77.6) 52 (22.4) 
Days of inactivity        
   0 340(56.5) 313(43.5) 340(73.5) 21(34.3) 555 (83.6) 116(16.4) 
   1-13 56 (55.0) 51 (45.1) 56 (12.6) 36 (40.0) 92 (86.8) 21 (13.2) 
   14-30 62 (53.7) 59 (46.3) 62 (13.9) 38 (14.0) 100 (72.5) 37 (27.4) 
*row percentages=100, percentages do not reflect sample size in each cell due to weighted analyses. 
** Statistically significant differences at the 0.05 level appear in bold.  
†Designed based Pearson statistics performed to account for complex survey design.  
 
Self-rated general health 
 As shown in the cross-tabulations distributions (table.8), self-rated health groups 
did not differ significantly with respect to suboptimal, borderline, and poor glycemic 
control. In addition, in the univariable logistic regression models, neither suboptimal 
glycemic control (OR=0.97 [CI=0.67-1.40]), borderline (OR=0.99 [CI=0.67-1.47]), or 
poor glycemic control (OR=1.02 [CI=0.62-1.67]), were associated with fair/poor self-
rated general health (versus excellent, very good, or good health) among adults with type 
2 diabetes sampled from 2001-2004. 
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Days of poor mental health in the past 30 days 
 As shown in the cross-tabulations (table 8), the proportions of suboptimal, 
borderline, and poor glycemic control were significantly different among poor mental 
health groups. In the univariable models, suboptimal, and poor glycemic control were 
each associated with greater number of days of poor mental health days among adults 
with type 2 diabetes who were 20 years of age or older sample in NHANES 2001-2004 
(table 9). Specifically, suboptimal glycemic control (OR=0.59 [CI=0.38-0.92]) was 
associated with lower odds of having 1-13 days of poor mental health versus ‘0 days of 
poor mental health in the past 30 days. However, poor glycemic control was associated 
with greater odds of having 14 days or more versus 0 days of poor health in the past 30 
days (OR=2.04 [CI=1.34-3.11]). In addition, borderline glycemic control was marginally 
associated with 1-13 days of poor mental health (OR=0.59 [CI=0.36-1.00). Since there 
was marginal significance for the relationship between borderline glycemic control and 
poor mental health, further multinomial logistic regression analyses were conducted 
adjusting for potential confounders.  
 
Table 9.  Multinomial logistic regression. Relationship between days of poor physical and mental 
health and activity limitation among adults with type 2 diabetes with suboptimal (HbA1c > 7.0%), 
borderline (HbA1c > 7.0-8.9%), and poor (HbA1c > 9.0%) glycemic control, NHANES 2001-2004 
 Days of  
 Poor Physical Health  Poor Mental Health  Limited Activity  
 1-13 days  >= 14 
days  
1-13 days  >= 14 days  1-13 days  >= 14 days  
Characteristic  OR  
(95% CI) 
OR  
(95% CI) 
OR  
(95% CI) 
OR  
(95% CI) 
OR  
(95% CI) 
OR  
(95% CI) 
Suboptimal  
glycemic 
control 
      
   No 1.00 1.00 1.00 1.00 1.00 1.00 
   Yes 1.18  
(0.84-
1.66) 
1.23  
(0.78-
1.95) 
0.59  
(0.89-0.92) 
1.25  
(0.89-1.74) 
1.06  
(0.63-1.78) 
1.12  
(0.65-1.93) 
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Table 9 (continue) 
 Days of 
 Poor Physical Health  Poor Mental Health  Limited Activity  
 1-13 days  >= 14 
days  
1-13 days >= 14 
days  
1-13 days  >= 14 days  
 OR  
(95% CI) 
OR  
(95% CI) 
OR  
(95% CI) 
OR  
(95% CI) 
OR  
(95% CI) 
OR  
(95% CI) 
Borderline        
   No 1.00 1.00 1.00 1.00 1.00 1.00 
   Yes 1.53  
(1.00-
2.34) 
1.31  
(0.89-
1.92) 
0.59  
(0.36-
1.00) 
1.17  
(0.77-
1.76) 
1.28  
(0.75-2.18) 
1.05  
(0.60-1.82) 
Poor        
   No 1.00 1.00 1.00 1.00 1.00 1.00 
   Yes 0.72  
(0.40-
1.32) 
1.36 
 (0.81-
2.29) 
0.85  
(0.48-
1.52) 
2.04  
(1.34-
3.11) 
0.78  
(0.42-1.43) 
1.93  
(1.01-3.70) 
Note: 0 days of poor physical, mental health or activity limitation is the reference category.  
 
Multivariable model development: For the models built to assess the relationship 
between number of days of poor physical health and all of the three glycemic control 
variables, the variables were entered in this multinomial logistic regression model in the 
following order: 1) sex, 2) age group, 3) race/ethnicity, 4) education, 5) employment 
status, 6) insurance status, and 7) taking insulin. The order for the model was based on 
adding variables that had the greatest magnitude in the association with glycemic control 
in the univariable model. Only the variables statistically associated with both day of poor 
physical health and glycemic control and that had clinical significance were entered in 
the model. There were no meaningful changes in the direction, strength or significance of 
the odds ratio of the glycemic control variables or the other covariates added at each 
point that a covariate was entered. 
Table 10 shows the final multivariable multinomial logistic regression model for 
the relationship between suboptimal glycemic control and poor mental health. Adults 
with type 2 diabetes who had suboptimal glycemic control were less likely to have > 1-13 
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days versus 0 days of poor mental health compared to those with good glycemic control 
(OR=0.50 [CI=0.30-0.83]), after controlling for sex, age group, race/ethnicity, education, 
insurance, employment status and taking insulin.  
 
Table 10. Multinomial logistic regression. Relationship between suboptimal glycemic control 
(HbA1c >7.0%) and days with poor mental health among adults with type 2 diabetes, NHANES 
2001-2004 
 Days of poor mental health 
 1-13 days ≥14 days 
Characteristics OR 95% CI OR 95% CI 
Suboptimal 
glycemic control 
    
   No 1.00  1.00  
   Yes 0.50 0.30-0.83 1.03 0.67-1.60 
Sex     
  Male 1.00  1.00  
  Female 1.07 0.69-1.67 1.53 0.86-2.72 
Age group (yrs)     
 20-44 1.00  1.00  
 45-64 1.29 0.65-2.55 0.90 0.41-2.01 
 65+ 0.49 0.20-1.19 0.20 0.08-0.47 
Race/Ethnicity     
  NH White  1.00  1.00  
  NH Black         0.98 0.57-1.67 0.69 0.38-1.24 
  Hispanic         1.22 0.61-2.46 0.43 0.22-0.84 
  Other 0.36 0.18-1.11 0.65 0.21-2.03 
Education^     
 <HS 1.00  1.00  
  HS 1.23 0.63-2.38 0.74 0.35-1.56 
 >HS 1.40 0.77-2.53 0.43 0.24-0.75 
Employed     
  No     
  Yes 0.79 0.49-1.28 0.39 0.24-0.65 
Have insurance     
  No 1.00  1.00  
Taking Insulin     
  No 1.00  1.00   
  Yes 1.62 0.78-3.39 2.07 1.14-3.76 
Note: 0 days of poor physical, mental health or activity limitation is the reference category.  
^ HS=High School 
 
Table 11 shows the final multivariable multinomial logistic regression model for 
the relationship between borderline glycemic control and poor mental health. Adults with 
type 2 diabetes who had borderline glycemic control were less likely to have > 1-13 days 
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versus 0 days of poor mental health (OR=0.55 [CI=0.31-0.98]), after controlling for 
potential confounders.   
 
Table 11. Multinomial logistic regression. Relationship between borderline glycemic control 
(HbA1c 7-8.9%) and days with poor mental health among adults with type 2 diabetes, NHANES 
2001-2004 
 Days of poor mental health 
 1-13 days  ≥14 days 
Characteristic  OR  (95% CI) OR  (95% CI) 
Borderline glycemic 
control  
    
   No 1.00  1.00  
   Yes 0.55 0.31-0.98 1.00 0.60-1.67 
Sex     
  Male 1.00  1.00  
  Female 1.30 0.78-2.16 1.62 0.92-2.88 
Age group (yrs)     
 20-44 1.00  1.00  
 45-64 1.13 0.55-2.32 0.74 0.32-1.73 
 65+ 0.42 0.16-1.13 0.17 0.07-0.44 
Race/Ethnicity     
  NH White  1.00  1.00  
  NH Black         0.89 0.52-1.52 0.75 0.38-1.48 
  Hispanic         1.70 0.84-3.43 0.52 0.24-1.14 
  Other 0.39 0.13-1.14 0.63 0.19-2.10 
Education^     
 <HS 1.00  1.00  
  HS 1.27 0.61-2.61 0.84 0.43-1.64 
 >HS 1.54 0.82-2.92 0.51 0.29-0.92 
Employed     
  No 1.00  1.00  
  Yes 0.73 0.43-1.26 0.41 0.21-0.80 
Have insurance     
  No 1.00  1.00  
  Yes 0.94 0.36-2.48 2.18 0.89-5.36 
Taking insulin     
  No     
  Yes 1.43 0.59-3.48 1.94 1.01-3.74 
Note: 0 days of poor physical, mental health or activity limitation is the reference category.  
^ HS=High School 
 
 
Table 12 shows the final multivariable multinomial logistic regression model for 
the relationship between poor glycemic control and number of days of poor mental 
health. Adults with type 2 diabetes who had poor glycemic control were more likely to 
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have > 14  days versus 0 days of poor mental health compared to those with good 
glycemic control (OR=1.73 [CI=1.14-2.64]), after controlling for sex, age group, 
race/ethnicity, education, insurance, employment status and taking insulin. Although not 
statistically significant but similar to results using the other glycemic control variables, 
adults with poor glycemic control were less likely to have 1-13 days (versus 0 days) of 
poor mental health compared to those with good glycemic control.  
 
Table 12. Multinomial logistic regression. Relationship between poor glycemic control (HbA1c > 
9.0%) and days with poor mental health among adults with type 2 diabetes, NHANES 2001-2004 
 Days of poor mental health 
 1-13 days >= 14 days 
Characteristic  OR (95% CI) OR (95% CI) 
Poor glycemic 
control   
    
   No 1.00  1.00  
   Yes 0.69 0.38-1.26 1.73 1.14-2.64 
Sex     
  Male 1.00  1.00  
  Female  1.08 0.71-1.64 1.65 1.03-2.65 
Age group (yrs)     
  20-44 1.00  1.00  
  45-64 1.25 0.62-2.53 0.72 0.38-1.37 
  65+ 0.50 0.21-1.16 0.69 0.08-0.36 
Race/Ethnicity     
  NH White  1.00  1.00  
  NH Black         0.90 0.55-1.46 0.69 0.40-1.19 
  Hispanic         1.24 0.64-2.42 0.46 0.24-0.90 
  Other 0.30 0.10-0.93 0.66 0.24-1.81 
Education^     
 <HS 1.00  1.00  
  HS 1.22 0.61-2.45 0.66 0.33-1.32 
 >HS 1.64 0.90-3.00 0.44 0.25-0.76 
Employed     
  No     
  Yes 0.77 0.48-1.25 0.41 0.25-0.69 
Have insurance     
  No 1.00  1.00  
  Yes 0.91 0.39-2.10 1.54 0.70-3.39 
Taking insulin     
  No 1.00  1.00  
  Yes 1.37 0.68-2.79 2.32 1.51-3.58 
Note: 0 days of poor physical, mental health or activity limitation is the reference category.  
^ HS=High School 
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Days of poor physical health in the past 30 days 
 As shown in the cross-tabulations (table 8), the proportions of days of poor 
physical health were not statistically significantly different among the various glycemic 
control groups. In addition, in univariable models, neither suboptimal nor poor glycemic 
control was associated with number of days with poor physical health (table 9). However, 
borderline glycemic control was marginally associated with poor physical health at the 
0.20 alpha level. Specifically, borderline glycemic control was associated with greater 
odds of having 1-13 days of poor physical health versus 0 days of poor physical health in 
the past 30 days (OR=1.53 [CI=1.00-2.34]), p= 0.05). Since there was marginal 
significance for borderline glycemic control, further multinomial logistic regression 
analyses were conducted adjusting for potential confounders.  
Multivariable model development: For the model to assess the relationship 
between the number of days of poor physical health and borderline glycemic control, the 
variables were entered in this multinomial logistic regression model in the following 
order: 1) sex, 2) age group, 3) race/ethnicity 4) education, 5) employment status, 6) 
insurance status, and 7) taking insulin. The order for the model was based on adding 
variables that had the greatest magnitude in the association with glycemic control in the 
univariable model. Only the variables statistically associated with both number of days of 
poor physical health and glycemic control and that had clinical significance were entered 
in the model. There were no meaningful changes in the direction, strength or significance 
of the odds ratio for the borderline glycemic control variable or the other covariates 
added at each point a covariate was entered. 
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Table 13 shows the final multivariable multinomial logistic regression model 
assessing the relationship between borderline glycemic control and number of days of 
poor physical health. Adults with type 2 diabetes who had borderline glycemic control 
were statistically more likely to have 1-13 days versus 0 days of poor physical health 
compared to those with good control (OR=1.59 [CI=1.03-2.45]); the relationship was 
however not statistically significant for having at least 14 days of poor physical health 
(OR=1.30 [CI=0.81-2.07]), after controlling for sex, age group, race/ethnicity, education, 
insurance, employment status, and taking insulin. Being employed was protective against 
having > 14 days versus 0 days of poor physical health (OR=0.30 [CI=0.16-0.57]).  
 
Table 13. Multinomial logistic regression. Relationship between borderline glycemic control 
(HbA1c 7-8.9%) and days with poor physical health among adults with type 2 diabetes, NHANES 
2001-2004 
 Days of poor physical health 
 1-13 days ≥14 days 
Characteristic  OR  (95% CI) OR  (95% CI) 
Borderline glycemic 
control  
    
   No 1.00  1.00  
   Yes 1.59 1.03-2.45 1.30 0.81-2.07 
Sex     
  Male 1.00  1.00  
  Female 1.58 1.09-2.29 1.46 0.98-2.16 
Age group (yrs)     
 20-44 1.00  1.00  
 45-64 0.91 0.39-2.11 1.14 0.55-2.37 
 65+ 0.30 0.14-0.63 0.44 0.21-0.94 
Race/Ethnicity     
  NH White  1.00  1.00  
  NH Black         0.92 0.47-1.80 1.14 0.62-2.09 
  Hispanic         0.81 0.30-2.15 0.44 0.21-0.92 
  Other 1.05 0.43-2.55 0.74 0.26-2.11 
Education^     
 <HS 1.00  1.00  
  HS 1.38 0.77-2.48 0.72 0.36-1.43 
 >HS 1.69 0.98-2.91 0.53 0.27-1.01 
Employed     
  No     
  Yes 0.44 0.24-0.80 0.30 0.16-0.57 
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Table 13 (continue)     
 1-13 days ≥14 days 
Characteristic  OR  (95% CI) OR  (95% CI) 
Have insurance     
  No 1.00  1.00  
  Yes 0.69 0.28-1.70 1.30 0.59-2.79 
Taking insulin     
  No 1.00  1.00  
  Yes 1.83 0.85-3.96 1.44 0.73-2.85 
Note: 0 days of poor physical, mental health or activity limitation is the reference category.  
^ HS=High School 
 
 
Days of inactivity due to poor health in the past 30 days 
As shown in the cross-tabulations (table 8) proportions of suboptimal, borderline, 
or poor glycemic control were not significantly different among days of inactivity groups. 
In univariable models, while suboptimal or borderline glycemic control was not 
associated with number of inactivity days, poor glycemic control was. Specifically, 
among adults with type 2 diabetes, those with poor glycemic control were more likely to 
have > 14 days versus 0 days of inactivity (OR=1.93 [CI=1.01-3.70]) (table 9). 
Multivariable model development: For the model to assess the relationship 
between number of days of inactivity and poor glycemic control the order of how 
variables were entered in this multinomial logistic regression model was as follows: 1) 
sex, 2) age group, 3) race/ethnicity, 4) education, 5) employment status, 6) insurance 
status, and 7) taking insulin. The order for the model was based on adding variables that 
had the greatest magnitude in the association with glycemic control in the univariable 
model. Only the variables statistically associated with both inactivity days and glycemic 
control and that had clinical significance were entered in the model.  
Table 14 shows the final multivariable multinomial logistic regression model 
assessing the relationship between number of days of inactivity and poor glycemic 
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control. Adults with type 2 diabetes who had poor glycemic control were more likely to 
have > 14 days versus 0 days of inactivity compared to those with good control 
(OR=2.00 [CI=1.07-3.76]), after controlling for sex, age group, race/ethnicity, education, 
insurance, employment status, and taking insulin. Among the confounders, being 
Hispanic was inversely associated with having > 14 days versus 0 days of poor physical 
health (OR=0.32 [CI=0.14-0.71]).  
 
Table 14. Multinomial logistic regression.  Relationship between poor glycemic control (HbA1c > 
9.0%) and inactivity days among adults with type 2 diabetes, NHANES 2001-2004 
 Days of inactivity 
 1-13 days  ≥ 14 days 
Characteristic OR  (95% CI) OR  (95% CI) 
Poor glycemic 
control   
    
   No 1.00  1.00  
   Yes 0.71 0.35-1.43 2.00 1.07-3.76 
Sex     
  Male 1.00  1.00  
  Female 1.63 0.89-2.97 1.31 0.81-2.14 
Age group (yrs)     
 20-44 1.00  1.00  
 45-64 0.58 0.26-1.29 0.77 0.32-1.85 
 65+ 0.22 0.07-0.66 0.22 0.09-0.53 
Race/Ethnicity     
  NH White  1.00  1.00  
  NH Black         1.03 0.56-1.92 0.72 0.33-1.61 
  Hispanic         0.35 0.17-0.74 0.32 0.14-0.71 
  Other 0.7 0.24-2.12 0.88 0.36-2.14 
Education^     
 <HS 1.00  1.00  
  HS 0.81 0.43-1.50 0.35 0.15-0.86 
 >HS 0.73 0.31-1.69 0.38 0.17-0.85 
Employed     
  No     
  Yes 0.52 0.22-1.21 0.22 0.10-0.45 
Have insurance     
  No 1.00  1.00  
  Yes 1.61 0.58-4.50 4.01 1.56-10.28 
Taking insulin     
  No 1.00  1.00  
  Yes 1.83 0.99-3.34 1.68 0.86-3.26 
     Note: 0 days of poor physical, mental health or activity limitation is the reference category.  
^ HS=High School 
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Missed work days and glycemic control 
 Part of the second research question in this study was to examine whether 
suboptimal, borderline, and poor glycemic control were associated with greater number 
of missed work days in the past 12 months among workers with type 2 diabetes. It was 
hypothesized that suboptimal, borderline, and poor glycemic control was associated with 
greater number of missed work days in the past 12 months, after controlling for potential 
confounders. Neither suboptimal (beta coefficient -0.50 [-1.23, -0.23]), borderline 
glycemic control, or poor glycemic control (beta coefficient -0.39 [-0.98, -0.21]), were 
associated with number of missed work days.  
 
Employment and glycemic control  
 Part of the second research question in this study was whether suboptimal, 
borderline, and poor glycemic control was associated with employment among adults 
with type 2 diabetes. It was hypothesized that suboptimal, borderline, and poor glycemic 
control was inversely associated with employment, after controlling for potential 
confounders.  
 Cross-tabulations of employment and glycemic control and the corresponding 
Chi-square test statistics are shown in table 15. The proportions of employed versus 
unemployed did not vary by glycemic control groups. In univariable logistic regression, 
neither suboptimal glycemic control (OR=1.22 [CI=0.88-1.70]) nor borderline glycemic 
control (OR=1.05 [CI=0.75-1.48]) were significantly associated with employment. 
However, poor glycemic control was significantly associated with employment status 
(OR=1.62 [CI=1.05-2.53]). 
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Table 15.  Cross-tabulations† of health related quality of life variables and suboptimal (HbA1c > 
7.0%), borderline (HbA1c > 7.0-8.9%), and poor (HbA1c > 9.0%) glycemic control among adults 
classified with type 2 diabetes, NHANES 1999-2004 
 Glycemic Control* 
 Suboptimal** Borderline** Poor** 
 N (%) N (%) N (%) 
 No Yes No Yes No Yes 
Employed       
   No 449 (52.5) 454 (47.6) 449 (60.4) 314 (39.6) 763(86.8) 140 (13.2) 
   Yes 153 (47.4) 216 (52.6) 153  (59.2) 134 (40.8) 287(80.1) 82 (19.9) 
*row percentages=100, percentages do not reflect sample size in each cell due to weighted analyses. 
** Statistically significant differences at the 0.05 level appear in bold.  
†Designed based Pearson statistics performed to account for complex survey design.  
 
 Multivariable model development: For the model assessing the relationship 
between employment status and poor glycemic control the variables were added in the 
model as follows: 1) poor glycemic control, 2) sex, 3) age group, 4) race/ethnicity, 5) 
education,  6) insurance, 7) taking insulin, and 8) CVD status. The order for the model 
was based on adding variables that had the greatest magnitude in the association with 
glycemic control in the univariable model. Only the variables statistically associated with 
both employment and glycemic control and that had clinical significance were entered in 
the model. When age group was added in the model, the estimate for poor glycemic 
control changed direction, but was no longer statistically significant (0.98 [0.61-1.57]); 
there were no sex differences. When race/ethnicity was added, the direction of the 
estimates and the p values for the variables in the model remained relatively unchanged 
except that the direction for poor glycemic control changed (OR=1.02 [CI=0.65-1.63]). 
Sequential addition of the other covariates (i.e. education, insurance status, taking insulin, 
and CVD status) did not result in any meaningful changes in the direction or significance 
of the estimates for poor glycemic control or the other covariates.  
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Table 16 displays the final multivariable logistic regression model for the 
relationship between employment status and poor glycemic control. In the final adjusted 
model, although the results were not significant, adults with type 2 diabetes who had poor 
glycemic control were slightly more likely to be employed (OR=1.10 [CI=0.70-1.73]).  
Sex specific analyses were also conducted. Females with poor glycemic control 
were less likely to be employed (OR=0.84 [CI=0.39-1.79], while males with poor 
glycemic control were more likely to be employed (OR=1.55 [CI=0.76-3.18]). 
 
Table 16. Multivariable logistic regression. Relationship between employment status 
and poor glycemic control (HbA1c >9%) among adults with type 2 diabetes, 
NHANES 1999-2004 
Characteristic Odds Ratio 95% Confidence Interval 
Poor glycemic control   
Employment   
   No 1.00  
   Yes 1.10 0.70-1.73 
Sex   
  Male 1.00  
  Female 0.42 0.29-0.62 
Age group (yrs)   
 20-44 1.00  
 45-64 0.44 0.22-0.87 
 65+ 0.05 0.03-0.09 
Race/Ethnicity   
  NH White  1.00  
  NH Black         0.88 0.52-1.48 
  Hispanic         1.08 0.54-2.17 
  Other 0.77 0.37-1.57 
Education^   
 <HS 1.00  
  HS 2.10 1.20-3.68 
 >HS 2.46 1.50-4.02 
CVD history   
  No 1.00  
  Yes 0.46 0.29-0.74 
Taking insulin   
  No 1.00  
  Yes 0.63 0.38-1.03 
Have insurance   
  No 1.00  
  Yes 1.12 0.68-1.85 
^ HS=High School 
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Summary of results of research question 2  
 In summary, it was found that the odds having 1-13 days of poor mental health 
were greater among those having suboptimal and borderline glycemic control. 
Individuals with poor glycemic control were more likely to report at least 14 days of poor 
mental health as well as inactivity in the past 30 days. In addition, greater odds for having 
1-13 days of poor physical health in the past 30 days were reported among those with 
borderline glycemic control. However, the other measures of overall health and well-
being, such as self-rated general health, missed work in the past 30 days and employment 
status, were not statistically associated with having suboptimal, borderline, or poor 
glycemic control, after controlling for potential confounders.  
 
Glycemic control and all-cause mortality risk   
 Part of the third research question was whether suboptimal, borderline, and poor 
glycemic control were associated with greater all-cause mortality risk among US adults 
with type 2 diabetes, controlling for potential confounders. It was hypothesized that 
individuals with suboptimal, borderline, and poor glycemic control would have greater 
all-cause mortality risk.  
 Cross-tabulations of all-cause mortality and participant characteristics including 
glycemic control along with the corresponding chi-square test statistics are shown in table 
17. In un-adjusted Cox proportional hazards models, neither suboptimal (HR=1.22 
[CI=0.95-1.58]), borderline (HR=1.28 [CI=0.98-1.68]), or poor glycemic control 
(HR=1.03 [CI=0.98-1.57]) were associated with greater likelihood of all-cause mortality 
among adults with type 2 diabetes (Table 18). Factors associated with all-cause mortality 
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in un-adjusted analyses included being greater than 65 years of age (HR=6.01 [CI=2.36-
15.61]), being Hispanic (HR 0.59 [0.44-0.78]), being married or living with a partner 
(HR=1.75 [CI=1.29-2.36]), cancer history  (HR=1.58 [CI=1.05-2.38]), being obese (HR= 
0.54 [CI=0.37-0.78]), taking insulin (HR=0.59 [CI=0.41-0.85]), and being a high school 
graduate (HR=0.66 [CI=0.49-0.91]) or having more than a high school education 
(HR=0.57 [CI=0.37-0.88]) (Table 18). Since age is an important predictor of death, and 
because we wanted to assess the possibility of confounders, age and other variables were 
included in the adjusted model.  
The covariates included in the adjusted models for each of the glycemic control 
variables were entered in the following order: 1) age group, 2) sex, 3) race/ethnicity, 4) 
education, 5) BMI category, 6) duration of diabetes, 7) cancer history, and  
8) hypertension diagnosis.  However, there were no differences in the association 
between the glycemic control variables and mortality risk after each covariate was 
sequentially added to the model. There were also no changes in the hazard ratios of the 
other covariates as each variable was added in the model.  
 
Table 17.  Cross-tabulations† of cause of death with participant characteristics, 
adults classified with type 2 diabetes, NHANES 1986-1994 and NHANES III 
mortality linked data file 
 Cause of Death  
 All-cause Cardiovascular 
 N (%) N (%) 
 No Yes No Yes 
Suboptimal glycemic 
control  
    
   No 296 (67.6) 210 (32.4) 96 (42.2) 114 (57.8) 
   Yes 402 (63.5) 264 (36.5) 137(52.3) 127 (47.7) 
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Table 17 (continue)     
 Cause of Death 
 All-cause Cardiovascular 
 N (%) N (%) 
 No Yes No Yes 
Borderline glycemic  
control  
    
   No 296 (67.60 210 (32.4) 96 (42.2) 114 (57.8) 
   Yes 214 (62.1) 149 (37.9) 77 (56.2) 72 (43.8) 
Poor glycemic  
control  
    
   No 510 (65.3) 359 (34.7) 173(48.5) 186 (51.5) 
   Yes 188 (65.4) 115 (34.6) 60 46.6) 55 (53.4) 
Sex     
   Male 321 (66.4) 304 (33.6) 140(42.6) 164 (57.4) 
   Female 458 (64.2) 296 (35.8) 145(52.9) 151 (47.1) 
Age group     
   20-44 114 (87.7) 10 (12.3) 8 (69.0) 2 (31.0) 
   45-64 355 (79.9) 127 (20.1) 72 (54.1) 55 (45.9) 
   65+ 310 (44.2) 463 (55.8) 205(45.1) 258 (54.9) 
Race/ethnicity     
   Non-Hispanic White 261 (63.4) 301 (36.6) 127(46.5) 174 (53.5) 
   Non-Hispanic Black 212 (63.5) 153 (36.5) 84 (58.6) 69 (41.4) 
   Hispanic  267 (76.9) 134 (23.1) 70 (58.5) 64 (41.5) 
   Other 39 (81.5) 12 (18.5) 4 (36.3) 8 (63.7) 
Education^     
   < HS 465 (57.8) 395 (42.2) 183(48.6) 212 (51.4) 
      HS 178 (69.4) 109 (30.6) 56 (49.5) 53 (50.5) 
   >HS 130 (74.4) 85 (26.0) 39 (45.4) 46 (54.6) 
Marital status     
   Not married 506 (70.8) 322 (29.2) 145(42.7) 177 (57.3) 
   Married/living with 
partner  
270 (55.0) 276 (45.0) 139(55.2) 137 (44.8) 
Hypertension diagnosis      
   No  357 (66.6) 238 (33.4) 114(49.7) 124 (50.4) 
   Yes 422 (64.2) 359 (35.8) 170(47.1) 189 (52.9) 
Cancer history       
   No  718 (67.0) 505 (33.0) 234(45.6) 271 (54.4) 
   Yes 61 (53.9) 95 (46.1) 51 (60.7) 44 (39.2) 
Take insulin      
    No 197 (55.2) 211 (44.8) 132(46.5) 158 (53.5) 
    Yes 581 (68.8) 389 (31.2) 153(52.3) 153 (47.7) 
BMI category     
   Normal/under weight 122 (53.4) 131 (46.6) 65 (49.3)  66 (50.7) 
   Overweight 266 (64.5) 208 (35.5) 94 (41.8) 114 (58.2) 
   Obese 334 (70.6) 159 (39.4) 86 (54.0) 73 (46.0) 
*row percentages=100, percentages do not reflect sample size in each cell due to  
weighted analyses. 
** Statistically significant differences at the 0.05 level appear in bold.  
†Designed based Pearson statistics performed to account for complex survey design.  
^ HS=High School 
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Table 18. Un-adjusted Cox proportional hazards model. Factors associated with all-cause 
and cardiovascular mortality risk among adults with type 2 diabetes, NHANES III 
 Cause of Death 
 All-cause Cardiovascular 
 Hazards 
Ratio 
95% 
Confidence 
Interval 
Hazards 
Ratio 
95% 
Confidence 
Interval 
Suboptimal glycemic control      
   No 1.00  1.00  
   Yes 1.22 0.95-1.58 1.04 0.75-1.44 
Borderline glycemic  
control 
    
   No 1.00  1.00  
   Yes 1.28 0.98-1.68 1.00 0.68-1.49 
Poor glycemic  
control  
    
   No 1.00  1.00  
   Yes 1.03 0.98-1.57 1.09 0.54-2.19 
Sex     
   Male 1.00  1.00  
   Female 1.06 0.82-1.38 0.91 0.67-1.23 
Age group     
   20-44 1.00  1.00  
   45-64 1.57 0.63-3.94 2.14 0.34-13.19 
   65+ 6.01 2.36-15.61 10.56 1.77-63.21 
Race/ethnicity     
   Non-Hispanic White 1.00  1.00  
   Non-Hispanic Black 1.04 0.80-1.35 0.81 0.58-1.12 
   Hispanic  0.59 0.44-0.78 0.47 0.29-0.77 
   Other 0.53 0.21-1.37 0.63 0.19-2.15 
Education^     
   < HS 1.00  1.00  
      HS 0.66 0.49-0.91 0.57 0.39-0.83 
   > HS 0.57 0.37-0.88 0.66 0.44-0.99 
Marital status     
   Not married 1.00  1.00  
   Married/living with partner  1.75 1.29-2.36 1.40 0.91-2.16 
Hypertension diagnosis      
   No  1.00  1.00  
   Yes 1.05 0.77-1.42 1.08 0.74-1.58 
Cancer history      
   No 1.00  1.00  
   Yes 1.58 1.05-2.38 1.14 0.71-1.85 
Take insulin      
   No 1.00  1.00  
   Yes 0.59 0.41-0.85 0.67 0.41-1.09 
Duration of diabetes 1.03 1.02-1.04 1.03 1.01-1.04 
BMI category     
  Normal/under weight 1.00  1.00  
  Overweight 0.70 0.47-1.04 0.80 0.51-1.24 
  Obese 0.54 0.37-0.78 0.47 0.28-0.79 
^ HS=High School 
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Suboptimal glycemic control  
 The adjusted Cox proportional hazards model for the relationship between 
suboptimal glycemic control and all-cause mortality risk for a participants is presented in 
Table 19. Suboptimal glycemic control was not statistically associated with all-cause 
mortality risk among adults with type 2 diabetes (HR=1.24 [CI=0.99-1.56]).  
 
Table 19. Adjusted Cox proportional hazards model. Relationship between 
suboptimal glycemic control and all-cause mortality risk among adults with type 2 
diabetes, NHANES III 
Characteristic Hazards Ratio 95% Confidence Interval 
Suboptimal glycemic control   
   No 1.00  
   Yes 1.24 0.99-1.56 
Age group (yrs)   
  20-44 1.00  
  45-64 1.75 0.61-4.99 
  65+ 5.66 202-15.82 
Sex   
  Male 1.00  
  Female 0.90 0.68-1.18 
Race/Ethnicity   
  NH White  1.00  
  NH Black         1.05 0.77-1.43 
  Hispanic         0.62 0.48-0.80 
  Other 0.63 0.24-1.63 
Education^   
 <HS 1.00  
  HS 0.69 0.49-0.97 
 >HS 0.63 0.45-0.88 
BMI category   
  Under/normal weight 1.00  
  Overweight      0.67 0.45-0.99 
  Obese 0.65 0.45-0.94 
Duration of diabetes (yrs) 1.01 0.99-1.02 
Hypertension diagnosis   
  No 1.00  
  Yes 1.07 0.80-1.42 
Cancer history   
  No 1.00  
  Yes 1.21 0.79-1.86 
^ HS=High School 
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Borderline glycemic control  
 The adjusted Cox proportional hazards model for the relationship between 
borderline glycemic control and all-cause mortality risk is presented in Table 20. 
Borderline  glycemic control was not statistically associated with all-cause mortality risk 
among adults with type 2 diabetes in un-stratified analyses (HR=1.20 [CI=0.94-1.53]) or 
in the stratified analyses (HR=1.02 [CI=0.61-1.71] and HR=1.21 [CI=0.78-2.86]) for 
males and females, respectively.  
 
Table 20. Adjusted Cox proportional hazards model. Relationship between 
borderline glycemic control and all-cause mortality risk among adults with type 2 
diabetes, NHANES III 
Characteristic Hazards Ratio 95% Confidence Interval 
Borderline Glycemic control   
   No 1.00  
   Yes 1.20 0.94-1.53 
Age group (yrs)   
 20-44 1.00  
 45-64 1.11 0.37-3.35 
 65+ 3.69 1.25-10.87 
Sex   
  Male 1.00  
  Female 0.96 0.71-1.30 
Race/Ethnicity   
  NH White  1.00  
  NH Black         1.02 0.71-1.48 
  Hispanic         0.59 0.39-0.88 
  Other 0.46 0.16-1.34 
Education^   
 <HS 1.00  
  HS 0.77 0.54-1.09 
 >HS 0.60 0.39-0.93 
BMI category   
  Under/normal weight 1.00  
  Overweight      0.70 0.45-1.08 
  Obese 0.70 0.44-0.98 
Duration of diabetes (yrs) 1.01 1.00-1.02 
Hypertension diagnosis   
  No 1.00  
  Yes 1.16 0.88-1.54 
Cancer history   
  No 1.00  
  Yes 1.18 0.77-1.81 
^ HS=High School 
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Poor glycemic control  
 
 The adjusted Cox proportional hazards model for the relationship between poor 
glycemic control and all-cause mortality risk is presented in Table 21. Poor glycemic 
control was not statistically associated with all-cause mortality risk (HR=1.24 [CI=0.79-
1.95]). Of note, addition of the interaction term of BMI category and sex did not change 
the results in the in the adjusted model nor was it statistically significant when added in 
the model.  
 
Table 21. Adjusted Cox proportional hazards model. Relationship between poor 
glycemic control and all-cause mortality risk among adults with type 2 diabetes, 
NHANES III 
Characteristic Hazards Ratio 95% Confidence Interval 
Poor glycemic control   
  No 1.00  
  Yes 1.24 0.79-1.96 
Age group (yrs)   
 20-44 1.00  
 45-64 1.81 0.62-5.20 
 65+ 5.89 2.10-16.54 
Sex   
 Male 1.00  
 Female 0.89 0.68-1.17 
Race/Ethnicity   
  NH White  1.00  
  NH Black         1.03 0.77-1.41 
  Hispanic         0.63 0.49-0.81 
  Other 0.62 0.24-1.58 
Education^   
  < HS 1.00  
     HS 0.71 0.50-0.99 
  > HS 0.63 0.45-0.89 
BMI category   
  Under/normal weight 1.00  
  Overweight      0.67 0.45-1.00 
  Obese 0.64 0.44-0.93 
Duration of diabetes (yrs) 1.01 0.99-1.02 
Hypertension diagnosis   
  No 1.00  
  Yes 1.06 0.79-1.42 
Cancer history   
  No 1.00  
  Yes 1.19 0.76-1.85 
^ HS=High School 
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Sex-specific analyses were also conducted. In the sex-specific analyses, 
suboptimal glycemic control was not associated with all-cause mortality among males 
(HR=1.19 [CI=0.80-1.77.]) nor females (HR=1.19 [CI=0.77-1.83]). In addition, there 
were no statistically significant relationship between all-cause mortality risk and 
borderline glycemic control among males (HR=1.02 [CI=0.61-1.71]) nor females 
(HR=1.21 [CI=0.78-2.86]). In addition, all-cause mortality risk was not associated with 
poor glycemic control among males (HR=1.45 [CI=0.88-2.39] nor females (HR=1.09 
[CI=0.59-2.00]).  Furthermore, when using the continuous variable of HbA1c values as 
the independent variables, levels of HbA1c were not found to be statistically significantly 
associated with all-cause mortality (HR=1.06 [CI=0.98-1.15]). However, when stratifying 
by sex, a statistically significant association with all-cause mortality risk was found for 
males (HR=1.14 [CI=1.02-1.28]) but not for females (HR=1.05 [CI=0.94-1.16]) in 
multivariable analyses.  There was no statistically significant relationship between 
HbA1c values and CVD mortality risk. Sex-specific analyses for CVD mortality were not 
possible due to the few CVD deaths.  
Further analyses were also conducted using different HbA1c cut-offs. 
Specifically, the thresholds of 6.5% and 6.0% we used. Diabetic individuals with a 
HbA1c of less than 6.0% or 6.5% had a statistically significant lower mortality risk (HR 
0.69 [0.48-99] and 0.72 [0.57-0.92], respectively) compared to individuals with greater 
values, even after adjusting for potential confounders.  The HbA1c threshold of 6.5% was 
used since it is a cut-off used by AACE for suboptimal glycemic control.13 Additional 
hazard analyses were conducted among four diabetic groups. Specifically, these groups 
were the following: 1) 65 years of age or older (n=620), 2) 65 years of age or older and 
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taking insulin only (n=169), 3) 65 years of age or older, taking insulin only, 4) 65 years 
of age or older and being diagnosed with hypertension (n-344), 5) taking insulin only (n= 
332), and 6) being diagnosed with hypertension (n=644). Among these diabetic groups, 
statistically significant relationships between strict glycemic control and all-cause 
mortality risk were not found. Specifically, diabetics 65 years of age or older with an 
HbA1c of less than 6.5% had a mortality risk of 0.73 [CI=0.48-1.12]; diabetics 65 years 
of age or older and taking insulin only with a HbA1c of less than 6.5% had a mortality 
risk of 1.05 [CI=0.37-3.00]; diabetics 65 years of age or older and taking insulin only and 
diagnosed with hypertension with an HbA1c of less than 6.5% had a mortality risk of 
1.41 [CI=0.51-3.88]; 4) diabetics 65 years of age or older and diagnosed with 
hypertension with an HbA1c of less than 6.5% had a mortality risk of 0.87 [CI=0.64-
1.22]); 5) diabetics taking insulin only with an HbA1c of less than 6.5% had a mortality 
risk of 0.95 [CI=0.46-1.97]; and 6) diabetics diagnosed with hypertension and with an 
HbA1c of less than 6.5% had mortality risk of 0.84 [CI=0.52-1.36]. 
 
Glycemic control and cardiovascular mortality risk   
 Part of the third research question of this study was whether suboptimal, 
borderline, and poor glycemic control were associated with greater cardiovascular 
mortality risk among US adults with type 2 diabetes, after controlling for potential 
confounders. It was hypothesized that individuals with suboptimal, borderline, and poor 
glycemic control would have greater cardiovascular mortality risk.  
Cross-tabulations of cardiovascular mortality and participant characteristics 
including glycemic control along with the corresponding chi-square test statistics are 
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shown in the table 17. In un-adjusted Cox proportional hazards models, neither 
suboptimal (HR=1.04 [CI=0.75-1.44]), borderline (HR=1.0 [CI=0.68-1.49]), or poor 
glycemic control (HR=1.09 [CI=0.54-2.19]) were associated with greater likelihood of 
cardiovascular mortality among adults with type 2 diabetes (Table 18). To be consistent 
with the hazard models for all-cause mortality, adjusted hazards models were also 
performed with the same variables added in the model except for cancer diagnosis. 
However, there were no differences in the association between the glycemic control 
variables and CVD mortality risk after a covariate was added in the model. 
 
Suboptimal glycemic control  
 The adjusted Cox proportional hazards model for the relationship between 
suboptimal glycemic control and CVD mortality risk is presented in Table 22. 
Suboptimal glycemic control was not statistically associated with CVD mortality risk 
among adults with type 2 diabetes (HR=1.06 [CI=0.75-1.51]). 
 
Table 22. Adjusted Cox proportional hazards model. Relationship between 
suboptimal glycemic control (HbA1c >7.0%) and CVD mortality risk among adults 
with type 2 diabetes, NHANES III 
Characteristic Hazards Ratio 95% Confidence Interval 
Suboptimal glycemic control   
  No 1.00  
  Yes 1.06 0.75-1.51 
Age group (yrs)   
 20-44 1.00  
 45-64 1.69 0.26-10.84 
 65+ 6.92 1.12-42.69 
Sex   
  Male 1.00  
  Female 0.77 0.51-1.18 
Race/Ethnicity   
  NH White  1.00  
  NH Black         0.78 0.53-1.16 
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Table 22 (continue) 
Characteristic  Hazards Ratio 95% Confidence Interval 
  Hispanic         0.49 0.29-0.83 
  Other 0.86 0.29-2.57 
Education   
 <HS 1.00  
  HS 0.64 0.40-1.05 
 >HS 0.63 0.40-1.00 
BMI category   
  Under/normal weight   
  Overweight      0.74 0.40-1.13 
  Obese 0.57 0.36-0.89 
Duration of diabetes (yrs) 1.01 0.99-1.02 
Hypertension diagnosis   
  No 1.00  
  Yes 1.14 0.76-1.72 
 
 
Borderline glycemic control  
 The adjusted Cox proportional hazards model for the relationship between 
borderline glycemic control and CVD mortality risk is presented in Table 23. Borderline  
glycemic control was not statistically associated with CVD mortality risk among adults 
with type 2 diabetes (HR=0.91 [CI=0.62-1.33]). 
 
Table 23. Adjusted Cox proportional hazards model. Relationship between 
borderline glycemic control and CVD mortality risk among adults with type 2 
diabetes, NHANES III 
Characteristic Hazards Ratio 95% Confidence Interval 
Borderline glycemic control   
   No 1.00  
   Yes 0.91 0.62-1.33 
Age group (yrs)   
  20-44 1.00  
  45-64 1.10 0.17-7.33 
  65+ 4.30 0.73-25.34 
Sex   
  Male 1.00  
  Female 0.77 0.48-1.24 
Race/Ethnicity   
  NH White  1.00  
  NH Black         0.72 0.45-1.17 
  Hispanic         0.50 0.25-1.01 
  Other 0.48 0.12-2.08 
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Table 23 (continue)  
Characteristic Hazards Ratio 95% Confidence Interval 
Education^   
 <HS 1.00  
  HS 0.79 0.47-1.35 
 >HS 0.62 0.33-1.16 
BMI category   
  Under/normal weight 1.00  
  Overweight      0.80 0.49-1.29 
  Obese 0.60 0.34-1.04 
Duration of diabetes (yrs) 1.01 0.99-1.03 
Hypertension diagnosis   
  No 1.00  
  Yes 1.19 0.75-1.90 
^ HS=High School 
 
Poor glycemic control  
 The adjusted Cox proportional hazards model for the relationship between poor 
glycemic control and CVD mortality risk is presented in Table 24. Poor glycemic control 
was not statistically associated with CVD mortality risk in un-stratified analyses 
(HR=1.38 [CI=0.67-2.82]).  
 
Table 24. Adjusted Cox proportional hazards model. Relationship between poor 
glycemic control and CVD mortality risk among adults with type 2 diabetes, 
NHANES III 
Characteristic Hazards Ratio 95% Confidence Interval 
Poor glycemic control   
  No 1.00  
  Yes 1.38 0.67-2.82 
Age group (yrs)   
 20-44 1.00  
 45-64 1.76 0.27-11.22 
 65+ 7.25 1.14-45.90 
Sex   
  Male 1.00  
  Female 0.76 0.50-1.16 
Race/Ethnicity   
  NH White  1.00  
  NH Black         0.77 0.52-1.15 
  Hispanic         0.49 0.30-0.81 
  Other 0.87 0.29-2.59 
Education^   
 <HS 
 
1.00  
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Table 24 (continue)  
Characteristic Hazards Ratio 95% Confidence Interval 
  HS 0.65 0.41-1.06 
 >HS 0.64 0.40-1.01 
BMI category   
  Under/normal weight 1.00  
  Overweight      0.75 0.48-1.15 
  Obese 0.56 0.36-0.89 
Duration of diabetes (yrs) 1.01 0.99-1.02 
Hypertension diagnosis   
  No 1.00  
  Yes 1.13 0.75-1.72 
^ HS=High School 
 
 
Summary of results of research question 3  
 
 In summary, it was found that neither all-cause nor CVD mortality risk was 
statistically associated with having suboptimal, borderline, or poor glycemic control, after 
controlling for potential confounders.  However, when HbA1c was used as a continuous 
variable, males with greater HbA1c values were found to have greater all-cause mortality 
risk. In addition, lower all-cause mortality risk was found among individuals with an 
HbA1c of less than 6.5%. Stratification by diabetic groups did not result in any statically 
significant relationships although the hazard ratios were in some cases in opposite 
directions.  
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CHAPTER V. 
DISCUSSION  
Overview 
In diabetes management, although glycemic control is one of the main outcomes 
for determining treatment prognosis, it continues to be inadequate in the US diabetic 
population, with about half not having good control.27 Not being able to reach glycemic 
control, despite adherence to diabetes management recommendations, can lead to 
frustration, indifference, and unwillingness to continue treatment.135 In the present study 
we attempted to assess both risk factors for suboptimal, borderline, and poor glycemic 
control as well as its outcomes with the expectation of gaining knowledge of why there 
may continue to be a high prevalence of suboptimal and poor glycemic control among 
adults with diabetes despite medical awareness of their importance. 
 
Potentially new risk factors and glycemic control 
 There has been much research into the possible determinants of glycemic control.  
Most studies have repeatedly focused on demographic risk factors such as race-
ethnicity37 as well as characteristics specific to diabetes such as duration of diabetes and 
type of diabetes treatment.35, 136 From the review of the literature of suboptimal and poor 
glycemic control, it appears that other potential risk factors for suboptimal and poor 
glycemic control may exist. For example, although it is not surprising the lack of 
adherence to diabetes treatment is shown to be associated with poor glycemic control,39 
reasons for this incompliance are not entirely known.  Possible reasons for the 
incompliance and consequent poor glycemic control may include a diabetic’s fear of 
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weight gain. It may also be that there are barriers in the diabetic’s environment 
preventing them from being compliant to diabetic treatment advice, such as lack of time 
to take medication or eat regularly because of inflexible work schedules. Furthermore, 
although an association between diabetes complications and glycemic control and 
smoking has been found, 60-64 a factor closely associated, secondhand smoke exposure, 
has not been fully investigated.  
  
Glycemic control and work hours  
Work constitutes an important part of most adult lives and sometimes is even a 
culprit of ill health. Long work hours has been implicated as a risk factor for poor health, 
including increased risk of mortality,137, 138 increased accidents,139 cardiovascular 
disease,140-142 greater unhealthy behaviors such as alcohol consumption,143  increased 
smoking,144 and less participation in physical activity.145 Thus, it is possible that glycemic 
control is also affected by having long hours of work.  
Most research studies on the effects of long work hours on diabetes and glycemic 
control have been based on non-US populations.146, 147 However, the consequences of 
long work hours should be of particular concern for American workers given that they 
report some of the highest number of work hours among industrialized countries.147 In 
fact, the amount of overtime in the US has increased since the 1970’s. 148, 149 147 Among 
15 industrialized nations in the world, in 2003 the US ranked as the fourth highest in 
average annual work hours, preceded only by Thailand, Hong Kong, and South Korea.150 
Meanwhile, the European Union does not allow more than 48 hours per work week, and 
Japan does not permit more than 100 hours of overtime per month. Yet in the US, only 
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certain occupations (e.g. transport workers and medical residents)151 have restricted work 
hours by law, and there are regulations regarding the amount to be paid for overtime 
work but not limiting the number of overtime hours.152   
In the present study we sought to understand the relationship between work hours 
and glycemic control. We found that among adults with type 2 diabetes who worked 
greater than 40 hours (about 34% of the sample) relative to those that worked 1-20 hours 
were at least 7 times as likely to have suboptimal or borderline glycemic control.  
 Although research has shown a relationship between work hours and 
cardiovascular disease,140-142  there is limited research specifically looking at its 
relationship with diabetes or glycemic control. Thus, the findings from the present study 
cannot be adequately compared to other studies. However, our findings are in agreement 
with studies in which individuals have reported irregular work hours and inflexible work 
schedule as a barrier to proper diabetes management.44, 45 
There are several reasons why working a greater number of hours may be 
associated with worse glycemic control. First, the reason for suboptimal glycemic control 
among those working long work hours may be simply related to the lack of time (i.e. time 
scarcity) to properly manage diabetes.  For example, workers may not have enough time 
to check blood glucose levels or eat regularly or at scheduled time intervals.153, 154 In a 
study in the Netherlands, a higher work load was perceived as a barrier to proper diabetes 
management, particularly insulin injection, in both type 1 and type 2 diabetes patients.153 
Time scarcity has been associated with an increased risk of obesity and of making poor 
food choices.154  Weight gain and obesity, both risk factors for type 2 diabetes, have also 
been found to be greater among individuals working long hours.144 In addition, time 
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scarcity is one of the barriers noted to be associated with the lack of adherence to a 
diabetic regimen or treatment.155 Furthermore, lack of time because of greater work hours 
may also interfere with important diabetes management activities outside of work such as 
getting medical care or visiting a diabetes healthcare provider or educator. For example, 
it has been shown that individuals who work a full-time or even a part-time job (as 
opposed to being unemployed or retired) are more likely to discontinue going to diabetes 
self-management education programs.156-158  In addition, lack of time has been associated 
with self-reported inability to visit dieticians.159, 160  
Second, longer work hours may result in suboptimal glycemic control due to 
greater job stress or strain as a result of working greater hours. Job strain has been linked 
to higher HbA1c levels among employed individuals without diabetes in non-US 
studies,42, 46, 47 while stress management programs have been associated with improved 
glycemic control.161 Although the biological mechanism is not well understood, stress 
may affect glycemic control via behaviors and neurohumoral pathways such as the 
counter-regulatory hormones,162, 163 and glycemic control may be related to the allostatic 
load or body’s way of adjusting to long-term stress.164 Poor glycemic control could also 
be in part due to the release of catecholamine and stress hormones (such as cortisol), 
which have been linked with increased cardiovascular risk factors.165, 166 The elevated 
stress levels could also result in negative behavioral habits, such as increased eating, in 
order to cope with such stress. In fact, weight gain and obesity have been found to be the 
highest among individuals reporting high job strain.167   
Third, it is possible that greater work hours may lead to worse glycemic control 
due to a greater propensity of late night eating since the time of day that meals are 
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consumed has been reported to affect insulin levels and to increase glucose intolerance.168 
Nevertheless, greater research is needed to understand the mechanism behind the 
relationship between long work hours and suboptimal glycemic control among adult with 
diabetes.  
 
Glycemic control and farm workers  
With regards to our findings about farm workers being more likely to have 
suboptimal glycemic control compared to white collar workers, there are very few if any 
studies that have investigated the association between glycemic control and being a farm 
worker to compare to. There are several possible explanations to our findings 
nonetheless. For example, it may be possible that farm workers, compared to white collar 
workers, may have less knowledge about diabetes self-management,169have inflexible 
work schedules,170 and be more likely to have unhealthy eating behaviors;171 all factors 
that may be responsible for poor glycemic control. For example, unhealthy diets are said 
to be greater among workers with high workloads,172 low status jobs,173 low control at 
work,174 and among workers with lower education and income 175, 176 all characteristics 
that may be more predominant among farm workers. Moreover, other factors such as 
social isolation, lack of social support, and depression,177 178, 179among farm workers may 
explain their higher likelihood of poor glycemic control. For example, a study of farm 
workers with diabetes found that over 66% reported themselves as being depressed and 
were greatly concerned about the long-term consequences of diabetes.171 In addition, 
stress may be higher in farm workers compared to white collar workers and may be 
contributing to the worse glycemic control in this group. Farm workers may be stressed 
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due to not knowing for how long they will be employed (fear of being unemployed), 
working strenuous hours, being away from the family, fear of being deported or 
discriminated against and exploited.171 This fear of losing their job may make the worker 
more hesitant to ask for time off and therefore be less able to access healthcare180 and 
routinely get diabetes care including getting their HbA1c checked and getting physician 
advice about diabetes.181  
We could not assess the relationship between the above mentioned potential 
mediators of the relationship between work hours or farm worker occupation and 
glycemic control.  This is because the data were not available in NHANES, except for the 
number of visits to a healthcare professional in the last 12 months. Nevertheless, the 
mediation test with that variable was not significant suggesting that the number of visits 
to a healthcare professional in the last 12 months does not explain the relationship 
between work hours or farm worker occupation and suboptimal/poor glycemic control.  
 
Glycemic control and desire to lose weight 
Research has shown that one of the barriers to adherence to diabetes treatment 
regimen is the fear of weight gain commonly associated with treatment regimens such as 
taking insulin.66-72 Furthermore, adolescents with diabetes perceiving themselves as 
overweight have reported poor glycemic control.73 Thus, it may be that individuals that 
want to lose weight are less likely to be adherent to treatment regimens and consequently 
have suboptimal or poor glycemic control. However, the association between glycemic 
control and weight desirability among adults with diabetes has been understudied.   
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In the present study, a statistically significant association between glycemic 
control and desire to lose weight was not found. This finding is in agreement with a study 
among adolescents with both type 1 and type 2 diabetes that found that trying to lose 
weight or worrying about one’s weight was not associated with poor glycemic control, 
although perception of being overweight was.73 Nevertheless, the null finding could also 
be a reflection of the two possible directions of the association between glycemic control 
and weight desirability. As the literature review indicated and as hypothesized, it is 
possible that individuals who wanted to lose weight and who knew of the possible 
consequences of tighter glycemic control such as weight gain,182-186would be less likely 
to have suboptimal or poor glycemic control because of the lack of adherence to 
treatment. A typical recommendation in diabetes management is weight loss if the person 
is overweight or obese.187 Thus, it is also possible that those individuals who wanted to 
lose weight would adhere more to diabetes management advice and would therefore be 
more likely to have good glycemic control.  Thus, it is possible that the null finding in the 
present study is a factor of having two types of individuals, those not adherent to diabetes 
management treatment due to fear of weight gain, and those adherent to diabetes 
management treatment due to wanting to lose weight and already understanding the 
detrimental effects of being overweight on diabetes prognosis.  
There may also be other factors into play in the relationship between desire to lose 
weight and glycemic control. For example, among adolescents, research has shown that 
unhealthy weight loss practices is associated with poor glycemic control among females 
but not among males.73 Given the potential differences in the relationship between 
glycemic control and dieting behavior by sex, we tested the interaction between desire to 
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lose weight and sex. We also conducted sex-specific analyses but did not find any 
statistically significant results. Therefore, more research is needed to understand the 
association between desire to lose weight and glycemic control.  
 
Glycemic control and secondhand smoke exposure 
Studies have shown a relationship between smoking and glycemic control63, 64  as 
well as diabetes complications that are often a result of poor glycemic control.61, 62 
Research on the various effects of SHS exposure on health outcomes aside from 
respiratory function is also mounting. Studies have recently documented the potential 
effects of SHS on cardiovascular disease,188, 189 glucose intolerance and diabetes 
incidence.43, 65, 190-192 Given the literature, it is plausible that SHS affects glycemic control 
as well.   
We assessed the association between glycemic control and SHS among adults 
with type 2 diabetes but did not find a statistically significant relationship. Our results 
cannot be adequately compared to other studies since there are very few if any studies 
assessing the relationship between glycemic control and SHS exposure. Nevertheless, the 
lack of statistical significance may also be a result of lack of power. It may also be that 
our definition of SHS exposure did not properly capture individuals with SHS exposure 
due to the short half-life of detectable serum cotinine levels,193 not knowing how long 
individuals were exposed to secondhand smoke, the absence of self-reported exposure to 
smoke in other settings (e.g., restaurants, bars, or motor vehicles), and potential 
misclassification of smoking and SHS exposure status.124   Because of this potential 
misclassification, analyses were also done using cotinine as a continuous variable among 
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individuals who reported not being current smokers but no statistically significant 
relationship was found with this measure of SHS either. Therefore, because of the 
possibility of error in defining smoking and SHS exposure groups, the uncertainty of the 
accuracy of the measure for SHS exposure (which may explain the lack of statistical 
significance), and because other studies have suggested that SHS effects glycemic 
control,42, 64 further research is needed to fully understand the relationship between SHS 
exposure and glycemic control among US adults with type 2 diabetes.  
 
Glycemic control and health related quality of life 
Quality of life measures have been gaining interest in the medical and public 
health professions over the past years. In the late 1960’s to early 1970’s, HRQOL was 
mentioned approximately 40 times in the medical literature while in the late 1980’s to 
early 1990’s it was mentioned approximately 10,000 times.194  
The HRQOL measures may indicate how an individual views his or her health. 
This self-reflection of health status has been suggested to be a better indicator or ill health 
and good predictor of mortality.195 The determinants of how a person’s self-perceived 
health may be based on an array of factors such as family history and other risk factors, 
medical history, and psychological orientation (i.e., optimism or pessimism).195 
Furthermore, based on the premise of the “self-regulation theory”, one’s perception about 
the seriousness of one’s illness does affect how one’s disease is managed.196 
How HbA1c affects everyday activities may be important given that individuals 
may perform certain self-management tasks as a result of short-term benefits such as lack 
of negative symptoms that may accompany poor glycemic control.77, 197 Social activities 
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such as gatherings with friends are among the activities that may be affected by poor 
glycemic control because of fear of embarrassment from having the manifestation of 
hypoglycemia or hyperglycemia symptoms in public. An individual may be more likely 
to adhere to diabetes treatment if she or he knows that by following their physician’s 
advice about proper diet for glycemic control, their respective risk of hypoglycemia or 
hyperglycemia may be lowered. In fact, among adults with diabetes, knowledge of 
HbA1c levels has been noted as an important factor determining how a patient rates his 
or her health, particularly physical functioning, mobility, and satisfaction with physical 
health and family life.198 In addition, among adults with diabetes, barriers for lack of 
compliance have been noted to include lack of symptoms155 and the belief that having 
diabetes is not serious.199 Patients with diabetes have stated that managing their diabetes 
is associated with an impaired ability to engage in activities with their family and 
friends.200 Thus, bringing awareness of how poor glycemic control affects everyday life 
may lead to better treatment compliance.  
Diabetes is a disease that requires self-management behaviors to improve 
treatment prognosis. The adherence to treatment and the positive self-management 
behaviors may be influenced by symptoms and physiologic changes due to the diabetes 
disease, which may take years develop or be physiological manifested.200 Thus, 
understanding the impact of good management practices on day-to-day activities and 
well-being may lead to better adherence and ultimately improved glycemic control.  
There have been studies assessing the relationship between glycemic control and 
quality of life, but these have been contradictory and/or are not based on nationally-
representative US population.83-88, 201, 202  Thus, we attempted to assess the relationship 
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between glycemic control and HRQOL.  We found that these relationships were not the 
same for all HRQOL indicators. Specifically, we observed a statistically significant 
relationship between poor glycemic control and number of days with poor mental health 
and inactivity. However, poor glycemic control was not associated with number of days 
of poor physical health or poor self-reported general health.  
Our findings are in agreement with the literature which has shown that suboptimal 
and/or poor glycemic control is not related to all aspects of health in the same fashion.83-
88 These studies have however defined quality of life based on SF-36 scores, the validated 
instrument with 36 questions about perceived health status and number of disability days. 
This instrument is considered the gold standard for evaluating overall health including 
physical and mental health. 78 
For example, one study of patients from community health clinics in California 
followed for one year showed a slight inverse relationship (-0.21 regression) between 
HbA1c levels and SF-36 Mental composite scores (higher score indicating better mental 
health). 83 However, in that same study83 no significant relationship was observed with 
the SF-36 Physical Composite Score. In another study of diabetic adult patients from a 
Veterans Affairs Health Care system, perceived poor health (as indicated by SF-36 
scores) was associated higher HbA1c levels but mental health was not associated.85 Other 
studies have not found any significant relationship between overall quality of life and 
glycemic control.81, 201, 202 For example, in a study of non-insulin diabetic patients of a 
Veteran’s clinic in North Carolina, HbA1c levels and HRQOL assessed using SF-36 were 
not correlated.202  
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Glycemic control and self-reported general health, physical health, and activity limitation  
A statistically significant relationship between self-reported general health and 
glycemic control was not found in our study, which is not surprising given the 
inconsistent findings in previous studies. For example, in a double-blind randomized 
controlled trial of adults with type 2 diabetes, the treatment group with more strict 
diabetes treatment regimen (aimed at improving glycemic control) reported better self-
perceived general health and improved cognitive functioning.102 However, other studies 
have not found a statistically significant relationship between self-reported general health 
and quality of life.88   
We also did not observe a statistically significant relationship between glycemic 
control and number of days of poor physical health. This is in contradiction to research 
that has suggested poor glycemic control to be associated with poor physical health given 
the greater likelihood of diabetes complications that cause chronic pain such as 
neuropathy among diabetic adults with poor glycemic control.194 Nevertheless, we cannot 
compare our findings to other studies due to the lack of studies specifically investigating 
the relationship between glycemic control and number of days of poor physical health. 
We did, however, find a statistically significant relationship between days of 
limited activity and glycemic control. Specifically, those with poor glycemic control were 
more likely to have ≥14 days of inactivity (versus 0 days) but were less likely to have 1-
13 days (versus 0 days). These findings are inconsistent with the literature on disability 
and diabetes and glycemic control.94, 100 For example, a study using data from the Midlife 
Development in the United States Survey among adults between the ages of 25 and 54 
years, noted diabetics to have an average of 3.6 impairment days per month although 
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diabetes ranked lower than other conditions such as cancer, ulcer, heart disease, and 
generalized anxiety disorder in terms of the number of impairment days per month.94 
Studies specifically investigating the relationship between self-reported activity limitation 
and glycemic control were not found however.  
 A potential reason for the lack of statistically significant associations between 
days of poor physical health and days of inactivity and glycemic control could be due to 
the categorization of these variables, as these are somewhat arbitrary categories used in 
previous studies.115, 116 The application of categories for these variables could have also 
accounted for the differences in the directions of the estimates for days of poor mental 
health. Since the numerical variables of number of days of poor physical health, number 
of days of poor mental health, and days of inactivity showed over-dispersion and excess 
zeros, ZIP analyses were conducted as opposed to traditional linear regression analyses. 
The ZIP analyses showed no statistically significant relationships between number of 
days of poor mental or physical health or inactivity with glycemic control. Therefore, 
further research may be needed, with perhaps better measures, to establish is there is a 
relationship between number of days of poor health and inactivity and glycemic control 
among US adults with type 2 diabetes.  
 
Glycemic control and mental health 
In the present study suboptimal and borderline glycemic control was associated 
with lower odds for having 1-13 days of poor mental health (versus 0 days). These 
findings suggest that individuals with suboptimal glycemic control rather than good 
glycemic control have better mental health. Thus, there may be a level of distress or 
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mental discomfort associated with having to maintain very low HbA1c levels among 
adults with type 2 diabetes. Our findings are in agreement with studies that have found 
that tight or strict glycemic control (e.g. HbA1c levels of less than or equal to 6.5%) is 
associated with poor quality of life measures of mental health and physical health.198, 203, 
204 One of the reasons why those individuals with tight glycemic control rate their health 
as poorer may be due to greater episodes of hypoglycemia when HbA1c levels are 
lower,198, 205, 206which can range from 2 to 4 episodes per year among those type 2 
diabetics trying to manage their diabetes. For example, the Diabetes Control and 
Complications Trial (DCCT) study showed that strict glycemic control increases the 
chances of severe hypoglycemia.206 Hypoglycemia may cause psychological symptoms 
such as displeasure, feelings of anger, and fatigue207 as well as more visible physiologic 
symptoms such as poor coordination, nausea, drowsiness, shaking and sweating.208, 209  
Researchers have also suggested a curvilinear relationship between HbA1c levels and 
quality of life likely due to the negative aspects of either the intricate treatment regimen 
and/or the greater episodes of hypoglycemia due to tight glycemic control.79  
In addition to the symptoms of hypoglycemia, the greater days of reported poor 
mental health may be due to the sometimes overwhelming chore of diabetes self-
management. The diabetes regimen can be mentally taxing since it may require drastic 
dietary changes, and the re-scheduling of activities (due to, for example, having to take 
medications or insulin injections at certain times of the day or having to eat regularly).39 
Furthermore, these lifestyle changes in everyday activities may make others annoyed 
which may then result in conflict between the individual with diabetes and his/her 
friends, family and co-workers. This conflict may be a contributor to the mental stress 
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that adults with diabetes often report.194 Finally, the fear of hypoglycemic events due to 
such strict glycemic control, particularly in social settings, may place an additional level 
of emotional distress to the individual with diabetes.194 There are no known studies 
however investigating the relationship between fear of hypoglycemia and glycemic 
control among adults with type 2 diabetes. As hypothesized however, poor glycemic 
control (i.e. HbA1c >9) was found to be associated with having greater days of poor 
mental health. There are several potential explanations for our findings. One is that the 
negative symptoms associated with hyperglycemia (i.e. increased thirst, urination, and 
weight loss, as well as fatigue, drowsiness, depression) 210are higher when the person has 
their blood glucose levels out of control, thereby leading to reduced feelings of well-
being and consequently report of poor mental heath.80, 211  
On the other hand, it may be that these individuals with diabetes have poor 
glycemic control because they are depressed and are in poor mental health to begin with. 
This scenario is very likely given the high prevalence of depression among adults with 
diabetes, with data suggesting that as many as 9-27% of the diabetes population may 
experience depression.212, 213 Thus, it is possible that depression preceded poor glycemic 
control in our study sample.  These individuals with depression may be having poor 
glycemic control due to being more likely to be non-adherent to treatment regimens.214 
Individuals with poor mental health may be in denial of their condition and therefore not 
follow diabetes management steps thereby leading to further poor glycemic control.215 In 
addition, for a percentage of hard to treat individuals with type 2 diabetes, particularly 
those newly diagnosed, the lack of reaching good glycemic control levels despite taking 
measures may lead to feelings of disappointment despair, emotional distress, and 
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consequently poor self-reported mental health. 39, 194, 216 Thus there may be a “negative 
reinforcing cycle” in which lack of attainment of good glycemic control despite good 
efforts leads to emotional distress, and the emotional distress leads to lack of 
encouragement and hope and consequently lack of adherence to treatment, which further 
leads to even worse glycemic control.39 Finally, there may be biological mechanisms for 
the relationship between depression and glycemic control. For, example it has been 
suggested that decreases in serotonin and cortisol due to depression may increase fasting 
glucose levels.217 More research is need in this area however.  
Although we did not find a statistically significant interaction between sex and 
number of days with poor mental health, to be consistent with the literature suggesting a 
relationship218, 219, 220 221 we conducted sex-specific analyses for the relationship between 
poor glycemic control and poor mental health. In sex-specific analyses, we found that 
among females with type 2 diabetes, poor glycemic control was associated with lower 
odds for having 1-13 days (versus 0 days) of poor mental health while among males, poor 
glycemic control was associated with greater odds of 1-13 days (versus 0 days) of poor 
mental health. Our findings are in agreement with studies that have shown that among 
women, poor glycemic control is associated with poor overall quality of life (i.e., not 
specifically mental or physical health).218, 219  Furthermore, in a Netherlands study, there 
was an observed positive association between depression and poor glycemic control 
among women but not among men.220 This association may be greater among women 
because of the lower estrogen levels as women become older.221 In fact, a study found 
that estrogen replacement therapy was associated with improvement in glycemic 
control.221 In addition, depression has been associated with changes in estrogen levels.222 
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However, one study found depression to be associated with higher HbA1c levels in men 
but not in women.223 Thus, the contradictory study findings suggests that further research 
is needed to truly understand the sex differences in the relationship between depression 
and poor mental health and glycemic control.  
 Finally, to further investigate why there was a difference in the direction of the 
estimate for the relationship between poor mental heath and glycemic control, 
multinomial logistic regression analyses for poor mental heath were repeated using 
collapsing zero to 5 days of poor mental health into one category. The results, however, 
did not reveal any difference whether having zero days as one category by itself or 
grouping it with 1-5 days.  
 
Workforce participation and glycemic control  
In addition to morbidity outcomes and HRQOL including self report of well-
being, workforce participation is another measure of the effect of ill health and the 
overall burden of disease. Two commonly used measures of workforce participation are 
employment status and missed work or absenteeism. Research has shown that adults with 
diabetes are less likely to be employed and more likely to miss work,57, 97-99, 201, 224-226 
particularly if they have complications from diabetes.94, 100, 101, 227-229 This may be due to 
diabetes being a health condition unlike many others that requires self-management in 
order to improve disease prognosis, reduce the risk of complications, and increase overall 
quality of life.230 Individuals with diabetes usually need to follow strict dietary regimens 
as well as medication regimens that require medication (such as insulin injections) to be 
followed in a scheduled manner. These regimens may thus need to be implemented 
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during work hours, which may appear burdensome to both the employee and the 
employer. Such frustration and inability or unwillingness to properly accommodate the 
employee may lead to unemployment.  In turn, the lack of proper diabetes management 
and consequently poor glycemic control and related symptoms may result in greater 
absenteeism from work.  
Since poor glycemic control is a factor that greatly increases the chance of 
diabetes complications, it is more likely that glycemic control is associated with 
unemployment and missed work. In the present study the relationship between 
employment status, missed work days, and glycemic control was assessed.  
 
Glycemic control and missed work 
In the present study, a statistically significant relationship between glycemic 
control and missed work days in the previous month was not found. The null finding in 
the present study could be due to two reasons.  
First, there may not be a relationship between glycemic control and missed work, 
since there are contradictory findings in the literature. Similar to the present study, some 
studies have not found a statistically significant relationship. For example, in a cross-
sectional study of adults with diabetes referred to a diabetes program (the Control 
Diabetes Services Program) from several centers in the US, there was marginally 
statistically association between an HbA1c level of > 8% and self-reported days lost from 
work or school during the previous year, after controlling for confounders.104  However, 
in that study,104 an HbA1c of 8-10% was not statistically associated with days lost from 
work or school during the previous year. Furthermore, HbA1c levels of 7-8%, HbA1c 8-
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10%, or HbA1c of >10%  was associated with having greater than five days of missed 
work in the previous month or with difficultly accomplishing work tasks among adults 
with diabetes enrolled in health maintenance organization in the US.227  However, other 
studies have found a statistically significant relationship. In a cross-sectional of patients 
with diabetes from Michigan, having an HbA1c of 8-8.9% was associated with greater 
probability of missing at least one hour of work using probit models. However, a 
statistically significant relationship was not found for HbA1c levels of 7.0-7.99% or 
greater than 9.0%.103 Furthermore, in that study,103 missed work was based on hours 
missed from work in only the last 4 weeks, which may not be accurate estimation of the 
habitual missed work due to glycemic control issues.  
Second, literature on absenteeism related to health, or sickness absence, has 
suggested that absenteeism is not a factor that is solely determined by the presence of a 
medical condition, but rather based on different factors such as an individual’s perception 
of his/her health and symptoms related to disease, attitudes related to work and missing 
work, job demands and accommodations at work, job strain, and other factors.231 Thus, it 
is possible for example that some of these individuals with diabetes are resistant to 
missing work regardless of how ill they feel from being in poor glycemic control.232   
 
Glycemic control and unemployment 
In the present study we did not observe a statistically significant relationship 
between glycemic control and employment status. Our findings are in disagreement with 
the sparse studies assessing the relationship between glycemic control and employment 
status. In a study of health maintenance organization enrollees with diabetes, HbA1c 
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levels of > 10% were associated with greater disability and unemployment.227 
Furthermore, in a double-blind randomized controlled trial of adults with type 2 diabetes 
the treatment group with more restrictive diabetes treatment regimen were less likely to 
report losing their jobs during the follow-up period.102   
There are several potential reasons for the lack of a statistically significant 
relationship between employment and glycemic control. First, there is the potential of 
misclassification of employment given that employment is based on working in the prior 
week. Thus the person would be considered unemployed when in fact they were 
employed. Second, it is possible that unemployment (or employment) is a result of other 
factors not related to health. For example adults 65 years of age or older may be more 
likely to unemployed because of retirement and not necessarily due to their level of 
glycemic control. However, when analyses were repeated removing those 65 years and 
older, there were no statistically significant relationships between glycemic control and 
employment status in those less than 65 years of age or 65 years of age or older. Third 
and lastly, there may be the potential for healthy worker effect bias. If healthy worker 
effect bias is present, then the true association between employment and glycemic control 
would be masked given that those employed are generally in better health than those not 
employed. 
Although no statistically significant interactions were found, since the literature 
suggests that there may be differences in employment due to sex129, sex-specific analyses 
were conducted. When the full model was stratified by sex, the results remained non-
statistically significant but the direction of the association was different for males and 
females.  
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Mortality and glycemic control 
 It is well established that individuals with diabetes are at an increased risk of 
death compared to individuals without. The mortality rate ratio of the mortality rates 
comparing individuals with diabetes versus those without has been shown to range from 
1.5 among individuals age 65-74 years of age to 3.6 among individuals 25-44 years of  
age.233 Not surprisingly, diabetes is the sixth leading cause of death based on the most 
current national death statistics with a death rate of 23.3 per 100,000 US population 
according to CDC 2006 data.6, 234 One of the proposed reasons for the higher mortality 
risk is poor glycemic control among individuals with diabetes since poor glycemic 
control is associated with increased diabetes complications.10  
Several studies have assessed the relationship between glycemic control and all-
cause and cause-specific mortality risk, although these have led to conflicting findings, 
particularly when analyses were sex-specific analyses, and/or based on non nationally 
representative sample of adults with diabetes, specifically type 2 diabetes.105-107The only 
nationally representative study assessing glycemic control among adults with type 2 
diabetes that was recently published found that there was a curvilinear relationship 
between HbA1c levels and all-cause and CVD mortality risk.235 However, that study 235 
did not assess the relationship between mortality risk glycemic control among diabetic 
groups such as those that may be in presumably worse health (e.g. older, insulin taking 
type 2 diabetics, or those with hypertension) and therefore be at greater risk of 
complications from very strict glycemic control. In addition, that study 235 did not address 
the potential impact of confounding by depression in the relationship between glycemic 
control and mortality risk. Assessing the role of depression in mortality risk is important 
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given it has been associated with increased mortality risk among adults with diabetes.236 
In addition, depression has been associated with poor glycemic control, 214, 223plus we 
found poor glycemic control to be associated with number of days of poor mental health.   
In this study we assessed the effect of suboptimal, borderline, and poor glycemic 
control on all-cause and CVD mortality risk. We found that neither suboptimal, 
borderline, or poor glycemic control was significantly associated with increased all-cause 
or CVD mortality risk, after adjusting for several potential confounders.  Nevertheless, 
the results did show an effect in the hypothesized direction, with higher non-statistically 
significant mortality hazards due to suboptimal or poor glycemic control.  
Since the literature suggests that there are differences in mortality by sex130 and 
because there was an interaction between BMI category and sex, sex-specific adjusted 
hazards models were also undertaken. Even in sex-specific analyses, non-statistically 
significant relationships were found between the mortality risk and the dichotomous 
variables for glycemic control.  
In order to be consistent with the studies on mortality risk and glycemic control, 
we also used the HbA1c measure as a continuous variable,106-108 but no statistically 
significant relationship was found, except for when stratifying the results by sex, with 
statistically significant results found for males only.  This finding suggest that perhaps the 
benefits in life expectancy due to improved glycemic control may be more pronounced in 
males rather than females, however more research in this area is needed.  
We did not find that depression was associated with any of the glycemic control 
groups nor was it associated with increased mortality risk. Therefore, it was not believed 
to be a potential confounder in the relationship between glycemic control and all-cause 
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mortality risk and thus was not added in the final hazard models. Indeed, adding 
depression in the hazard models did not result in any change in the association between 
all-cause mortality and glycemic control. 
Although we hypothesized that suboptimal, borderline, and poor glycemic control 
would be associated with greater odds of mortality, the findings are not surprising given 
the contradictory findings in previous studies. Among studies that have looked at all-
cause mortality only, a statistically significant relationship with inadequate glycemic 
control has been observed. For example, poor glycemic control has been associated with 
all-cause mortality among advanced chronic kidney disease (CKD) and dialysis 
patients.105 In a study of patients undergoing maintenance hemodialysis, greater HbA1c 
values predicted a greater risk of all-cause and cardiovascular mortality among adults 
with diabetes after three years of follow-up, after adjusting for confounders such as 
demographics, malnutrition and anemia.107  In a prospective study of individuals 
primarily without diabetes in the United Kingdom to assess the relationship between 
HbA1c values and all-cause mortality and CVD mortality after a 6 year follow-up,108 it 
was shown for every 1% increase in HbA1c level, the all-cause and CVD mortality risk 
increased in a dose response fashion. However this study108 did not control for family 
history of diabetes or CVD and other potential confounders.  
One study, however, did not find a statistically significant relationship between 
glycemic control and both all-cause mortality or CVD mortality risk.106 In a study using 
data from the Modification of Diet and Renal Disease (MDRD) study, a randomized 
controlled study of non-diabetics with CKD, a 1% increase in HbA1c was associated with 
a greater risk of all cause mortality, but the association with CVD mortality was not 
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significant, after approximately a 7-11 year follow-up period.106 However, in this study, 
the incidence of diabetes was not established, a factor which could have distorted the 
results. Moreover, most of the studies investigating the relationship between diabetes 
management measures (e.g., fasting blood glucose, HbA1c value) and CVD events 
including mortality risk has been primarily in men.108-110, 237   
 In addition to studies on the effect of suboptimal and poor glycemic control on 
mortality risk, there has been recent attention to the effects of more strict thresholds for 
glycemic control on mortality.238-240 Strict glycemic control is generally considered an 
HbA1c value of less than or equal to 6.5% and is often reached by intensive diabetes 
management, for example with treatment with sulfonylurea or insulin and with the goal 
of reducing their fasting plasma glucose concentration to less than 108 mg/dl. Such 
intensive treatment has been associated with reductions in the incidence of nephropathy, 
neuropathy, and retinopathy complications by as much as 27%241 and has been shown to 
lead to increases in life expectancy, with a slight increase in complications due to longer 
survival time.241 However, negative health outcomes due to strict glycemic control, such 
as increased mortality risk, have also been reported. For example, in the Action to 
Control Cardiovascular Risk in Diabetes (ACCORD) study, individuals in the strict 
glycemic control arm, who achieved on average an HbA1c of 6.4%, had greater deaths 
(n=257) compared to the group not in the strict glycemic control (with average HbA1c of 
7.0-7.95) (n=203 deaths) event after four years of follow-up.242 This translates into a 
1.4% death rate per year for the strict glycemic control arm versus 1.1% death rate per 
year for the control group.242 This unexpected result in the ACCORD study resulted in 
termination of the trial and suggested that very strict glycemic control among certain 
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individuals with type 2 diabetes is harmful to health.242 However, the findings of this trial 
should be interpreted with caution since the participants were perhaps more 
representative of the diabetics with worse health given that most had elevated HbA1c 
(average of 8.2 at baseline), had greater length of diabetes duration, were smokers, had 
high cholesterol and high blood pressure and were obese; these factors could have 
increased the mortality risk.242  Nevertheless, continued debate exists as to whether strict 
glycemic control is beneficial in terms of decreasing mortality risk to all individuals, or 
whether for some more chronically-ill individuals, intensive treatment can cause more 
harm than good.  
 Given the recent controversy and remaining questions as to which threshold of 
glycemic control is most beneficial for improving overall health and reducing mortality 
risk,238-240 we performed additional analyses using stricter thresholds for glycemic 
control. We found that indeed having an HbA1c value of less than 6.5% was protective 
against all-cause mortality among adults with type 2 diabetes. These results are in 
agreement with studies among hemodialysis patients.107 
The literature also suggests that strict glycemic control may be particularly 
harmful to certain diabetic groups such as the older (and therefore likely more frail), 
those taking insulin only, and/or those with comorbid conditions such as hypertension, as 
implied by results of the ACCORD study.242 However, analyses conducted stratifying by 
diabetic groups did not show statistically significant differences associations between 
mortality risk and glycemic control, although the hazard ratios were sometimes in the 
opposite directions, suggesting possible moderation. Given the differences in direction of 
the relationship between all-cause mortality risk and strict glycemic control, the results 
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suggest that the effect of strict glycemic control on mortality risk may depend on the age, 
gravity of diabetes condition (i.e. whether dependent on insulin or not), and the presence 
of other comorbid conditions. Greater research is needed in this area however since these 
results were not statistically significant.  
Thus, our findings suggest that strict glycemic control may indeed be beneficial in 
increasing survival among adults with type 2 diabetes after a 6 to 12 year follow-up, 
assuming glycemic control remained relatively constant through the follow-up period. 
These findings would be therefore in disagreement with recent findings from the 
ACCORD study.242 Differences in diabetic populations in the ACCORD study and the 
present study could account for the different findings related to mortality risk from strict 
glycemic control.  
 
Strengths and limitations 
This study has both strengths and limitations. A limitation of this study was its 
cross-sectional design, which does not allow for the establishment of causal relationships. 
However, the information gained from this research can generate hypotheses that could 
be tested in future analytical studies using for example cohort and prospective designs. 
In addition, the individual’s diabetes status and duration of diabetes were based 
on self-reported information. However, self report of diabetes has been found to be fairly 
accurate when compared to medical criteria, with overall agreement of 96.3% (sensitivity 
of 85.2% and specificity of 98.3%).243 In addition, whether the individual had type 1 or 
type 2 diabetes is not truly known as individuals were only asked about diagnosis of 
diabetes in general not whether their diabetes was type 1 or type 2. The definition for 
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type 2 diabetes that was used in the present study was modeled after definitions used in 
several studies in which diagnosis of diabetes after the age of 30 was considered type 2 
diabetes.30, 244, 245 However, since type 2 diabetes has been shown to be increasingly 
diagnosed in much younger age groups,246 there is the potential for misclassification with 
the definition that was used that assumes that individuals diagnosed before the age of 30 
have type 1 diabetes.  
Also, glycemic control was based on only one HbA1c reading leaving the 
possibility of measurement error of glycemic control. However, the possibility of 
measurement error is minimal given that the NCHS HbA1c laboratory protocol includes 
strict quality control procedures to limit measurement error.114 Specifically, a subset of 
laboratory specimens of HbA1c are randomly selected and replicated to test the validity 
of the measurements. The coefficient of variation of these specimens of range from 0.90-
2.54%,114 thereby showing high accuracy of the measurements retested. In addition, 
research using NHANES III data has shown low variability and high sensitivity of 
HbA1c measurements repeated after a two week period in an subset of individuals from 
NHANES, with a within-person coefficient of variation of 3.6%.247 Thus, not only do the 
HbA1c measurements in NHANES data appear to be relatively free of measurement error 
due to for example faulty equipment or laboratory procedures. In addition, an individual’s 
level of glycemic control as determined from HbA1c tests do not appear to vary much 
even if taken within a few weeks apart.  Nonetheless, given the cross-sectional design of 
the study and that a diabetic’s degree of glycemic control may vary from a time point to 
another (e.g. year to year) and that the consequences of unhealthy lifestyles or 
environments (e.g. arduous working conditions) may take months or years to be 
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manifested physiologically, the exact nature of the relationship between glycemic control, 
work characteristics and mental health may not be ascertained from this study.   
Furthermore, although the likelihood of these to alter results are minimal, there 
may be some factors affecting the HbA1c reading that could lead to erroneous results 
such as hemoglobin disorders, erythrocyte mass and plasma volume, renal disorders, liver 
or cardiac function problems, anemia, and menstruation.248, 249 There is also the 
possibility of recall-bias, for example for hours of missed work in the past 12 months and 
self-report of age of diagnosis, although studies have shown that age of diagnosis of some 
diseases is reliable.250  
Furthermore, our findings may be skewed due to the healthy worker effect bias, 
which says that individuals tend to be in better health than non-employed individuals, or 
those working more hours are in better health than those putting fewer hours at work. If 
such bias is present in this study, then our results would be attenuated and the association 
between suboptimal/poor glycemic control and long work hours is even stronger than 
what the study showed. In other words, one would expect those working 1-20 hours to be 
in worse glycemic control than those working greater than 20 hours, yet we found the 
opposite relationship. In addition, we did not find a statistically significant association 
between employment status and glycemic control. Thus, a healthy worker effect bias is 
somewhat unlikely in the present study. Of note, only the analyses for hypothesis 1 and 
2b using the work variables were based on the employed sample. The analyses for 
assessing the relationship between glycemic control and SHS, weight desirability, 
HRQOL, and mortality risk were done using both employed and unemployed individuals, 
with most analyses controlling for employment status.  
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Another limitation in the present study is that other possible determinants of 
glycemic control were not measured, such as patient adherence to medication dietary 
regimen,251, 252 frequency of self blood glucose monitoring,253 health literacy, 254, 255 diet 
256, 257 and frequency of meals consumed per day and caloric beverages.45 Psychological 
factors that may also be related to glycemic control were not assessed because these were 
not available in NHANES. These factors include stress,258 depression,214 beliefs 
regarding how serious the disease is.259 It would have also been beneficial to know the 
length of diabetes management or treatment. The length of time the individuals have had 
either good or poor glycemic control is also not known. Yet, the length of time of 
glycemic control is important given that the risk of diabetic complications, morbidity and 
mortality may be dependent on this.105 For example,  in the DCCT study, renal 
improvements were evident after three years of good glycemic control.206 In addition, the 
degree of hypoglycemic events in the individuals is not known, although hypoglycemia 
and fear of hypoglycemia is a barrier to good glycemic control,208, 260, 261 particularly 
among those treated with insulin.262 We may have also an unreliable measure of missed 
work in the present study. This absenteeism measure is based on self report of missed 
work in the past month, which may be subject to some recall bias. In addition, ideally 
missed work would be based on the missed work in the last three months, given that 
glycemic control is based in average glucose levels in the last three months. We also 
assume that missed work is directly due to poor glycemic control when in fact it could be 
related to other factors not related to health. For example, sickness absence has been 
reported to be due to a combination of personality factors such as “coping mechanism” 
231 and “behavior of social inequity,” 263 and burnout. 264 In addition, the use of ZIP 
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analyses could have possibly not captured the association between missed work days and 
glycemic control. However, categorization of the variable missed work days (as opposed 
to leaving it as a count variable) did not result in any statistically significant relationship 
between it and glycemic control groups either. All of these factors could have led to the 
null finding when assessing the relationship between missed work and glycemic control.  
We also do not have data on depression for NHANES 1999-2004, yet it may 
partially explain the relationship between employment and glycemic control since 
depression has been linked with poor glycemic control214 and with unemployment and 
disability.227  In addition, reduced performance while at work due to ill health, in other 
words presenteeism, was not measured although it can be an additional indicator of the 
negative effects of poor glycemic control.  
Furthermore, the NHANES utilized a generic instrument to measure quality of life 
that was used instead of a disease specific one, which can result in reduced sensitivity.81 
Although CDC’s measure for HRQOL is a generic measure, therefore having the benefits 
of being able to be compared to findings from people living with other conditions,77, 79 it 
might not be the most appropriate measure for diabetics. HRQOL scales that are more 
“illness-oriented” for diabetics include the Diabetes Quality of life Measure, the Diabetes 
Treatment Satisfaction Questionnaire, and the Problem Areas in Diabetes 
Questionnaire.77, 79 These measures are better in that they can assess the impact of 
activities or experiences specific to diabetics, such as issues related to using 
pharmacological medication and diet.79  
Another limitation is that mortality risk is only based on a 6-12 year follow up 
since NHANES III data was collected from 1988 to 1994 but the mortality linkage data 
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are up to 2000. However the psychological and physiologic effects of poor glycemic 
control may take longer to be manifested. There may also be some degree of 
misclassification of cause of death.265 For example, a study comparing death certificates 
for coding of coronary heart disease as the underlying cause of death with cause of death 
judged by a panel of physicians showed that these death certificates have a sensitivity of 
83.8%, with a 24.3% overrepresentation of coronary heart disease deaths.265  
Furthermore, level of glycemic control was only assessed at baseline in NHANES III and 
therefore level of glycemic control at time of death is not known, leading to potential 
misclassification.  Finally, the small sample size of farm workers likely resulted in loss of 
precision of the estimates; this was evident in the widening of the confidence intervals as 
covariates were added in the regression models.   
Despite these limitations, the present study has many strengths. The strengths of 
the present study included the use of data from a nationally representative sample of 
adults with type 2 diabetes, the availability of several potential confounders, the 
availability of a 6 to 12 year mortality follow-up of a nationally representative sample of 
adult with diabetes,  the first known study to address the association between health 
related quality of life, workforce participation and glycemic control while adjusting for 
potential confounders, and the first study to assess the relationship between glycemic 
control and weight desirability, secondhand smoke, and work hours and type of 
occupation among US adults with diabetes. 
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CHAPTER VI. 
 
CONCLUSION 
 
 The aims of the present study were to assess the relationship between four 
potentially new risk factors (number of hours worked per week, type of occupation, 
secondhand smoke exposure, and desire to lose weight) and suboptimal, borderline, and 
poor glycemic control using nationally representative secondary data (NHANES III and 
1999-2004). We also investigated the consequences of suboptimal, borderline, and poor 
glycemic control in terms of HRQOL, employment status, absenteeism, and mortality. 
 Our findings suggest that the number of hours of work and possibly the type of 
occupation an adult with diabetes has does affect their level of glycemic control. 
However, whether the adult with diabetes is exposed to secondhand smoke or whether he 
or she wishes to lose weight may not have a significant bearing on their degree of 
glycemic control and further studies are needed to define these relationships accurately. 
In addition, we found that poor mental health to be among those with poor glycemic 
control yet better for those with suboptimal glycemic control. Furthermore, individuals 
with poor glycemic control may be more likely to have greater days of inactivity. 
Interestingly, although greater number of days of poor mental health and inactivity were 
reported among those with poor glycemic control, there was no statistically significant 
relationship between employment status and missed work days and glycemic control. 
Thus, our data suggest that individuals with poor glycemic control are attending work yet 
probably are not performing at their optimal level; in other words, there may be greater 
preseenteism among adults with poor glycemic control. Finally, our findings imply that 
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their may be a linear relationship between HbA1c levels and mortality risk among males. 
In addition, strict glycemic control appears to be protective of mortality after a 6 to 12 
year follow-up among adults with diabetes, even after controlling for potential 
confounders including comorbidity, which contradicts recent reports.242 These main 
findings from this study summarized in figure 2 (shown below).  
 
Figure 2. A diagrammatic view of main study findings   
 Research Question 1:                                          Research Questions 2 and 3: 
 
Note: NS=non-significant; statistically significant findings appear in bold. 
Suboptimal/ 
Borderline/Poor 
Glycemic Control 
Working more 
hours 
Secondhand Smoke 
Exposure (NS) 
Desire to lose 
weight (NS) 
More days of 
inactivity and 
poor mental 
More missed work 
days (NS) 
Unemployment 
(NS) 
All-cause mortality 
prevented if strict 
glycemic control  
Being a service 
or blue collar 
worker (NS) 
More days of poor 
physical health 
Being a farm worker  
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Figure 3. A diagrammatic view of key recommendations for good glycemic control 
 
 
 
Good 
glycemic 
control 
Employer:  
o Provide workplace 
accommodations 
such as greater 
breaks and flexible 
schedules. 
o Provide workplace 
social support. 
o Gain 
understanding of 
true work 
performance 
issues of diabetics.  
Patient:  
o Communicate to 
both employer and 
healthcare 
provider about 
barriers related to 
work environment. 
o Gain awareness of 
rights as employee 
and consequences 
of poor glycemic 
control in terms of 
QOL. 
Healthcare provider:  
o Learn about the risk of poor 
metal health due to poor 
glycemic control; provide 
referral to mental health 
services if needed 
o Discuss with patient reasons 
for lack of adherence if that is 
the reason for poor glycemic 
control.  
o Educate the patient on how to 
manage diabetes at the 
workplace, discussing several 
medication options. 
o Discuss with patient about the 
potential protective effects of 
strict glycemic control on 
mortality risk.  
Public health professionals and researchers:  
o Develop, implement, and evaluate workplace policies 
and prevention programs. 
o Continue research to understand determinants of poor 
glycemic control as well as it consequences 
o Disseminate research findings related to the known and 
novel risk factors of poor glycemic control. 
o Educate employees on their roles in glycemic control. 
o Provide employees information on potential workplace 
accommodations. 
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 There are several implications and recommendations for employers, adults with 
diabetes and their primary healthcare providers, and public health advocates, 
professionals and researchers from our study findings. The key recommendations are 
presented in figure 3.  
 
Employers  
Given that work related factors appear to affect glycemic control, it is important 
to raise awareness among employers regarding issues that their employees with diabetes 
may have in terms of managing their diabetes. Employers should understand the benefits 
of having certain minor yet important workplace accommodations for their employees 
with diabetes. Such workplace accommodations, and as recommended by the American 
Diabetes Association,266 may include healthier food choices at work, private places to 
check blood sugars or self-administer insulin, greater or more frequent breaks, more 
flexible work-schedules including the option to take time off to be able to visit their 
diabetes educator or health care provider, and even provision of diabetes educational 
materials and/or educational items or prevention programs on good overall health 
practices such as exercise and diet.267  
Provision of workplace accommodations may be contingent on the workers with 
diabetes telling their employer of their illness. However, because of fear of work 
discrimination, the individual with diabetes may choose not to disclose their illness to the 
employer, even though such disclosure could result in employer support and workplace 
accommodations.268, 269 In fact, compared to individuals with other chronic conditions, 
individuals with diabetes may be particularly less likely to disclose their medical status 
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for various reasons such as loss of job, rejection by co-workers and employer, and 
discrimination.268 The employer may discriminate against an employee with diabetes due 
to the false perception that the employee cannot carry on a normal workload, may have 
reduced performance due to ill health, may have episodes of hypoglycemia or 
hyperglycemia that may lead to hazardous workplace situations, or the belief that these 
employees with diabetes may require costly special workplace accommodations. 
However, these reasons for discrimination are perhaps without merit. For example, 
studies have shown that individuals with diabetes perform well or even better in the job 
compared to individuals without diabetes.224, 270 In addition, hypoglycemic events during 
work are unlikely262, 271and if they do occur, they typically do not result in any significant 
disruptions at work,272 and are particularly less common among adults with type 2 
diabetes.208, 273 Thus, the notion that diabetes is an impediment in the workplace has to be 
rethought. However, as suggested from our findings, it may be that poor glycemic 
control, not necessarily diagnosis of diabetes, may results in poor work performance and 
productivity, given the reported greater days of inactivity. This further highlight’s the 
importance of workplace policies and programs aimed at supporting effective diabetes 
management.   
Furthermore, the importance of social support in the workplace needs to be 
underscored, since social support, especially among Hispanics, has resulted in 
improvements in diabetes management behavior.177, 179 In addition, social support 
provided by promotoras (i.e. community health workers) for farm workers has also been 
associated with reduced HbA1c levels as well as greater participation in diabetes support 
groups.171  
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According to the American Diabetes Association, good diabetes control costs 
approximately $24 a month, a much lower expense than the $115 a month it would cost 
the employer in medical expenditures and loss in productivity to have diabetic workers in 
poor health, including those experiencing diabetic complications.274 Thus, it may be cost-
effective for employers to understand the important role they in the diabetes management 
of their employees diagnosed with diabetes. From an economic point of view that 
stipulates that individual earnings are a result of the individual’s level of productivity,275 
inadequate diabetes management may result in lower income, which could further hinder 
the ability of the diabetic patient to purchase pharmacological agents or meals essential 
for proper diabetes management.  
 
Individuals with diabetes and their healthcare providers 
Given that long work hours or inflexible schedules are sometimes inevitable, 
certain accommodations should be considered for individuals with type 2 diabetes to 
make sure their blood glucose levels are normalized as much as possible. These 
accommodations may involve taking medications that have various duration of action or 
extended release properties based on work schedule. This may require keeping logs of the 
different work schedules and when each meal would be eaten, especially for workers with 
changing schedules.276, 277 For insulin-taking individuals with inflexible work schedules, 
awareness of the implications of such work schedule is important so that when speaking 
with their health care provider, the employee may be able to ask the physician about this 
concern and what actions should be taken to mitigate such consequences; this may 
include switching to different diabetes medication options and dosing regimens.278  
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Moreover, because some patients may be fearful of hypoglycemic episodes, 
which may lead to lack of adherence to treatment regimens,208, 272 patient education and 
strategies to prevent hypoglycemia is imperative. For example, the integration of coping 
strategies in order to provide the diabetic patient with a “sense of control” may be of 
great benefit in diabetes management programs.208  Furthermore, it may be beneficial to 
have diabetes self-management programs, particularly among those that are fearful of 
hypoglycemia as a consequence of strict diabetes regimens, as these programs have been 
shown to reduce the risk of hypoglycemia.279   
 In addition, health care provider or diabetes educators should take into account 
barriers to healthy food choices for an individual with diabetes, particularly barriers due 
to work factors such as break times, work hours, and food availability and/or place to 
store/prepare foods.280  Given that eating in a scheduled pattern or timely manner may not 
be feasible in certain occupations no matter how planned it is, it may be imperative to 
provide more tailored diabetes education. For example, one approach may be to educate 
how to adjust insulin based on the carbohydrate intake rather than carbohydrate intake 
based on insulin administration. A study among the Australian population showed that 
tailored eating program can result in benefits such as reduced HbA1c levels, minimal 
hypoglycemic episodes, and improved quality of life.281 
Diabetes management has been associated with a degree of burden and 
consequently perceived worse quality of life282 and techniques such as cognitive 
behavioral therapy, coping skills training, counseling, and patient empowerment 
programs have been found to be successful among individuals with diabetes.283-285 Thus, 
the use of these techniques in diabetes management programs is recommended. These 
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strategies may help off-set the feelings of emotional distress among adults with diabetes 
and consequent risk of poor adherence and poor glycemic control.286  However, since it 
has been suggested that primary health care providers may not know how to properly 
counsel a diabetic patient with poor mental health,286 referrals to professionals in the 
psychology or mental health field is recommended.   
 
Public health advocates and professionals 
Given the association between glycemic control and work-related factors and the 
fact that much of a person’s time is spent at work, the workplace should be an avenue in 
which to educate both employers and employees with diabetes about diabetes 
management. Workplace health programs have in fact been shown to be effective at 
improving health among employees.287  Furthermore, increasing the prevalence of health 
promotion programs in the US is one of the goals of Healthy People 2010.288 However, it 
is important that these worksite health promotion programs be available to all workers, 
which appears to not be the current situation. For example, one study found that non-
professional, Black, and less educated workers were less likely to report having received 
any sort of health promotion in the worksite.289 In addition, when these worksite health 
programs are available, certain workers, such as those workers receiving a higher salary 
and white collar workers appear more likely to participate than other workers.290, 291 The 
lack of participation in these worksite programs may be in part due to the work schedule 
of these individuals.292  Public health professionals should also work to address 
discrimination encountered by adults with diabetes that can hinder the proper 
management of diabetes.  
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To offset such discrimination, awareness of the rights of workers with diabetes 
and education of both the employers and employees should be required. This should  
entail proper education on the reality of living with diabetes as well as the legal 
terminology when speaking about individuals with chronic conditions including what the 
term “disability” means.293 When individuals with diabetes argue that they need special 
accommodations, assuming these are considered “reasonable”, the employers should 
provide them in accordance with the Americans with Disabilities Act (ADA). 267 
However, since this act is based on individuals with more clear cut disabilities such as 
blindness, diabetes is often times not considered a hindering disability or covered by this 
act, and there is lack of clarity of the rights of adults with diabetes.267, 293 Thus, changes 
to the ADA, such as clear statements regarding what constitutes a reasonable and 
justifiable accommodation for an adult with diabetes should be implemented.267 
Furthermore, policies such as insurance reimbursement of nutrition education services or 
free nutrition education among adults without insurance may prove to be beneficial since 
research has shown that adults with diabetes may not know the importance of nutrition 
and have been shown to not be compliant with visiting their dietitian; yet proper nutrition 
is key to diabetes management and improved patient prognosis.159  
 
Future research  
  Further research is needed however to clearly understand the mechanisms 
involved in the relationships between work hours, the type of occupation, and glycemic 
control. Such studies would benefit from including surveys or questionnaires that ask 
about several work related characteristics, such as shift-work, night shift, number of 
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breaks, degree of flexibility to take time off from work, and usual tasks at work. In 
addition, studies on the relationship between presenteeism and glycemic control are 
needed.  However this is contingent on the availability and feasibility of reliable 
measures of presenteeism.  
Moreover, research is needed to understand the mechanisms involved in the 
relationship between poor mental health and glycemic control. Finally, prospective and 
longitudinal studies assessing the risk of mortality due to various degrees of glycemic 
control among a nationally representative sample of adults are needed. These studies 
would benefit from recording data on the number of hospitalizations, diabetes 
complications, changes in diabetes treatment, and episodes of hypo and hyperglycemia, 
as well as repeated measures of HbA1c tests. 
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